"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. . "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. cytarabine. this classification denotes an antimetabolite, antineoplastic, antiviral agent, and immunosuppressive agent with the molecular formula c9h13n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 04079a1rdz, chemically known as 4-amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine but generally known as cytarabine, which bears us nih compound identifier 596. european medicines agency schedules cytarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06880mig. the term cytarabine is an international non-proprietary name. world health organization schedules cytarabine in its anatomical therapeutic chemical (atc) classification. most nations schedule cytarabine under hs 29349990 and sitc 51579. as of q4 2014, cytarabine remains the us fda preferred term for this commodity. cytarabine bears us nlm identifiers umls id c0010711 and nci concept code c408. smiles: o1c(n2ccc(nc2=o)n)c(o)c(o)c1co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. floxuridine. this classification denotes a pyrimidine antagonist with the molecular formula c9h11fn2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 039lu44i5m, chemically known as uridine, 2-deoxy-5-fluoro- but generally known as floxuridine, which bears us nih compound identifier 3363. european medicines agency schedules floxuridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07659mig. the term floxuridine is an international non-proprietary name. floxuridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule floxuridine under hs 29349990 and sitc 51579. as of q4 2014, floxuridine remains the us fda preferred term for this commodity. floxuridine bears us nlm identifiers umls id c0947603 and nci concept code c504. smiles: fc1cn(c2oc(c(o)c2)co)c(=o)[nh]c1=o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. hydroxycarbamide or hydroxyurea. this classification denotes a ribonucleotide reductase inhibitor and miscellaneous antimetabolite with the molecular formula ch4n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x6q56qn5qc, chemically known as urea, n-hydroxy- but generally known as hydroxycarbamide, which bears us nih compound identifier 3657. european medicines agency schedules hydroxycarbamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08076mig. the term hydroxycarbamide is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules hydroxycarbamide in its anatomical therapeutic chemical (atc) classification. hydroxycarbamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, hydroxyurea remains the us fda preferred term for this commodity. hydroxyurea bears us nlm identifiers umls id c0020402 and nci concept code c560. smiles: onc(=o)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. methotrexate. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula c20h22n8o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yl5fz2y5u1, chemically known as poly(imino((1s)-1-carboxy-4-oxo-1,4-butanediyl)), alpha-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-omega-hydroxy- but generally known as methotrexate, which bears us nih compound identifier 4112. european medicines agency schedules methotrexate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08856mig. the term methotrexate is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules methotrexate in its anatomical therapeutic chemical (atc) classification. methotrexate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methotrexate under hs 29335995 and sitc 51576. as of q4 2014, methotrexate remains the us fda preferred term for this commodity. methotrexate bears us nlm identifiers umls id c0025677 and nci concept code c642. smiles: oc(=o)c(nc(=o)c1ccc(n(cc2nc3c(nc2)nc(nc3n)n)c)cc1)ccc(=o)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. teniposide. this classification denotes an epipodophyllotoxin compound, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 957e6438qa. european medicines agency schedules teniposide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10895mig. teniposide generally arises in the molecular formula c32h32o13s. the term teniposide is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16.) teniposide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teniposide under hs 29389090 and sitc 54161. as of q4 2014, teniposide remains the us fda preferred term for this commodity. teniposide bears us nlm identifiers umls id c0039512 and nci concept code c857. smiles: s1c(c2oc3c(o)c(o)c(oc4c5c(c(c6c4cc4ococ4c6)c4cc(oc)c(o)c(oc)c4)c(=o)oc5)oc3co2)ccc1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. lenograstim. this classification denotes a recombinant protein and immunologic adjuvant with the molecular formula c9h14n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6ws4c399gb. european medicines agency schedules lenograstim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02888mig. the term lenograstim is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31.). world health organization schedules lenograstim in its anatomical therapeutic chemical (atc) classification. most nations schedule lenograstim under hs 30012010 and sitc 54162. as of q4 2014, lenograstim remains the us fda preferred term for this commodity. lenograstim bears us nlm identifiers umls id c0218640 and nci concept code c49234. smiles: n/a.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. glutathione. this classification denotes an antioxidant with the molecular formula c10h17n3o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gan16c9b8o, chemically known as glycine, n-(n-l-gamma-glutamyl-l-cysteinyl)- but generally known as glutathione, which bears us nih compound identifier 745. european medicines agency schedules glutathione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13990mig. world health organization schedules glutathione in its anatomical therapeutic chemical (atc) classification. as of q4 2014, glutathione remains the us fda preferred term for this commodity. glutathione bears us nlm identifiers umls id c0017817 and nci concept code c523. smiles: c(cc(=o)nc(cs)c(=o)ncc(=o)o)c(c(=o)o)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. gemcitabine. this classification denotes a ribonucleotide reductase inhibitor and pyrimidine antagonist with the molecular formula c9h11f2n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b76n6sbz8r, chemically known as 2-deoxy-.beta.-d-2,2-difluorocytidine but generally known as gemcitabine, which bears us nih compound identifier 60750. european medicines agency schedules gemcitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07892mig. the term gemcitabine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules gemcitabine in its anatomical therapeutic chemical (atc) classification. gemcitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gemcitabine under hs 29349990 and sitc 51579. as of q4 2014, gemcitabine remains the us fda preferred term for this commodity. gemcitabine bears us nlm identifiers umls id c0045093 and nci concept code c66876. smiles: fc1(f)c(o)c(oc1n1ccc(nc1=o)n)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. brequinar. this classification denotes a pyrimidine antagonist and dihydroorotate dehydrogenase inhibitor with the molecular formula c23h15f2no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 5xl19f49h6 chemically known as 4-quinolinecarboxylic acid, 6-fluoro-2-(2-fluoro(1,1-biphenyl)-4-yl)-3-methyl- but generally known as brequinar, which bears us nih compound identifier 57030. european medicines agency schedules brequinar in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05885mig. the term brequinar is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). most nations schedule brequinar under hs 29334990 and sitc 51575. as of q4 2014, brequinar remains the us fda preferred term for this commodity. brequinar bears us nlm identifiers umls id c0280509 and nci concept code c1560. smiles: cc1=c(n=c2c=cc(=cc2=c1c(=o)o)f)c3=cc=c(c=c3)c4=cc=cc=c4f.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. acadesine. this classification denotes a purine antagonist with the molecular formula c9h14n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 53ief47846, chemically known as 1h-imidazole-4-carboxamide, 5-amino-1-beta-d-ribofuranosyl- but generally known as acadesine, which bears us nih compound identifier 17513. acadesine most often appears in base and phosphate form. european medicines agency schedules acadesine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07365mig. the term acadesine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules acadesine in its anatomical therapeutic chemical (atc) classification. acadesine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acadesine under hs 29349990 and sitc 51579. as of q4 2014, acadesine remains the us fda preferred term for this commodity. acadesine bears us nlm identifiers umls id c0051027 and nci concept code c71537. smiles: o1c(n2c(n)c(nc2)c(=o)n)c(o)c(o)c1co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. acivicin. this classification denotes a glutamine amidotransferase inhibitor with the molecular formula c5h7cln2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o0x60k76i6, chemically known as 5-isoxazoleacetic acid, alpha-amino-3-chloro-4,5-dihydro-, (s-(r*,r*))- but generally known as acivicin, which bears us nih compound identifier 2007. european medicines agency schedules acivicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05241mig. the term acivicin is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). acivicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acivicin under hs 29349990 and sitc 51579. as of q4 2014, acivicin remains the us fda preferred term for this commodity. acivicin bears us nlm identifiers umls id c0050560 and nci concept code c986. smiles: clc1=noc(c(n)c(=o)o)c1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. adenine. this classification denotes a purine with the molecular formula c5h5n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jac85a2161, chemically known as 3,6-dihydro-6-iminopurine but generally known as adenine, which bears us nih compound identifier 190. adenine comes in many forms, including arabinoside, deoxyribonucleoside, deoxyribose, dihydroiodide, hemisulfate, hydrochloride, nucleoside, octosyl acid, phosphate, propenal, riboside, sulfate, and xyloside. european medicines agency schedules adenine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12455mig. most nations schedule adenine under hs 29335990 and sitc 51576. as of q4 2014, adenine remains the us fda preferred term for this commodity. adenine bears us nlm identifiers umls id c0001407 and nci concept code c206. smiles: [nh]1c2c(nc1)ncnc2n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. amonafide. this classification denotes a topoisomerase-ii inhibitor and intercalating agent with the molecular formula c16h17n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1q8d39n37l, chemically known as 3-amino-n-(2-(dimethylamino)ethyl)-1,8-naphthalindicarboximid but generally known as amonafide, which bears us nih compound identifier 50515. amonafide most often comes in base and dihydrochloride forms. european medicines agency schedules amonafide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05473mig. the term amonafide is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). amonafide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amonafide under hs 29251995 and sitc 51482. as of q4 2014, amonafide remains the us fda preferred term for this commodity. amonafide bears us nlm identifiers umls id c0126606 and nci concept code c71628. smiles: o=c1n(ccn(c)c)c(=o)c2c3c1cc(n)cc3ccc2.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. ancitabine. this classification denotes a pyrimidine antagonist with the molecular formula c9h11n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier do2d32w0vc, chemically known as 2,2-o-cyclocytidine but generally known as ancitabine, which bears us nih compound identifier 25051. ancitabine most often comes in base and hydrochloride forms. european medicines agency schedules ancitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05507mig. the term ancitabine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). ancitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ancitabine under hs 29349990 and sitc 51579. as of q4 2014, ancitabine remains the us fda preferred term for this commodity. ancitabine bears us nlm identifiers umls id cl406826 and nci concept code c80636. smiles: o1c2n3c(oc2c(o)c1co)nc(=n)cc3.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. azacitidine. this classification denotes a pyrimidine antagonist with the molecular formula c8h12n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m801h13nru, chemically known as 1,3,5-triazin-2 (1h)-one, 4-amino-1-.beta.-d-ribofuranosyl- but generally known as azacitidine, which bears us nih compound identifier 1805. european medicines agency schedules azacitidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05624mig. the term azacitidine is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules azacitidine in its anatomical therapeutic chemical (atc) classification. azacitidine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azacitidine under hs 29349990 and sitc 51579. as of q4 2014, azacitidine remains the us fda preferred term for this commodity. azacitidine bears us nlm identifiers umls id c0004475 and nci concept code c288. smiles: o1c(c(o)c(o)c1n1c(=o)nc(nc1)n)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. bexarotene. this classification denotes a retinoic acid agent with the molecular formula c24h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a61rxm4375, chemically known as 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid but generally known as bexarotene, which bears us nih compound identifier 82146. european medicines agency schedules bexarotene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00795mig. the term bexarotene is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules bexarotene in its anatomical therapeutic chemical (atc) classification. most nations schedule bexarotene under hs 29163900 and sitc 51379. as of q4 2014, bexarotene remains the us fda preferred term for this commodity. bexarotene bears us nlm identifiers umls id c0765273 and nci concept code c1635. smiles: oc(=o)c1ccc(c(=c)c2cc3c(ccc(c3cc2c)(c)c)(c)c)cc1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. doxifluridine. this classification denotes a pyrimidine antagonist with the molecular formula c9h11fn2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v1jk16y2jp, chemically known as 1-((4s,2r,3r,5r)-3,4-dihydroxy-5-methyloxolan-2-yl)-5-fluoro-1,3-dihydropyrimidine-2,4-dione but generally known as doxifluridine, which bears us nih compound identifier 18343. european medicines agency schedules doxifluridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06389mig. the term doxifluridine is an international non-proprietary name. doxifluridine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doxifluridine under hs 29349990 and sitc 51579. as of q4 2014, doxifluridine remains the us fda preferred term for this commodity. doxifluridine bears us nlm identifiers umls id c0048808 and nci concept code c978. smiles: fc1cn(c2oc(c(o)c2o)c)c(=o)[nh]c1=o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. carmofur. this classification denotes a pyrimidine antagonist with the molecular formula c11h16fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ha82m3rab2, chemically known as 2,4-dioxo-5-fluoro-n-hexyl-3,4-dihydro-1(2h)-pyrimidinecarboxamidme but generally known as carmofur, which bears us nih compound identifier 2577. european medicines agency schedules carmofur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06130mig. the term carmofur is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules carmofur in its anatomical therapeutic chemical (atc) classification. carmofur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carmofur under hs 29335995 and sitc 51576. as of q4 2014, carmofur remains the us fda preferred term for this commodity. carmofur bears us nlm identifiers umls id c0044401 and nci concept code c955. smiles: ccccccnc(=o)n1c=c(c(=o)nc1=o)f.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. clofarabine. this classification denotes a ribonucleotide reductase inhibitor and purine antagonist with the molecular formula c10h11clfn5o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 762rdy0y2h, chemically known as 9h-purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-d-arabinofuranosyl)- but generally known as clofarabine, which bears us nih compound identifier 119182. european medicines agency schedules clofarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21902. the term clofarabine is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 3, 2004, list 52). world health organization schedules clofarabine in its anatomical therapeutic chemical (atc) classification. most nations schedule clofarabine under hs 29349990 and sitc 51579. as of q4 2014, clofarabine remains the us fda preferred term for this commodity. clofarabine bears us nlm identifiers umls id c0092777 and nci concept code c26638. smiles: c1=nc2=c(n1c3c(c(c(o3)co)o)f)n=c(n=c2n)cl.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. decitabine. this classification denotes a fbxw4 gene with the molecular formula c8h12n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 776b62cq27, chemically known as 1,3,5-triazin-2(1h)-one, 4-amino-1-(2-deoxy-beta-d-erythro-pentofuranosyl)- but generally known as decitabine, which bears us nih compound identifier 16886. european medicines agency schedules decitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06932mig. the term decitabine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules decitabine in its anatomical therapeutic chemical (atc) classification. decitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule decitabine under hs 29349990 and sitc 51579. as of q4 2014, decitabine remains the us fda preferred term for this commodity. decitabine bears us nlm identifiers umls id c0049065 and nci concept code c981. smiles: o1c(c(o)cc1n1c(=o)nc(nc1)n)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. dezaguanine. this classification denotes a purine antagonist with the molecular formula c6h6n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9drb973hui, chemically known as 6-aminoimidazo(4,5-c)pyridin-4(5h)-one but generally known as dezaguanine, which bears us nih compound identifier 55710. european medicines agency schedules dezaguanine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07057mig. the term dezaguanine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). dezaguanine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dezaguanine under hs 29337900 and sitc 51561. as of q4 2014, dezaguanine remains the us fda preferred term for this commodity. dezaguanine bears us nlm identifiers umls id c0047332 and nci concept code c968. smiles: o=c1[nh]c(n)cc2[nh]cnc12.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. diflomotecan. this classification denotes a camptothecin analogue with the molecular formula c21h16f2n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qkt1lc4j1p, chemically known as 3h,15h-oxepino(3,4:6,7)indolizino(1,2-b)quinoline-3,15-dione, 5-ethyl-9,10-difluoro-1,4,5,13-tetrahydro-5-hydroxy-, (5r)- but generally known as diflomotecan, which bears us nih compound identifier 219023. the term diflomotecan is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations schedule diflomotecan under hs 29399900 and sitc 54149. as of q4 2014, diflomotecan remains the us fda preferred term for this commodity. diflomotecan bears us nlm identifiers umls id c1541796 and nci concept code c90824. smiles: cc[c@]1(cc(=o)occ2=c1c=c3c4=c(cn3c2=o)c=c5c=c(c(=cc5=n4)f)f)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. edatrexate. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula c22h25n7o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jt4x6z1hrr, chemically known as n-(p-(1-((2,4-diamino-6-pteridinyl)methyl)propyl)benzoyl)-l-glutamic acid but generally known as edatrexate, which bears us nih compound identifier 54586. european medicines agency schedules edatrexate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06454mig. the term edatrexate is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). edatrexate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule edatrexate under hs 29335995 and sitc 51576. as of q4 2014, edatrexate remains the us fda preferred term for this commodity. edatrexate bears us nlm identifiers umls id c0044667 and nci concept code c958. smiles: o=c(nc(ccc(=o)o)c(=o)o)c1ccc(c(cc2nc3c(nc2)nc(nc3n)n)cc)cc1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. emitefur. this classification denotes a pyrimidine antagonist with the molecular formula c28h19fn4o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9i50nf4aq2, chemically known as m-((3-(ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2h)-pyrimidinyl)carbonyl)benzoic acid, 2-ester with 2,6-dihydroxynicotinonitrile, benzoate but generally known as emitefur, which bears us nih compound identifier 65910. european medicines agency schedules emitefur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06508mig. the term emitefur is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). emitefur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule emitefur under hs 29335995 and sitc 51576. as of q4 2014, emitefur remains the us fda preferred term for this commodity. emitefur bears us nlm identifiers umls id c0053902 and nci concept code c1022. smiles: fc1cn(c(=o)n(c(=o)c2cc(ccc2)c(=o)oc2nc(oc(=o)c3ccccc3)ccc2c#n)c1=o)cocc.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. eniluracil. this classification denotes a pyrimidine antagonist and dihydropyrimidine dehydrogenase inhibitor with the molecular formula c6h4n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2e2w0w5xiu, chemically known as 2,4(1h,3h)-pyrimidinedione, 5-ethynyl- but generally known as eniluracil, which bears us nih compound identifier 43157. european medicines agency schedules eniluracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13674mig. the term eniluracil is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 1 1998, list 39). eniluracil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eniluracil under hs 29335995 and sitc 51576. as of q4 2014, eniluracil remains the us fda preferred term for this commodity. eniluracil bears us nlm identifiers umls id c0098361 and nci concept code c1773. smiles: o=c1[nh]c(=o)[nh]cc1c#c.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. enocitabine. this classification denotes a pyrimidine antagonist with the molecular formula c31h55n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9yvr68w306, chemically known as docosanamide,nucleoside deriv but generally known as enocitabine, which bears us nih compound identifier 3228. european medicines agency schedules enocitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06537mig. the term enocitabine is an international non-proprietary name. enocitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule enocitabine under hs 29349990 and sitc 51579. as of q4 2014, enocitabine remains the us fda preferred term for this commodity. enocitabine bears us nlm identifiers umls id c0059364 and nci concept code c1082. smiles: o1c(c(o)c(o)c1n1ccc(nc1=o)nc(=o)ccccccccccccccccccccc)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. evandamine. this classification denotes a lipooxygenase inhibitor with the molecular formula c11h16n4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zg2l2878md, chemically known as (- )-2-(3-amino-5-methyl-2-pyrazolin-1-yl)-4,5,6,7-tetrahydrobenzothiazole. but generally known as evandamine, which bears us nih compound identifier 3038554. european medicines agency schedules evandamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07353mig. the term evandamine is an international non-proprietary name. evandamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule evandamine under hs 29341000 and sitc 51579. as of q4 2014, evandamine remains the us fda preferred term for this commodity. evandamine bears us nlm identifiers umls id c1880595 and nci concept code c65604. smiles: cc1cc(=nn1c2=nc3=c(s2)cccc3)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. exatecan. this classification denotes a camptothecin analogue with the molecular formula c24h22fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oc71pp0f89, chemically known as 10h,13h-benzo(de)pyrano(3,4:6,7)indolizino(1,2-b)quinoline-10,13-dione, 1-amino-9-ethyl-5-fluoro-1,2,3,9,12,15-hexahydro-9-hydroxy-4-methyl-, (1s-trans)- but generally known as exatecan, which bears us nih compound identifier 151115. the term exatecan is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). most nations schedule exatecan under hs 29399900 and sitc 54149. as of q4 2014, exatecan remains the us fda preferred term for this commodity. exatecan bears us nlm identifiers umls id c0965941 and nci concept code c66720. smiles: ccc1(c2=c(coc1=o)c(=o)n3cc4=c5c(ccc6=c5c(=cc(=c6c)f)n=c4c3=c2)n)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. fazarabine. this classification denotes a pyrimidine antagonist with the molecular formula c8h12n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5v71d8jokk, chemically known as 1,3,5-triazin-2 (1h)-one, 4-amino-1-.beta.-d-ribofuranosyl- but generally known as fazarabine, which bears us nih compound identifier 1805. european medicines agency schedules fazarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07517mig. the term fazarabine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). fazarabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fazarabine under hs 29349990 and sitc 51579. as of q4 2014, fazarabine remains the us fda preferred term for this commodity. fazarabine bears us nlm identifiers umls id c0060103 and nci concept code c1096. smiles: o1c(c(o)c(o)c1n1c(=o)nc(nc1)n)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. masoprocol. this classification denotes a lipooxygenase inhibitor and antioxidant with the molecular formula c18h22o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7bo8g1byqu, chemically known as 1,2-benzenediol, 4,4-(2,3-dimethyl-1,4-butanediyl)bis-, (r*,s*)- but generally known as masoprocol, which bears us nih compound identifier 71398. european medicines agency schedules masoprocol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08652mig. the term masoprocol is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules masoprocol in its anatomical therapeutic chemical (atc) classification. masoprocol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule masoprocol under hs 29072900 and sitc 51243. as of q4 2014, masoprocol remains the us fda preferred term for this commodity. masoprocol bears us nlm identifiers umls id c0733397 and nci concept code c701. smiles: oc1cc(cc(c(cc2cc(o)c(o)cc2)c)c)ccc1o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. galocitabine. this classification denotes a pyrimidine antagonist with the molecular formula c19h22fn3o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x9788xi79o, chemically known as 5-deoxy-5-fluoro-n-(3,4,5-trimethoxybenzoyl)cytidine but generally known as galocitabine, which bears us nih compound identifier 65950. european medicines agency schedules galocitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07875mig. the term galocitabine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). galocitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule galocitabine under hs 29349990 and sitc 51579. as of q4 2014, galocitabine remains the us fda preferred term for this commodity. galocitabine bears us nlm identifiers umls id c0084382 and nci concept code c73254. smiles: fc1cn(c2oc(c(o)c2o)c)c(=o)nc1nc(=o)c1cc(oc)c(oc)c(oc)c1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. irinotecan. this classification denotes a camptothecin analogue with the molecular formula c33h38n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7673326042, chemically known as irinotecan, cpt-11 but generally known as irinotecan, which bears us nih compound identifier 60838. european medicines agency schedules irinotecan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08295mig. the term irinotecan is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules irinotecan in its anatomical therapeutic chemical (atc) classification. irinotecan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule irinotecan under hs 29399900 and sitc 54149. as of q4 2014, irinotecan remains the us fda preferred term for this commodity. irinotecan bears us nlm identifiers umls id c0123931 and nci concept code c62040. smiles: o(c(=o)n1ccc(n2ccccc2)cc1)c1cc2c(c3cn4c(c3nc2cc1)cc1c(o)(cc)c(=o)occ1c4=o)cc.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. ketotrexate. this classification denotes a folate antagonist with the molecular formula c21h27n7o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 504rn634mm, chemically known as n-(p-((2-(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)ethyl)amino)benzoyl)-l-glutamic acid but generally known as ketotrexate, which bears us nih compound identifier 68691. european medicines agency schedules ketotrexate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08378mig. the term ketotrexate is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). ketotrexate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ketotrexate under hs 29335995 and sitc 51576. as of q4 2014, ketotrexate remains the us fda preferred term for this commodity. ketotrexate bears us nlm identifiers umls id c2697842 and nci concept code c77403. smiles: o=c1nc([nh]c2ncc(n(c12)c)ccnc1ccc(cc1)c(=o)nc(ccc(=o)o)c(=o)o)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. lonidamine. this classification denotes a radiosensitizing agent and multidrug resistance modulator with the molecular formula c15h10cl2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u78804bidr, chemically known as 1h-indazole-3-carboxylic acid, 1-((2,4-dichlorophenyl)methyl)- (9ci) but generally known as lonidamine, which bears us nih compound identifier 39562. european medicines agency schedules lonidamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08571mig. the term lonidamine is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules lonidamine in its anatomical therapeutic chemical (atc) classification. lonidamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lonidamine under hs 29339990 and sitc 51577. as of q4 2014, lonidamine remains the us fda preferred term for this commodity. lonidamine bears us nlm identifiers umls id c0065175 and nci concept code c1146. smiles: clc1c(cn2nc(c3c2cccc3)c(=o)o)ccc(cl)c1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. pralatrexate. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula c23h23n7o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a8q8i19q20, more generally known as pralatrexate. european medicines agency schedules pralatrexate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32989. the term pralatrexate is an international non-proprietary name or inn. see who inn reference publication, volume 19, no. 3, 2005, list 54. most nations schedule pralatrexate under hs 29335995 and sitc 51576. as of q4 2014, pralatrexate remains the us fda preferred term for this commodity. pralatrexate bears us nlm identifiers umls id c0879404 and nci concept code c2250. smiles: c#ccc(cc1=cn=c2c(=n1)c(=nc(=n2)n)n)c3=cc=c(c=c3)c(=o)nc(ccc(=o)o)c(=o)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. nelarabine. this classification denotes a purine antagonist with the molecular formula c11h15n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 60158cv180, chemically known as 9h-purin-2-amine, 9beta-d-arabinofuranosyl-6-methyl- but generally known as nelarabine, which bears us nih compound identifier 151121. european medicines agency schedules nelarabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09188mig. world health organization schedules nelarabine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, nelarabine remains the us fda preferred term for this commodity. nelarabine bears us nlm identifiers umls id c0907349 and nci concept code c1704. smiles: coc1=nc(=nc2=c1n=cn2c3c(c(c(o3)co)o)o)n. .. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. nolatrexed. this classification denotes a thymidylate synthase inhibitor and folate antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k75zun743q. european medicines agency schedules nolatrexed in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09342mig. nolatrexed generally arises in the molecular formula c14h12n4os. the term nolatrexed is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40.) nolatrexed is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nolatrexed under hs 29335995 and sitc 51576. as of q4 2014, nolatrexed remains the us fda preferred term for this commodity. smiles: s(c1c2c([nh]c(nc2=o)n)ccc1c)c1ccncc1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. oteracil. this classification denotes a pyrimidine antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5vt6420tig. european medicines agency schedules oteracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30899. oteracil generally arises in the molecular formula c4h3n3o4. the term oteracil is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42.) most nations schedule oteracil under hs 29336980 and sitc 51576. as of q4 2014, oteracil remains the us fda preferred term for this commodity. oteracil bears us nlm identifiers umls id c0030032 and nci concept code c76917. smiles: c1(=nc(=o)nc(=o)n1)c(=o)[o-].[k+].. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. peldesine. this classification denotes a purine nucleoside phosphorylase inhibitor with the molecular formula c12h11n5o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7b646rj70f, chemically known as 4h-pyrrolo(3,2-d)pyrimidin-4-one, 2-amino-3,5-dihydro-7-(3-pyridinylmethyl)- but generally known as peldesine, which bears us nih compound identifier 60817. european medicines agency schedules peldesine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09649mig. the term peldesine is an international non-proprietary name. peldesine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule peldesine under hs 29335995 and sitc 51576. as of q4 2014, peldesine remains the us fda preferred term for this commodity. peldesine bears us nlm identifiers umls id c0338278 and nci concept code c1650. smiles: c1=cc(=cn=c1)cc2=cnc3=c2nc(=nc3=o)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. pemetrexed. this classification denotes a thymidylate synthase inhibitor and folate antagonist with the molecular formula c20h21n5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 04q9aiz7no, chemically known as n-(4-(2-(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid but generally known as pemetrexed, which bears us nih compound identifier 60843. european medicines agency schedules pemetrexed in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09655mig. the term pemetrexed is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules pemetrexed in its anatomical therapeutic chemical (atc) classification. pemetrexed is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pemetrexed under hs 29335995 and sitc 51576. as of q4 2014, pemetrexed remains the us fda preferred term for this commodity. pemetrexed bears us nlm identifiers umls id c0210657 and nci concept code c61614. smiles: o=c1nc([nh]c2[nh]cc(ccc3ccc(cc3)c(=o)nc(ccc(=o)o)c(=o)o)c12)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. pirazofurin or pyrazofurin. this classification denotes a pyrimidine antagonist and orotidylate decarboxylase inhibitor with the molecular formula c9h13n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4b15044gqz, chemically known as 1h-pyrazole-5-carboxamide, 4-hydroxy-3-beta-d-ribofuranosyl- but generally known as pirazofurin, which bears us nih compound identifier 5360877. european medicines agency schedules pirazofurin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09897mig. the term pirazofurin is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). pirazofurin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. pirazofurin or pyrazofurin bears us nlm identifiers umls id c0072661 and nci concept code c1208. smiles: c(c1c(c(c(o1)c2=nnc(=c(n)o)c2=o)o)o)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. piritrexim. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula c17h19n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, mk2a783zut chemically known as 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido(2,3-d)pyrimidine but generally known as piritrexim, which bears us nih compound identifier 54369. european medicines agency schedules piritrexim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09921mig. the term piritrexim is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). most nations schedule piritrexim under hs 29335995 and sitc 51576. as of q4 2014, piritrexim remains the us fda preferred term for this commodity. piritrexim bears us nlm identifiers umls id c0054332 and nci concept code c1031. smiles: cc1=c2c(=nc(=nc2=nc=c1cc3=c(c=cc(=c3)oc)oc)n)n.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. tocladesine. this classification denotes a purine antagonist and differentiation inducer with the molecular formula c10h11cln5o6p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bq94z7e5or, chemically known as 8-chloroadenosine 3,5-monophosphate but generally known as tocladesine, which bears us nih compound identifier 100299. most nations schedule tocladesine under hs 29349990 and sitc 51579. as of q4 2014, tocladesine remains the us fda preferred term for this commodity. tocladesine bears us nlm identifiers umls id c0050063 and nci concept code c2571. smiles: c1c2c(c(c(o2)n3c4=c(c(=nc=n4)n)n=c3cl)o)op(=o)(o1)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. raltitrexed. this classification denotes a thymidylate synthase inhibitor and folate antagonist with the molecular formula c21h22n4o6s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fcb9egg971, chemically known as n-(5-(n-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-n-methylamino)-2-thenoyl)-l-glutamic acid but generally known as raltitrexed, which bears us nih compound identifier 104758. european medicines agency schedules raltitrexed in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10244mig. the term raltitrexed is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules raltitrexed in its anatomical therapeutic chemical (atc) classification. raltitrexed is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule raltitrexed under hs 29349990 and sitc 51579. as of q4 2014, raltitrexed remains the us fda preferred term for this commodity. raltitrexed bears us nlm identifiers umls id c0677667 and nci concept code c1804. smiles: s1c(n(cc2cc3c([nh]c(nc3=o)c)cc2)c)ccc1c(=o)nc(ccc(=o)o)c(=o)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. rubitecan. this classification denotes a camptothecin analogue with the molecular formula c20h15n3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h19c446xxb, chemically known as 4-ethyl-4-hydroxy-9-nitro-1h-pyrano(3,4:6,7)indolizino(1,2-b)quinoline-3,14(4h,12h)-dione but generally known as rubitecan, which bears us nih compound identifier 123613. european medicines agency schedules rubitecan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33089. the term rubitecan is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule rubitecan under hs 29399900 and sitc 54149. as of q4 2014, rubitecan remains the us fda preferred term for this commodity. rubitecan bears us nlm identifiers umls id c0213800 and nci concept code c1485. smiles: o1cc2c(c(o)(cc)c1=o)cc1n(cc3c1nc1c(c3)c([n](=o)o)ccc1)c2=o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. tegafur. this classification denotes a thymidylate synthase inhibitor and pyrimidine antagonist with the molecular formula c8h9fn2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1548r74nsz, chemically known as 2,4(1h,3h)-pyrimidinedione, 5-fluoro-1-(tetrahydro-2-furanyl)-, (r)- but generally known as tegafur, which bears us nih compound identifier 5386. european medicines agency schedules tegafur in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10870mig. the term tegafur is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules tegafur in its anatomical therapeutic chemical (atc) classification. tegafur is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tegafur under hs 29349990 and sitc 51579. as of q4 2014, tegafur remains the us fda preferred term for this commodity. tegafur bears us nlm identifiers umls id c0016778 and nci concept code c513. smiles: fc1cn(c2occc2)c(=o)[nh]c1=o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. tezacitabine. this classification denotes a ribonucleotide reductase inhibitor and pyrimidine antagonist with the molecular formula c10h12fn3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7607y95n9s, chemically known as mdl 101,731 but generally known as tezacitabine, which bears us nih compound identifier 6435808. the term tezacitabine is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations schedule tezacitabine under hs 29349990 and sitc 51579. as of q4 2014, tezacitabine remains the us fda preferred term for this commodity. tezacitabine bears us nlm identifiers umls id c0253087 and nci concept code c1539. smiles: c1=cn(c(=o)n=c1n)c2c(=cf)c(c(o2)co)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. tiazofurin or tiazofurine. this classification denotes a purine antagonist and inosine monophosphate dehydrogenase inhibitor with the molecular formula c9h12n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ulj82834re, chemically known as 4-thiazolecarboxamide, 2-.beta.-d-ribofuranosyl- but generally known as tiazofurin, which bears us nih compound identifier 323701. european medicines agency schedules tiazofurin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27111. the term tiazofurine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules tiazofurin in its anatomical therapeutic chemical (atc) classification. as of q4 2014, tiazofurin remains the us fda preferred term for this commodity. tiazofurin bears us nlm identifiers umls id c0076656 and nci concept code c1254. smiles: s1c(nc(c1)c(=o)n)c1oc(c(o)c1o)co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. topotecan. this classification denotes a camptothecin analogue, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7m7ykx2n15. european medicines agency schedules topotecan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11191mig. topotecan generally arises in the molecular formula c23h23n3o5. the term topotecan is an international non-proprietary name or inn. topotecan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule topotecan under hs 29399900 and sitc 54149. as of q4 2014, topotecan remains the us fda preferred term for this commodity. topotecan bears us nlm identifiers umls id c0146224 and nci concept code c1413. smiles: o1cc2c(c(o)(cc)c1=o)cc1n(cc3c1nc1c(c3)c(cn(c)c)c(o)cc1)c2=o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. triciribine. this classification denotes a purine antagonist and inosine monophosphate dehydrogenase inhibitor and amidophosphoribosyltransferase inhibitor with the molecular formula c13h16n6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2421hmy9n6, chemically known as 1,4,5,6,8-pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-d-ribofuranosyl- (9ci) but generally known as triciribine, which bears us nih compound identifier 65399. european medicines agency schedules triciribine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11266mig. the term triciribine is an international non-proprietary name. triciribine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule triciribine under hs 29349990 and sitc 51579. as of q4 2014, triciribine remains the us fda preferred term for this commodity. smiles: o1c(n2c3ncnc4n(nc(n)c(c2)c34)c)c(o)c(o)c1co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. troxacitabine. this classification denotes a pyrimidine antagonist with the molecular formula c8h11n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 60kqz0388y, chemically known as 2(1h)-pyrimidinone, 4-amino-1-((2s,4s)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)- but generally known as troxacitabine, which bears us nih compound identifier 151173. european medicines agency schedules troxacitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22612. the term troxacitabine is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). most nations schedule troxacitabine under hs 29349990 and sitc 51579. as of q4 2014, troxacitabine remains the us fda preferred term for this commodity. troxacitabine bears us nlm identifiers umls id c0877874 and nci concept code c1438. smiles: o1c(n2ccc(nc2=o)n)coc1co.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. uracil. this classification denotes a pyrimidine with the molecular formula c4h4n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 56hh86zvct, chemically known as 2,4-pyrimidinedione but generally known as uracil, which bears us nih compound identifier 1174. european medicines agency schedules uracil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20762. most nations schedule uracil under hs 29335990 and sitc 51576. as of q4 2014, uracil remains the us fda preferred term for this commodity. uracil bears us nlm identifiers umls id c0041917 and nci concept code c917. smiles: o=c1[nh]c(=o)cc[nh]1.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. valopicitabine. this classification denotes a pyrimidine antagonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i2t0b5g94m. european medicines agency schedules valopicitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35614. valopicitabine generally arises in the molecular formula c15h24n4o6. the term valopicitabine is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55.) valopicitabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule valopicitabine under hs 29349990 and sitc 51579. as of q4 2014, valopicitabine remains the us fda preferred term for this commodity. valopicitabine bears us nlm identifiers umls id c1664150 and nci concept code c66649. smiles: o1c(n2ccc(nc2=o)n)c(o)(c(oc(=o)c(n)c(c)c)c1co)c.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. aminopterin. this classification denotes a folate antagonist and dihydrofolate reductase inhibitor with the molecular formula c19h20n8o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jyb41ctm2q, chemically known as folic acid, 4-amino- but generally known as aminopterin, which bears us nih compound identifier 2154. aminopterin most often comes in base, hydrate, n-hydroxysuccinimide ester, and sodium forms. european medicines agency schedules aminopterin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00464mig. aminopterin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, aminopterin remains the us fda preferred term for this commodity. aminopterin bears us nlm identifiers umls id c0002583 and nci concept code c235. smiles: oc(=o)c(nc(=o)c1ccc(ncc2nc3c(nc2)nc(nc3n)n)cc1)ccc(=o)o.. "
"antimetabolites. this classification denotes drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways.. thioguanine or tioguanine. this classification denotes a purine antagonist and amidophosphoribosyltransferase inhibitor with the molecular formula c5h5n5s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ftk8u1gznx, chemically known as 6h-purine-6-thione, 2-amino-1,7-dihydro- but generally known as thioguanine, which bears us nih compound identifier 2723601. european medicines agency schedules tioguanine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11084mig. world health organization schedules thioguanine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, thioguanine remains the us fda preferred term for this commodity. thioguanine bears us nlm identifiers umls id c0039902 and nci concept code c876. smiles: s=c1nc([nh]c2nc[nh]c12)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. . "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. daunorubicin citrate. this classification denotes an anthracycline antibiotic with the molecular formula c27h29no10.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5l84t2z6np. european medicines agency schedules daunorubicin citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22734. the term daunorubicin citrate is a u.s. fda designation. most nations schedule daunorubicin citrate under hs 29419000 and sitc 54139. as of q4 2014, daunorubicin citrate remains the us fda preferred term for this commodity. daunorubicin citrate bears us nlm identifiers umls id c1289972 and nci concept code c47471. smiles: cc1c(c(cc(o1)oc2cc(cc3=c(c4=c(c(=c23)o)c(=o)c5=c(c4=o)c=cc=c5oc)o)(c(=o)c)o)n)o.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. mitomycin. this classification denotes an alkylating agent, antibiotics, antineoplastic, cross-linking reagent, and nucleic acid synthesis inhibitor with the molecular formula c15h18n4o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50sg953sk6, chemically known as 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methylazirino(2,3:3,4)pyrrolo(1,2-a)indole-4,7-dione carbamate (ester) but generally known as mitomycin, which bears us nih compound identifier 5746. european medicines agency schedules mitomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09006mig. the term mitomycin is an international non-proprietary name. world health organization schedules mitomycin in its anatomical therapeutic chemical (atc) classification. mitomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mitomycin under hs 29419000 and sitc 54139. as of q4 2014, mitomycin remains the us fda preferred term for this commodity. mitomycin bears us nlm identifiers umls id c0002475 and nci concept code c1820. smiles: o(c12n(cc3nc13)c1=c(c2coc(=o)n)c(=o)c(=c(c1=o)c)n)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. deoxycoformycin or pentostatin. this classification denotes an adenosine deaminase inhibitor with the molecular formula c11h16n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 395575mzo7, chemically known as (r)-3-(2-deoxy-beta-d-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol but generally known as pentostatin, which bears us nih compound identifier 40926. european medicines agency schedules pentostatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09704mig. the term pentostatin is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules pentostatin in its anatomical therapeutic chemical (atc) classification. pentostatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. deoxycoformycin or pentostatin bears us nlm identifiers umls id c0030896 and nci concept code c732. smiles: c1c(c(oc1n2c=nc3=c2nc=ncc3o)co)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. rituximab. this classification denotes a monoclonal antibody with the molecular formula c6416h9874n1688o1987s44, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4f4x42syq6, more generally known as rituximab. european medicines agency schedules rituximab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12570mig. the term rituximab is an international non-proprietary name or inn. see who inn reference publication, volume 12 no. 1 1998, list 39. most nations schedule rituximab under hs 30021091 and sitc 54163. as of q4 2014, rituximab remains the us fda preferred term for this commodity. rituximab bears us nlm identifiers umls id c0732355 and nci concept code c1702. smiles: cc(=o)nc1c(c(c(oc1n)co)o)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. trastuzumab. this classification denotes a monoclonal antibody with the molecular formula c6470h10012n1726o2013s42, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p188anx8ck, more generally known as trastuzumab. european medicines agency schedules trastuzumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12612mig. the term trastuzumab is an international non-proprietary name or inn. see who inn reference publication, volume 12 no. 2 1999, list 40. trastuzumab is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trastuzumab under hs 30021091 and sitc 54163. as of q4 2014, trastuzumab remains the us fda preferred term for this commodity. trastuzumab bears us nlm identifiers umls id c0728747 and nci concept code c1647. smiles: cc(ccc(=o)o)c1ccc2c1(ccc3c2ccc4c3(ccc(c4)o)c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. anthramycin or antramycin. this classification denotes a miscellaneous antineoplastic antibiotic and dna minor groove binding agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0wzd9y66wn. european medicines agency schedules antramycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05531mig. anthramycin generally arises in the molecular formula c16h17n3o4. the term anthramycin is an international non-proprietary name or inn. anthramycin or antramycin bears us nlm identifiers umls id c0003167 and nci concept code c252. smiles: cc1=c(c2=c(c=c1)c(=o)n3c=c(cc3cn2)c=cc(=o)n)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. acodazole. this classification denotes an intercalating agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8m28a9o41g. european medicines agency schedules acodazole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05245mig. acodazole generally arises in the molecular formula c20h19n5o. the term acodazole is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) acodazole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acodazole under hs 29339990 and sitc 51577. as of q4 2014, acodazole remains the us fda preferred term for this commodity. acodazole bears us nlm identifiers umls id c0050565 and nci concept code c988. smiles: cl.o=c(n(c1ccc(nc2c3c4nc[nh]c4ccc3nc(c2)c)cc1)c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ambazone. this classification denotes an antineoplastic antibiotic with the molecular formula c8h11n7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier byk4592a3q, chemically known as 1,4-benzoquinone guanylhydrazone thiosemicarbazone but generally known as ambazone, which bears us nih compound identifier 1549158. european medicines agency schedules ambazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12841mig. the term ambazone is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules ambazone in its anatomical therapeutic chemical (atc) classification. ambazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ambazone under hs 29309085 and sitc 51549. as of q4 2014, ambazone remains the us fda preferred term for this commodity. ambazone bears us nlm identifiers umls id c0043983 and nci concept code c72627. smiles: s=c(/n=n/c1ccc(n/n=c(/n)n)cc1)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. amsacrine. this classification denotes an intercalating agent with the molecular formula c21h19n3o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 00dpd30soy, chemically known as methansulfon-m-aniside, 4-(9-acridinylamino)-, monohydrochloride but generally known as amsacrine, which bears us nih compound identifier 2179. amsacrine most often comes in hydrochloride and lactate forms. european medicines agency schedules amsacrine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05495mig. the term amsacrine is an international non-proprietary name. world health organization schedules amsacrine in its anatomical therapeutic chemical (atc) classification. amsacrine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amsacrine under hs 29350090 and sitc 51580. as of q4 2014, amsacrine remains the us fda preferred term for this commodity. amsacrine bears us nlm identifiers umls id c0591085 and nci concept code c240. smiles: s(=o)(=o)(nc1cc(oc)c(nc2c3c(nc4c2cccc4)cccc3)cc1)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. cabazitaxel. this classification denotes a taxane compound and taxane-site binding agent with the molecular formula c45h57no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51f690397j. european medicines agency schedules cabazitaxel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31282. the term cabazitaxel is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 3, 2008, list 60). most nations schedule cabazitaxel under hs 29329990 and sitc 51569. as of q4 2014, cabazitaxel remains the us fda preferred term for this commodity. cabazitaxel bears us nlm identifiers umls id c2830183 and nci concept code c66937. smiles: cc1=c2c(c(=o)c3(c(cc4c(c3c(c(c2(c)c)(cc1oc(=o)c(c(c5=cc=cc=c5)nc(=o)oc(c)(c)c)o)o)oc(=o)c6=cc=cc=c6)(co4)oc(=o)c)oc)c)oc.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. arsenic trioxide. this classification denotes a differentiation inducer, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s7v92p67ho. european medicines agency schedules arsenic trioxide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12467mig. arsenic trioxide generally arises in the molecular formula as2o3. the term arsenic trioxide is a united states adopted name designation. most nations schedule arsenic trioxide under hs 28112990 and sitc 52239. as of q4 2014, arsenic trioxide remains the us fda preferred term for this commodity. arsenic trioxide bears us nlm identifiers umls id c0052416 and nci concept code c1005. smiles: o1[as]2o[as]1o2.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. azotomycin. this classification denotes an antineoplastic antibiotic with the molecular formula c17h23n7o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6tqy580e8m, chemically known as l-norleucine, 6-diazo-n-(6-diazo-n-l-gamma-glutamyl-5-oxo-l-norleucyl)-5-oxo- but generally known as azotomycin, which bears us nih compound identifier 24281. azotomycin most often comes in base and sodium forms. the term azotomycin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). azotomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule azotomycin under hs 29419000 and sitc 54139. as of q4 2014, azotomycin remains the us fda preferred term for this commodity. azotomycin bears us nlm identifiers umls id c0052821 and nci concept code c28803. smiles: c(cc(=o)nc(ccc(=o)c1n=n1)c(=o)nc(ccc(=o)c2n=n2)c(=o)o)c(c(=o)o)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. bevacizumab. this classification denotes a monoclonal antibody anti-vegf with the molecular formula c6638h10160n1720o2108s44, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2s9zzm9q9v, more generally known as bevacizumab. european medicines agency schedules bevacizumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16402mig. the term bevacizumab is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45. most nations schedule bevacizumab under hs 30021091 and sitc 54163. smiles:. as of q4 2014, bevacizumab remains the us fda preferred term for this commodity. . bevacizumab bears us nlm identifiers umls id c0796392 and nci concept code c2039.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. bisantrene. this classification denotes an anthraquinone compound with the molecular formula c22h22n8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 39c34m111k, chemically known as 9,10-anthracenedicarboxaldehyde, bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)- but generally known as bisantrene, which bears us nih compound identifier 5351322. bisantrene most often comes in base, dihydrochloride, and hydrochloride forms. european medicines agency schedules bisantrene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05847mig. the term bisantrene is an international non-proprietary name. bisantrene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bisantrene under hs 29332990 and sitc 51573. as of q4 2014, bisantrene remains the us fda preferred term for this commodity. bisantrene bears us nlm identifiers umls id c0053776 and nci concept code c1019. smiles: n1ccn=c1n/n=c/c1c2c(c(c3c1cccc3)/c=n/nc1=nccn1)cccc2.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. bleomycin. this classification denotes a bleomycin antibiotic with the molecular formula c55h84n17o21s3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40s1vhn69b, more generally known as bleomycin. european medicines agency schedules bleomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00842mig. the term bleomycin is an international non-proprietary name or inn. most nations schedule bleomycin under hs 29419000 and sitc 54139. as of q4 2014, bleomycin remains the us fda preferred term for this commodity. bleomycin bears us nlm identifiers umls id c0005740 and nci concept code c313. smiles: cc1=c(n=c(n=c1n)c(cc(=o)n)ncc(c(=o)n)n)c(=o)nc(c(c2=cn=cn2)oc3c(c(c(c(o3)co)o)o)oc4c(c(c(c(o4)co)o)oc(=o)n)o)c(=o)nc(c)c(c(c)c(=o)nc(c(c)o)c(=o)nccc5=nc(=cs5)c6=nc(=cs6)c(=o)nccc[s+](c)c)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. butantrone. this classification denotes an anthraquinone compound with the molecular formula c18h16o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9p148iba8m, chemically known as 10-butyryl-1,8-dihydroxyanthrone but generally known as butantrone, which bears us nih compound identifier 53271. european medicines agency schedules butantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06006mig. the term butantrone is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). butantrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule butantrone under hs 29145000 and sitc 51629. as of q4 2014, butantrone remains the us fda preferred term for this commodity. butantrone bears us nlm identifiers umls id c0044655 and nci concept code c74164. smiles: o=c(c1c2c(c(=o)c3c1cccc3o)c(o)ccc2)ccc.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. cemadotin. this classification denotes a vinca-site binding agent with the molecular formula c35h56n6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6sq8m7zsfv, chemically known as l-prolinamide, n,n-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-n-(phenylmethyl)- but generally known as cemadotin, which bears us nih compound identifier 178028. european medicines agency schedules cemadotin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07438mig. the term cemadotin is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). cemadotin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cemadotin under hs 29339990 and sitc 51577. as of q4 2014, cemadotin remains the us fda preferred term for this commodity. cemadotin bears us nlm identifiers umls id c0754175 and nci concept code c75875. smiles: o=c(n(c(=o)c1n(ccc1)cc1ccccc1)c(=o)c(nc(=o)c(n(c)c)c(c)c)c(c)c)c1n(ccc1)c(=o)c(nc)c(c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. cetuximab. this classification denotes a monoclonal antibody with the molecular formula c6484h10042n1732o2023s36, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pqx0d8j21j, more generally known as cetuximab. european medicines agency schedules cetuximab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01178mig. the term cetuximab is an international non-proprietary name or inn. see who inn reference publication, volume 14, no. 3, 2000, list 44. most nations schedule cetuximab under hs 30021091 and sitc 54163. as of q4 2014, cetuximab remains the us fda preferred term for this commodity. cetuximab bears us nlm identifiers umls id c0995188 and nci concept code c1723. smiles: cc(=o)nc1c(c(c(oc1n)co)o)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. crisnatol. this classification denotes an intercalating agent with the molecular formula c23h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 2j71ur51ue chemically known as 1,3-propanediol, 2-((6-chrysenylmethyl)amino)-2-methyl- but generally known as crisnatol, which bears us nih compound identifier 57062. european medicines agency schedules crisnatol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06820mig. the term crisnatol is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28). most nations schedule crisnatol under hs 29221980 and sitc 51461. as of q4 2014, crisnatol remains the us fda preferred term for this commodity. crisnatol bears us nlm identifiers umls id c0056493 and nci concept code c81191. smiles: cc(co)(co)ncc1=cc2=c(c=cc3=cc=cc=c32)c4=cc=cc=c41.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. datelliptium. this classification denotes an intercalating agent with the molecular formula c23h28n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l374y6we0d, chemically known as 2-(2-(diethylamino)ethyl)-9-hydroxy-5,11-dimethyl-6h-pyrido(4,3-b)carbazolium but generally known as datelliptium, which bears us nih compound identifier 72035. european medicines agency schedules datelliptium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06916mig. the term datelliptium is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). as of q4 2014, datelliptium remains the us fda preferred term for this commodity. datelliptium bears us nlm identifiers umls id c0057571 and nci concept code c83649. smiles: ccn(cc)cc[n+]1=cc2=c(c=c1)c(=c3c(=c2c)c4=c(n3)c=cc(=c4)o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. etoposide. this classification denotes an epipodophyllotoxin compound, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6plq3cp4p3. european medicines agency schedules etoposide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07337mig. etoposide generally arises in the molecular formula c29h32o13. the term etoposide is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16.) etoposide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etoposide under hs 29389090 and sitc 54161. as of q4 2014, etoposide remains the us fda preferred term for this commodity. etoposide bears us nlm identifiers umls id c0015133 and nci concept code c491. smiles: o(c1c2c(c(c3c1cc1ococ1c3)c1cc(oc)c(o)c(oc)c1)c(=o)oc2)c1oc2c(oc(oc2)c)c(o)c1o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. daunorubicin hydrochloride. this classification denotes an anthracycline antibiotic with the molecular formula c27h29no10.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ud984i04lz, chemically known as 5,12-naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, radical ion(1-), (8s,10s)- but generally known as daunorubicin hydrochloride, which bears us nih compound identifier 2958. european medicines agency schedules daunorubicin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01556mig. most nations schedule daunorubicin hydrochloride under hs 29419000 and sitc 54139. as of q4 2014, daunorubicin hydrochloride remains the us fda preferred term for this commodity. daunorubicin hydrochloride bears us nlm identifiers umls id c0701062 and nci concept code c1583. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)c)c1oc(c(o)c(n)c1)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. demecolcine. this classification denotes a colchicine-site binding agent with the molecular formula c21h25no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z01ive25ki, chemically known as 6,7-dihydro-1,2,3,10-tetramethoxy-7-(methylamino)-benzo(alpha)heptalen-9(5h)-one but generally known as demecolcine, which bears us nih compound identifier 2832. european medicines agency schedules demecolcine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06964mig. the term demecolcine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules demecolcine in its anatomical therapeutic chemical (atc) classification. demecolcine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule demecolcine under hs 29399900 and sitc 54149. as of q4 2014, demecolcine remains the us fda preferred term for this commodity. demecolcine bears us nlm identifiers umls id c0011259 and nci concept code c419. smiles: o(c1c2c(ccc(nc)c3c2ccc(oc)c(=o)c3)cc(oc)c1oc)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. eribulin. this classification denotes a ketones and halichondrin b derivative and antimitotic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lr24g6354g. european medicines agency schedules eribulin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub31134. eribulin generally arises in the molecular formula c40h59no11. the term eribulin is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 1, 2008, list 59.) as of q4 2014, eribulin remains the us fda preferred term for this commodity. eribulin bears us nlm identifiers umls id c2350866 and nci concept code c96748. smiles: cc1cc2ccc3c(=c)cc(o3)ccc45cc6c(o4)c7c(o6)c(o5)c8c(o7)ccc(o8)cc(=o)cc9c(cc(c1=c)o2)oc(c9oc)cc(cn)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. medorubicin. this classification denotes an anthracycline antibiotic with the molecular formula c26h27no10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nu158dgh9e, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-9-(hydroxyacetyl)-6,9,11-trihydroxy-, (7s-cis)- but generally known as medorubicin, which bears us nih compound identifier 68837. european medicines agency schedules medorubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08695mig. the term medorubicin is an international non-proprietary name. medorubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule medorubicin under hs 29419000 and sitc 54139. as of q4 2014, medorubicin remains the us fda preferred term for this commodity. medorubicin bears us nlm identifiers umls id c0048224 and nci concept code c87599. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)cccc2)c(=o)co)c1oc(c(o)c(n)c1)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. galarubicin. this classification denotes an anthracycline antibiotic with the molecular formula c30h32fno13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6f39648e92, chemically known as (8s,10s)-10-((2.6-dideoxy-2-fluoro-alpha-l-talopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 8(2)-ester with beta-alanine. but generally known as galarubicin, which bears us nih compound identifier 219086. european medicines agency schedules galarubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02302mig. the term galarubicin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule galarubicin under hs 29419000 and sitc 54139. as of q4 2014, galarubicin remains the us fda preferred term for this commodity. galarubicin bears us nlm identifiers umls id c2825624 and nci concept code c81422. smiles: fc1c(oc2cc(o)(cc3c2c(o)c2c(c3o)c(=o)c3c(c2=o)c(oc)ccc3)c(=o)coc(=o)ccn)oc(c(o)c1o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. gemtuzumab. this classification denotes an anti-cd33 immunotoxin, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8gzg754x6m. european medicines agency schedules gemtuzumab ozogamicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20794. gemtuzumab generally arises in the molecular formula c73h96in6o25s3. the term gemtuzumab is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45.) most nations schedule gemtuzumab under hs 30021091 and sitc 54163. smiles:. as of q4 2014, gemtuzumab remains the us fda preferred term for this commodity. .. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ipilimumab. this classification denotes a monoclonal antibody with the molecular formula c6472h9972n1732o2004s40, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6t8c155666, more generally known as ipilimumab. european medicines agency schedules ipilimumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29397. the term ipilimumab is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56. most nations schedule ipilimumab under hs 30021020 and sitc 54163. smiles:. as of q4 2014, ipilimumab remains the us fda preferred term for this commodity. . ipilimumab bears us nlm identifiers umls id c1367202 and nci concept code c2654.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ixabepilone. this classification denotes an epothilone b analogue with the molecular formula c27h42n2o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k27005np0a, chemically known as 17-oxa-4-azabicyclo(14.1.0)heptadecane-5,9-dione, 7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-((1e)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)-, (1s,3s,7s,10r,11s,12s,16r)- but generally known as ixabepilone, which bears us nih compound identifier 6445540. european medicines agency schedules ixabepilone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16422mig. the term ixabepilone is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 1, 2004, list 51). world health organization schedules ixabepilone in its anatomical therapeutic chemical (atc) classification. most nations schedule ixabepilone under hs 29419000 and sitc 54139. as of q4 2014, ixabepilone remains the us fda preferred term for this commodity. ixabepilone bears us nlm identifiers umls id c1135132 and nci concept code c37452. smiles: s1cc(nc1c)/c=c(/c1nc(=o)cc(o)c(c(=o)c(c(o)c(cccc2(oc2c1)c)c)c)(c)c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ladirubicin. this classification denotes an anthracycline antibiotic with the molecular formula c29h31no11s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u395ero49h. the term ladirubicin is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45. ). most nations schedule ladirubicin under hs 29419000 and sitc 54139. as of q4 2014, ladirubicin remains the us fda preferred term for this commodity. ladirubicin bears us nlm identifiers umls id c2827222 and nci concept code c83861. smiles: cc1c(c(cc(o1)oc2cc(cc3=c(c4=c(c(=c23)o)c(=o)c5=cc=cc=c5c4=o)o)(c(=o)c)o)n6cc6)os(=o)(=o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. leurubicin. this classification denotes an anthracycline antibiotic with the molecular formula c33h40n2o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1z20mgk851, chemically known as (8s,10s)-10-((3-((s)-2-amino-4-methylvaleramido)-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione but generally known as leurubicin, which bears us nih compound identifier 68897. european medicines agency schedules leurubicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08450mig. the term leurubicin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). leurubicin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule leurubicin under hs 29419000 and sitc 54139. as of q4 2014, leurubicin remains the us fda preferred term for this commodity. leurubicin bears us nlm identifiers umls id c2825623 and nci concept code c81421. smiles: o(c1cc(o)(cc2c1c(o)c1c(c2o)c(=o)c2c(c1=o)c(oc)ccc2)c(=o)co)c1oc(c(o)c(nc(=o)c(n)cc(c)c)c1)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. losoxantrone. this classification denotes an anthrapyrazole antibiotic with the molecular formula c22h27n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47kph00809, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 7-hydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-((2-hydroxyethyl)amino)ethyl)amino)- but generally known as losoxantrone, which bears us nih compound identifier 72116. european medicines agency schedules losoxantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08597mig. the term losoxantrone is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). losoxantrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule losoxantrone under hs 29339990 and sitc 51577. as of q4 2014, losoxantrone remains the us fda preferred term for this commodity. losoxantrone bears us nlm identifiers umls id c0245032 and nci concept code c1521. smiles: o=c1c2c3c(n(nc3c3c1c(o)ccc3)ccncco)ccc2nccncco.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ortetamine. this classification denotes an anorexiant with the molecular formula c10h15n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vf4n11kkkr, chemically known as 1,1-dimethyl-2-phenylethylamine but generally known as ortetamine, which bears us nih compound identifier 4771. european medicines agency schedules ortetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09472mig. the term ortetamine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). ortetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ortetamine under hs 29214980 and sitc 51454. as of q4 2014, ortetamine remains the us fda preferred term for this commodity. ortetamine bears us nlm identifiers umls id c2698659 and nci concept code c75115. smiles: cc(c)(cc1=cc=cc=c1)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. menogaril. this classification denotes an anthracycline antibiotic with the molecular formula c28h31no10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8jsv4o30hq, chemically known as 2,6-epoxy-2h-naphthaceno(1,2-b)oxocin-9,16-dione, 4-(dimethylamino)-3,4,5,6,11,12,13,14-octahydro-3,5,8,10,13-pentahydroxy-11-methoxy-6,13-dimethyl-, (2r-(2alpha,3beta,4alpha,5beta,6alpha,11alpha,13alpha))- but generally known as menogaril, which bears us nih compound identifier 51370. european medicines agency schedules menogaril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08742mig. the term menogaril is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). menogaril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule menogaril under hs 29419000 and sitc 54139. as of q4 2014, menogaril remains the us fda preferred term for this commodity. menogaril bears us nlm identifiers umls id c0127527 and nci concept code c1389. smiles: o1c2(c(o)c(n(c)c)c(o)c1oc1c2cc(o)c2c1c(=o)c1c(c2=o)c(o)c2c(oc)cc(o)(cc2c1)c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. mitoguazone. this classification denotes a s-adenosyl-methionine decarboxylase inhibitor and polyamine inhibitory agent with the molecular formula c5h12n8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier od5q0l447w, chemically known as 1,1-((methylethanediylidene)dinitrilo)diguanidine but generally known as mitoguazone, which bears us nih compound identifier 5351154. european medicines agency schedules mitoguazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09004mig. the term mitoguazone is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules mitoguazone in its anatomical therapeutic chemical (atc) classification. mitoguazone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mitoguazone under hs 29252900 and sitc 51482. as of q4 2014, mitoguazone remains the us fda preferred term for this commodity. mitoguazone bears us nlm identifiers umls id c0026251 and nci concept code c661. smiles: n(=c(\\c)/c=n/n=c(/n)n)\\n=c(\\n)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. mitonafide. this classification denotes an intercalating agent with the molecular formula c16h15n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 06q0v17si9, chemically known as 2-((dimethylamino)ethyl)-2,3-dihydro-5-nitro-2-azaphenalen-1,3-dion but generally known as mitonafide, which bears us nih compound identifier 41202. european medicines agency schedules mitonafide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09007mig. the term mitonafide is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). mitonafide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mitonafide under hs 29251995 and sitc 51482. as of q4 2014, mitonafide remains the us fda preferred term for this commodity. mitonafide bears us nlm identifiers umls id c0066614 and nci concept code c66165. smiles: o=c1[nh]c(=o)c2c3c1c(ccn(c)c)ccc3c([n](=o)o)cc2.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. nogalamycin. this classification denotes an anthracycline antibiotic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l059dcd6ip. european medicines agency schedules nogalamycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09341mig. nogalamycin generally arises in the molecular formula c39h49no16. the term nogalamycin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) nogalamycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nogalamycin under hs 29419000 and sitc 54139. as of q4 2014, nogalamycin remains the us fda preferred term for this commodity. nogalamycin bears us nlm identifiers umls id c0028261 and nci concept code c700. smiles: o1c2(c(o)c(n(c)c)c(o)c1oc1c2cc(o)c2c1c(=o)c1c(c(o)c3c(oc4oc(c(oc)c(oc)(c4oc)c)c)cc(o)(c(c3c1)c(=o)oc)c)c2=o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ofatumumab. this classification denotes a monoclonal antibody with the molecular formula c6480h10022n1742o2020s44, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m95kg522r0, more generally known as ofatumumab. european medicines agency schedules ofatumumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25221. the term ofatumumab is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55. ofatumumab is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ofatumumab under hs 30021091 and sitc 54163. smiles:. as of q4 2014, ofatumumab remains the us fda preferred term for this commodity. . ofatumumab bears us nlm identifiers umls id c1832027 and nci concept code c66952.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. teloxantrone. this classification denotes an anthrapyrazole antibiotic with the molecular formula c21h25n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96521wl61b, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)-5-((2-(methylamino)ethyl)amino)- but generally known as teloxantrone, which bears us nih compound identifier 5364123. european medicines agency schedules teloxantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10875mig. the term teloxantrone is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). teloxantrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule teloxantrone under hs 29339990 and sitc 51577. as of q4 2014, teloxantrone remains the us fda preferred term for this commodity. teloxantrone bears us nlm identifiers umls id c0244823 and nci concept code c1520. smiles: oc1c2c3c([nh]n(c3ccc2nccnc)ccncco)c2c1c(=o)c=cc2=o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. panitumumab. this classification denotes a monoclonal antibody with the molecular formula c6398h9878n1694o2016s48, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6a901e312a, more generally known as panitumumab. european medicines agency schedules panitumumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25390. the term panitumumab is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53. most nations schedule panitumumab under hs 30021091 and sitc 54163. smiles:. as of q4 2014, panitumumab remains the us fda preferred term for this commodity. . panitumumab bears us nlm identifiers umls id c0879427 and nci concept code c1857.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. piroxantrone. this classification denotes an anthrapyrazole antibiotic with the molecular formula c21h25n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yl4ty9wh22, chemically known as anthra(1,9-cd)pyrazol-6(2h)-one, 5-((3-aminopropyl)amino)-7,10-dihydroxy-2-(2-((2-hydroxyethyl)amino)ethyl)- but generally known as piroxantrone, which bears us nih compound identifier 5362372. european medicines agency schedules piroxantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09935mig. the term piroxantrone is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). piroxantrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piroxantrone under hs 29339990 and sitc 51577. as of q4 2014, piroxantrone remains the us fda preferred term for this commodity. piroxantrone bears us nlm identifiers umls id c0069736 and nci concept code c1182. smiles: oc1c2c3c([nh]n(c3ccc2ncccn)ccncco)c2c1c(=o)c=cc2=o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. pixantrone. this classification denotes an intercalating agent with the molecular formula c17h19n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f5sxn2knmr, chemically known as 6,9-bis((2-aminoethyl)amino)benzo(g)isoquinoline-5,10-dione but generally known as pixantrone, which bears us nih compound identifier 134019. european medicines agency schedules pixantrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21304. the term pixantrone is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 1, 2004, list 51). world health organization schedules pixantrone in its anatomical therapeutic chemical (atc) classification. most nations schedule pixantrone under hs 29339990 and sitc 51577. as of q4 2014, pixantrone remains the us fda preferred term for this commodity. pixantrone bears us nlm identifiers umls id c0253355 and nci concept code c26663. smiles: o=c1c2c(c(nccn)ccc2nccn)c(=o)c2c1ccnc2.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. ranibizumab. this classification denotes an immunoconjugate with the molecular formula c2158h3282n562o681s12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zl1r02vt79, more generally known as ranibizumab. european medicines agency schedules ranibizumab in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22314. the term ranibizumab is an international non-proprietary name or inn. see who inn reference publication, volume 18, no. 3, 2004, list 52. most nations schedule ranibizumab under hs 30021091 and sitc 54163. as of q4 2014, ranibizumab remains the us fda preferred term for this commodity. ranibizumab bears us nlm identifiers umls id c1566537 and nci concept code c67562. smiles: none.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. romidepsin. this classification denotes an antineoplastic antibiotic and depsipeptide with the molecular formula c24h36n4o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cx3t89xqbk, chemically known as l-valine, n-((3s,4e)-3-hydroxy-7-mercapto-1-oxo-4-heptenyl)-d-valyl-d-cysteinyl-(2z)-2-amino-2-butenoxyl-, (4-1)-lactone, cyclic (1-2)-disulfide but generally known as romidepsin, which bears us nih compound identifier 5352062. european medicines agency schedules romidepsin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26362. world health organization schedules romidepsin in its anatomical therapeutic chemical (atc) classification. most nations schedule romidepsin under hs 29349990 and sitc 51579. as of q4 2014, romidepsin remains the us fda preferred term for this commodity. romidepsin bears us nlm identifiers umls id c1527027 and nci concept code c1544. smiles: s1sccc=cc2oc(=o)c(nc(=o)c(=c\\c)\\nc(=o)c(nc(=o)c(nc(=o)c2)c(c)c)c1)c(c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. soblidotin. this classification denotes a vinca-site binding agent and dolastatin compound with the molecular formula c39h67n5o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dqc51a0wqh, chemically known as n(2)-(n,n-dimethyl-valyl)-n-(2-methoxy-4-(2-(1-methoxy-2-methyl-3-oxo-3-((2-phenylethyl)amino)propyl)-1-pyrrolidinyl)-1-(1-methylpropyl)-4-oxobutyl)-n-methyl-valinamide but generally known as soblidotin, which bears us nih compound identifier 124092. the term soblidotin is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations schedule soblidotin under hs 29339990 and sitc 51577. as of q4 2014, soblidotin remains the us fda preferred term for this commodity. soblidotin bears us nlm identifiers umls id c1328702 and nci concept code c26672. smiles: ccc(c)c(c(cc(=o)n1ccc(c1)c(c(c)c(=o)nccc2=cc=cc=c2)oc)oc)n(c)c(=o)c(c(c)c)nc(=o)c(c(c)c)n(c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinepidine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c46h56n4o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, w3375j6v0y chemically known as vincaleukoblastine, 4-deoxy-22-oxo-, (4.alpha.)- but generally known as vinepidine, which bears us nih compound identifier 125688. european medicines agency schedules vinepidine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00062mig. the term vinepidine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). most nations schedule vinepidine under hs 29399900 and sitc 54149. as of q4 2014, vinepidine remains the us fda preferred term for this commodity. vinepidine bears us nlm identifiers umls id c0078255 and nci concept code c1274. smiles: ccc1cc2cn(c1)c3c2c(c4=c(c3)c5=cc=cc=c5n4)(c6=c(c=c7c(=c6)c89ccn1c8c(ccc1)(c(c(c9n7c=o)(c(=o)oc)o)oc(=o)c)cc)oc)c(=o)oc.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. trabectedin. this classification denotes a dna minor groove binding agent with the molecular formula c39h43n3o11s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier id0yzq2tcp, chemically known as spiro(6,16-(epithiopropanoxymethano)-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2,-b)(3)benzazocine-20,1(2h)-isoquinolin)-19-one, 5-(acetyloxy)-3,4,6,6a,7,13,14,16-octahydro-6,8,14-trihydroxy-7,9-dimethoxy-4,10,23-trimethyl-, (1r,6r,6ar,7r,13s,14s,16r)- but generally known as trabectedin, which bears us nih compound identifier 108150. european medicines agency schedules trabectedin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20756. the term trabectedin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48). world health organization schedules trabectedin in its anatomical therapeutic chemical (atc) classification. most nations schedule trabectedin under hs 29349990 and sitc 51579. as of q4 2014, trabectedin remains the us fda preferred term for this commodity. trabectedin bears us nlm identifiers umls id c1311070 and nci concept code c1691. smiles: s1c2c3n(c(o)c4n(c3c3c(c4)cc(c(oc)c3o)c)c)c(c3c2c(oc(=o)c)c(c2ococ32)c)coc(=o)c2(nccc3c2cc(oc)c(o)c3)c1.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinblastine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c46h58n4o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5v9klz54cy, chemically known as 1h-indolizino(8,1-cd)carbazole-5-carboxylic acid, 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2h-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-, methyl ester, (3ar-(3aalpha,4beta,5beta,5abeta,9(3r*,5s*,7r*,9s*),10br*,13aalpha))- but generally known as vinblastine, which bears us nih compound identifier 13342. european medicines agency schedules vinblastine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00052mig. the term vinblastine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules vinblastine in its anatomical therapeutic chemical (atc) classification. vinblastine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinblastine under hs 29399900 and sitc 54149. as of q4 2014, vinblastine remains the us fda preferred term for this commodity. vinblastine bears us nlm identifiers umls id c0042670 and nci concept code c930. smiles: o(c1c2(c3n(ccc43c(n(c3c4cc(c(oc)c3)c3(cc4cc(o)(cn(c4)ccc4c3[nh]c3c4cccc3)cc)c(=o)oc)c)c1(o)c(=o)oc)cc=c2)cc)c(=o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vincristine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c46h56n4o10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5j49q6b70f, chemically known as vincaleukoblastine, 22-oxo- but generally known as vincristine, which bears us nih compound identifier 5978. european medicines agency schedules vincristine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00059mig. the term vincristine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules vincristine in its anatomical therapeutic chemical (atc) classification. vincristine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vincristine under hs 29399900 and sitc 54149. as of q4 2014, vincristine remains the us fda preferred term for this commodity. vincristine bears us nlm identifiers umls id c0042679 and nci concept code c933. smiles: o(c1c2(c3n(ccc43c(n(c3c4cc(c(oc)c3)c3(cc4cc(o)(cn(c4)ccc4c3[nh]c3c4cccc3)cc)c(=o)oc)c=o)c1(o)c(=o)oc)cc=c2)cc)c(=o)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vindesine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c43h55n5o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rsa8ko39wh, chemically known as vincaleukoblastine, 3-(aminocarbonyl)-o(sup 4)-deacetyl-3-de(methoxycarbonyl)- but generally known as vindesine, which bears us nih compound identifier 40839. european medicines agency schedules vindesine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00061mig. the term vindesine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules vindesine in its anatomical therapeutic chemical (atc) classification. vindesine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vindesine under hs 29399900 and sitc 54149. as of q4 2014, vindesine remains the us fda preferred term for this commodity. vindesine bears us nlm identifiers umls id c0042682 and nci concept code c934. smiles: oc1(c2n(c3c(c42c2n(cc4)cc=cc2(c1o)cc)cc(c(oc)c3)c1(cc2cc(o)(cn(c2)ccc2c1[nh]c1c2cccc1)cc)c(=o)oc)c)c(=o)n.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinflunine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c45h54f2n4o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5bf646324k, chemically known as 4-deoxy-20,20-difluoro-c-norvincaleukoblastine but generally known as vinflunine, which bears us nih compound identifier 157688. european medicines agency schedules vinflunine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00063mig. the term vinflunine is an international non-proprietary name. world health organization schedules vinflunine in its anatomical therapeutic chemical (atc) classification. vinflunine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinflunine under hs 29399900 and sitc 54149. as of q4 2014, vinflunine remains the us fda preferred term for this commodity. vinflunine bears us nlm identifiers umls id c0672663 and nci concept code c61564. smiles: fc(f)(c1cc2cc(c3cc4c56c7n(cc6)cc=cc7(c(oc(=o)c)c(o)(c5n(c4cc3oc)c)c(=o)oc)cc)(c3[nh]c4c(c3cn(c2)c1)cccc4)c(=o)oc)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinfosiltine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c51h72n5o10p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier aw1uye6q9i, chemically known as vincaleukoblastine, o4-deacetyl-3-de(methoxycarbonyl)-3-((((1s)-1-(diethoxyphosphinyl)-2-methylpropyl)amino)carbonyl)- but generally known as vinfosiltine, which bears us nih compound identifier 3086608. european medicines agency schedules vinfosiltine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00065mig. the term vinfosiltine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). vinfosiltine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinfosiltine under hs 29399900 and sitc 54149. as of q4 2014, vinfosiltine remains the us fda preferred term for this commodity. vinfosiltine bears us nlm identifiers umls id c0084429 and nci concept code c2378. smiles: p(=o)(occ)(occ)c(nc(=o)c1(o)c2n(c3c(c42c2n(cc4)cc=cc2(c1o)cc)cc(c(oc)c3)c1(cc2cc(o)(cn(c2)ccc2c1[nh]c1c2cccc1)cc)c(=o)oc)c)c(c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinleucinol. this classification denotes a vinca alkaloid compound with the molecular formula c51h69n5o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier muj5bw9bwr, chemically known as vincaleukoblastine, o(sup 4)-deacetyl-3-de(methoxycarbonyl)-3-(((1-(ethoxycarbonyl)-2-methylbutyl)amino)carbonyl)-, (3(1s,2s))- but generally known as vinleucinol, which bears us nih compound identifier 72163. european medicines agency schedules vinleucinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00067mig. the term vinleucinol is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). vinleucinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinleucinol under hs 29399900 and sitc 54149. as of q4 2014, vinleucinol remains the us fda preferred term for this commodity. vinleucinol bears us nlm identifiers umls id c0247144 and nci concept code c95239. smiles: oc1(c2n(c3c(c42c2n(cc4)cc=cc2(c1o)cc)cc(c(oc)c3)c1(cc2cc(o)(cn(c2)ccc2c1[nh]c1c2cccc1)cc)c(=o)oc)c)c(=o)nc(c(cc)c)c(=o)occ.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinorelbine. this classification denotes a vinca alkaloid compound and vinca-site binding agent with the molecular formula c45h54n4o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q6c979r91y, chemically known as c-norvincaleukoblastine, 3,4-didehydro-4-deoxy-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (salt) but generally known as vinorelbine, which bears us nih compound identifier 60779. european medicines agency schedules vinorelbine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00069mig. the term vinorelbine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules vinorelbine in its anatomical therapeutic chemical (atc) classification. vinorelbine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinorelbine under hs 29399900 and sitc 54149. as of q4 2014, vinorelbine remains the us fda preferred term for this commodity. vinorelbine bears us nlm identifiers umls id c0078257 and nci concept code c1275. smiles: o(c1c2(c3n(ccc43c(n(c3c4cc(c(oc)c3)c3(cc4cn(cc5c3[nh]c3c5cccc3)cc(=c4)cc)c(=o)oc)c)c1(o)c(=o)oc)cc=c2)cc)c(=o)c.oc(c(o)c(=o)o)c(=o)o.oc(c(o)c(=o)o)c(=o)o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vinzolidine. this classification denotes a vinca-site binding agent with the molecular formula c48h58cln5o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 533u947v6q, chemically known as 2h-3,7-methanoazacycloundecino(5,4-b)indole-9-carboxylic acid, 9-((2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-3-(2-chloroethyl)-6,7-didehydro-16-methoxy-1-methyl-2,4-dioxospiro(aspidospermidine-3,5-oxazolidin)-15-yl)-5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-, methyl ester, (3r-(3r*,5s*,7r*,9s*))- but generally known as vinzolidine, which bears us nih compound identifier 49966. most nations schedule vinzolidine under hs 29399900 and sitc 54149. as of q4 2014, vinzolidine remains the us fda preferred term for this commodity. vinzolidine bears us nlm identifiers umls id c0078282 and nci concept code c1276. smiles: clccn1c(=o)c2(oc1=o)c1n(c3c(c41c1n(cc4)cc=cc1(c2oc(=o)c)cc)cc(c(oc)c3)c1(cc2cc(o)(cn(c2)ccc2c1[nh]c1c2cccc1)cc)c(=o)oc)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. vorinostat. this classification denotes a histone deacetylase inhibitor with the molecular formula c14h20n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 58ifb293ji, chemically known as saha, suberoylanilide hydroxamic acid but generally known as vorinostat, which bears us nih compound identifier 5311. european medicines agency schedules vorinostat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23356. the term vorinostat is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56). world health organization schedules vorinostat in its anatomical therapeutic chemical (atc) classification. most nations schedule vorinostat under hs 29280090 and sitc 51486. as of q4 2014, vorinostat remains the us fda preferred term for this commodity. vorinostat bears us nlm identifiers umls id c0672708 and nci concept code c1796. smiles: o=c(nc1ccccc1)ccccccc(=o)no.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. bizelesin. this classification denotes an antineoplastic alkylating agent with the molecular formula c43h36cl2n8o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l0o9obi87e, chemically known as 1,3-bis(2-(((s)-1-(chloromethyl)-1,6-dihydro-5-hydroxy-8-methylbenzo(1,2-b:4,3-b)dipyrrol-3(2h)-yl)carbonyl)indol-5-yl)urea but more generally known as bizelesin, which bears us nih compound identifier 60794. european medicines agency schedules bizelesin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05863mig. the term bizelesin is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). bizelesin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule bizelesin under hs 29339990 and sitc 51577. as of q4 2014, bizelesin remains us fdas preferred term for this commodity. bizelesin bears us nlm identifiers umls id c0209891 and nci concept code c1472. smiles: clcc1c2c(n(c1)c(=o)c1[nh]c3c(c1)cc(nc(=o)nc1cc4cc([nh]c4cc1)c(=o)n1cc(c4c1cc(o)c1[nh]cc(c41)c)ccl)cc3)cc(o)c1[nh]cc(c21)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. podofilox. this classification denotes a colchicine-site binding agent with the molecular formula c22h22o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l36h50f353, chemically known as furo(3,4:6,7)naphtho(2,3-d)-1,3-dioxol-6(5ah)-one, 5,8,8a,9-tetrahydro-9-hydroxy-5-(3,4,5-trimethoxyphenyl)- but more generally known as podofilox, which bears us nih compound identifier 4865. european medicines agency schedules podofilox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14925mig. world health organization schedules podofilox in its anatomical therapeutic chemical (atc) classification. as of q4 2014, podofilox remains us fdas preferred term for this commodity. podofilox bears us nlm identifiers umls id c0032334 and nci concept code c29368. smiles: o1cc2c(c(c3c(c2o)cc2ococ2c3)c2cc(oc)c(oc)c(oc)c2)c1=o.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. salinomycin. this classification denotes an antibiotic, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 62uxs86t64. the european medicines agency schedules salinomycin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10428mig. salinomycin generally arises in the molecular formula c42h70o11. the term salinomycin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 31, no10, 1977, list 17.) salinomycin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: o1c(ccc21oc1(oc(c(cc1c)c)c(c(=o)c(c(o)c(c1oc(ccc1c)c(cc)c(=o)o)c)c)cc)c=cc2o)(c1oc(c(o)(cc1)cc)c)c.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. alemtuzumab. drug prescribed and approved by the u.s. food and drug administration for the hiv infection treatment in adults and 6-year children. it is always used in combination with other drugs against the hiv. atazanavir is a type of drug against the hiv protease inhibitor (pi). it works by blocking the protease, an enzyme produced by the hiv. this prevents hiv multiplication and reduces the virus concentration in blood.. "
"antineoplastic antibiotics. this classification denotes antibiotics that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics, antineoplastics, or antineoplastic antibiotics.. carfilzomib. a type of proteasome inhibitor. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. . "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. bicalutamide. this classification denotes an anti-androgen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a0z3nau9dp. european medicines agency schedules bicalutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05817mig. bicalutamide generally arises in the molecular formula c18h14f4n2o4s. the term bicalutamide is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34.) bicalutamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bicalutamide under hs 29309085 and sitc 51549. as of q4 2014, bicalutamide remains the us fda preferred term for this commodity. bicalutamide bears us nlm identifiers umls id c0285590 and nci concept code c1599. smiles: s(=o)(=o)(cc(o)(c)c(=o)nc1cc(c(cc1)c#n)c(f)(f)f)c1ccc(f)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. estramustine. this classification denotes a tubulin binding agent and nitrogen mustard compound with the molecular formula c23h31cl2no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 35lt29625a, chemically known as 17-hydroxyestra-1,3,5(10)-trien-3-yl bis(2-chloroethyl)carbamate but generally known as estramustine, which bears us nih compound identifier 18140. european medicines agency schedules estramustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07246mig. the term estramustine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules estramustine in its anatomical therapeutic chemical (atc) classification. estramustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule estramustine under hs 29372300 and sitc 54153. as of q4 2014, estramustine remains the us fda preferred term for this commodity. estramustine bears us nlm identifiers umls id c0014921 and nci concept code c479. smiles: clccn(c(=o)oc1cc2c(c3c(c4c(c(o)cc4)(cc3)c)cc2)cc1)cccl.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. goserelin. this classification denotes a gonadotropin-releasing hormone analog with the molecular formula c59h84n18o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0f65r8p09n, chemically known as luteinizing hormone-releasing factor (pig), 6-(o-(1,1-dimethylethyl)-d-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide but generally known as goserelin, which bears us nih compound identifier 47725. european medicines agency schedules goserelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07962mig. the term goserelin is an international non-proprietary name. world health organization schedules goserelin in its anatomical therapeutic chemical (atc) classification. goserelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule goserelin under hs 29371900 and sitc 54154. as of q4 2014, goserelin remains the us fda preferred term for this commodity. goserelin bears us nlm identifiers umls id c0120107 and nci concept code c1374. smiles: o=c(n1c(ccc1)c(=o)nnc(=o)n)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1[nh]cnc1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)coc(c)(c)c)cc(c)c)ccc/n=c(/n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. leuprolide. this classification denotes a gonadotropin-releasing hormone analog, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier efy6w0m8tg. european medicines agency schedules leuprolide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08449mig. leuprolide generally arises in the molecular formula c59h84n16o12. the term leuprolide is a european pharmacopoeia designation. as of q4 2014, leuprolide remains the us fda preferred term for this commodity. leuprolide bears us nlm identifiers umls id c0085272 and nci concept code c62042. smiles: o=c(n1c(ccc1)c(=o)ncc)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1[nh]cnc1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc(c)c)cc(c)c)ccc/n=c(/n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. testolactone. this classification denotes a steroidal aromatase inhibitor with the molecular formula c19h24o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6j9bla949q, chemically known as d-homo-17a-oxaandrosta-1,4-diene-3,17-dione but generally known as testolactone, which bears us nih compound identifier 5407. european medicines agency schedules testolactone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10936mig. the term testolactone is an international non-proprietary name. testolactone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule testolactone under hs 29372900 and sitc 54153. as of q4 2014, testolactone remains the us fda preferred term for this commodity. testolactone bears us nlm identifiers umls id c0039600 and nci concept code c2301. smiles: o1c2(c(c3c(c4(c(=cc(=o)c=c4)cc3)c)cc2)ccc1=o)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. triptorelin. this classification denotes a gonadotropin-releasing hormone analog and anti-androgen with the molecular formula c64h82n18o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9081y98w2v, chemically known as luteinizing hormone-releasing factor (pig), 6-d-tryptophan but generally known as triptorelin, which bears us nih compound identifier 16129684. european medicines agency schedules triptorelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11324mig. the term triptorelin is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules triptorelin in its anatomical therapeutic chemical (atc) classification. triptorelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule triptorelin under hs 29371900 and sitc 54154. as of q4 2014, triptorelin remains the us fda preferred term for this commodity. triptorelin bears us nlm identifiers umls id c0077275 and nci concept code c1267. smiles: o=c(n1c(ccc1)c(=o)ncc(=o)n)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1nc[nh]c1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc1c2c([nh]c1)cccc2)cc(c)c)cccnc(=n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. letrozole. this classification denotes a non-steroidal aromatase inhibitor with the molecular formula c17h11n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7lkk855w8i, chemically known as 4,4-(1h-1,2,4-triazol-1-ylmethylene)dibenzonitrile but generally known as letrozole, which bears us nih compound identifier 3902. european medicines agency schedules letrozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08444mig. the term letrozole is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules letrozole in its anatomical therapeutic chemical (atc) classification. most nations schedule letrozole under hs 29339990 and sitc 51577. as of q4 2014, letrozole remains the us fda preferred term for this commodity. letrozole bears us nlm identifiers umls id c0246421 and nci concept code c1527. smiles: n1(ncnc1)c(c1ccc(cc1)c#n)c1ccc(cc1)c#n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. exemestane. this classification denotes a steroidal aromatase inhibitor with the molecular formula c20h24o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ny22hmq4bx, chemically known as 6-methyleneandrosta-1,4-diene-3,17-dione but generally known as exemestane, which bears us nih compound identifier 60198. european medicines agency schedules exemestane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07492mig. the term exemestane is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules exemestane in its anatomical therapeutic chemical (atc) classification. exemestane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule exemestane under hs 29372900 and sitc 54153. as of q4 2014, exemestane remains the us fda preferred term for this commodity. exemestane bears us nlm identifiers umls id c0851344 and nci concept code c1097. smiles: o=c1c2(c(c3c(cc2)c2(c(=cc(=o)c=c2)c(=c)c3)c)cc1)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. cyproterone. this classification denotes an anti-androgen with the molecular formula c22h27clo3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e61q31ek2f, chemically known as 3h-cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1-beta,2-beta-dihydro-17-hydroxy- but generally known as cyproterone, which bears us nih compound identifier 16417. european medicines agency schedules cyproterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06877mig. world health organization schedules cyproterone in its anatomical therapeutic chemical (atc) classification. cyproterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cyproterone under hs 29372900 and sitc 54153. as of q4 2014, cyproterone remains the us fda preferred term for this commodity. cyproterone bears us nlm identifiers umls id c0010621 and nci concept code c407. smiles: clc1=cc2c(c3(c4c(c4)c(=o)c=c13)c)ccc1(c2ccc1(o)c(=o)c)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. abarelix. this classification denotes a gonadotropin releasing hormone inhibitor with the molecular formula c72h95cln14o14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w486sj5824, chemically known as d-alaninamide, n-acetyl-3-(2-naphthalenyl)-d-alanyl-4-chloro-d-phenylalanyl-3-(3-pyridinyl)-d-alanyl-l-seryl-n-methyl-l-tyrosyl-d-asparaginyl-l-leucyl-n6-(1-methylethyl)-l-lysyl-l-prolyl- 10 but generally known as abarelix, which bears us nih compound identifier 16131215. european medicines agency schedules abarelix in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07359mig. the term abarelix is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules abarelix in its anatomical therapeutic chemical (atc) classification. abarelix is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule abarelix under hs 29371900 and sitc 54154. as of q4 2014, abarelix remains the us fda preferred term for this commodity. abarelix bears us nlm identifiers umls id c1174732 and nci concept code c2015. smiles: clc1ccc(cc(nc(=o)c(nc(=o)c)cc2cc3c(cc2)cccc3)c(=o)nc(c(=o)nc(c(=o)n(c(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(c)c(=o)n)ccccnc(c)c)cc(c)c)cc(=o)n)cc2ccc(o)cc2)c)co)cc2cccnc2)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. abiraterone. this classification denotes an anti-androgen with the molecular formula c24h31no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g819a456d0, chemically known as 17-(3-pyridyl)androsta-5,16-dien-3beta-ol but generally known as abiraterone, which bears us nih compound identifier 132971. abiraterone most often appears in forms base and acetate. european medicines agency schedules abiraterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07361mig. the term abiraterone is an international non-proprietary name or inn (see who inn reference publication, volume 10 no. 3, 1996, list 36). abiraterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule abiraterone under hs 29372900 and sitc 54153. as of q4 2014, abiraterone remains the us fda preferred term for this commodity. abiraterone bears us nlm identifiers umls id c0754011 and nci concept code c77333. smiles: oc1cc2=ccc3c(c2(cc1)c)ccc1(c3cc=c1c1cccnc1)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. acolbifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c29h31no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 815lj9x0d1, chemically known as 2h-1-benzopyran-7-ol, 3-(4-hydroxyphenyl)-4-methyl-2-(4-(2-(1-piperidinyl)ethoxy)phenyl)-, (2s) but generally known as acolbifene, which bears us nih compound identifier 155435. acolbifene most often comes in base and hydrochloride forms. acolbifene also comes in hydrochloride form. the term acolbifene is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48). most nations schedule acolbifene under hs 29349990 and sitc 51579. as of q4 2014, acolbifene remains the us fda preferred term for this commodity. acolbifene bears us nlm identifiers umls id c1122255 and nci concept code c64183. smiles: cc1=c([c@@h](oc2=c1c=cc(=c2)o)c3=cc=c(c=c3)occn4ccccc4)c5=cc=c(c=c5)o.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. aminoglutethimide. this classification denotes a non-steroidal aromatase inhibitor and anti-adrenal with the molecular formula c13h16n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0o54zq14i9, chemically known as 2,6-piperidinedione, 3-(4-aminophenyl)-3-ethyl- but generally known as aminoglutethimide, which bears us nih compound identifier 2145. aminoglutethimide most often comes in base, phosphate, and racemic forms. european medicines agency schedules aminoglutethimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05440mig. the term aminoglutethimide is an international non-proprietary name. world health organization schedules aminoglutethimide in its anatomical therapeutic chemical (atc) classification. aminoglutethimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aminoglutethimide under hs 29251995 and sitc 51482. as of q4 2014, aminoglutethimide remains the us fda preferred term for this commodity. aminoglutethimide bears us nlm identifiers umls id c0002555 and nci concept code c233. smiles: o=c1nc(=o)ccc1(cc)c1ccc(n)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. axitinib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c22h18n4os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c9lvq0yuxg. european medicines agency schedules axitinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25427. the term axitinib is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56. ). most nations schedule axitinib under hs 29333990 and sitc 51574. as of q4 2014, axitinib remains the us fda preferred term for this commodity. axitinib bears us nlm identifiers umls id c1700874 and nci concept code c38718. smiles: s(c1cc2[nh]nc(c2cc1)/c=c/c1ncccc1)c1c(cccc1)c(=o)nc.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. bazedoxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c30h34n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q16tt9c5bk, chemically known as 1h-indol-5-ol, 1-((4-(2-(hexahydro-1h-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl- but generally known as bazedoxifene, which bears us nih compound identifier 154257. bazedoxifene most often comes in basic and acetate forms. european medicines agency schedules bazedoxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26694. world health organization schedules bazedoxifene in its anatomical therapeutic chemical (atc) classification. most nations schedule bazedoxifene under hs 29339990 and sitc 51577. as of q4 2014, bazedoxifene remains the us fda preferred term for this commodity. bazedoxifene bears us nlm identifiers umls id c2346970 and nci concept code c73598. smiles: o(ccn1cccccc1)c1ccc(cn2c(c(c3c2ccc(o)c3)c)c2ccc(o)cc2)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. benorterone. this classification denotes an anti-androgen with the molecular formula c19h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j339q7im54, chemically known as b-norandrost-4-en-3-one, 17-hydroxy-17-methyl-, (17beta)- but generally known as benorterone, which bears us nih compound identifier 19126. european medicines agency schedules benorterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05723mig. the term benorterone is an international non-proprietary name. benorterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule benorterone under hs 29372900 and sitc 54153. as of q4 2014, benorterone remains the us fda preferred term for this commodity. benorterone bears us nlm identifiers umls id c0053110 and nci concept code c74121. smiles: oc1(c2(c(c3c(c4(c(=cc(=o)cc4)c3)c)cc2)cc1)c)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. bifluranol. this classification denotes an anti-androgen with the molecular formula c17h18f2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 47602x79jf, chemically known as phenol, 4,4-(1-ethyl-2-methyl-1,2-ethanediyl)bis(2-fluoro-, (r*,s*)- but generally known as bifluranol, which bears us nih compound identifier 71713. european medicines agency schedules bifluranol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05830mig. the term bifluranol is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). bifluranol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bifluranol under hs 29081900 and sitc 51244. as of q4 2014, bifluranol remains the us fda preferred term for this commodity. bifluranol bears us nlm identifiers umls id c0053569 and nci concept code c77332. smiles: fc1cc(c(c(c2cc(f)c(o)cc2)c)cc)ccc1o.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. bortezomib. this classification denotes a proteasome inhibitor with the molecular formula c19h25bn4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69g8bd63pp, chemically known as boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (s-(r*,s*))- but generally known as bortezomib, which bears us nih compound identifier 93860. european medicines agency schedules bortezomib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20020. the term bortezomib is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules bortezomib in its anatomical therapeutic chemical (atc) classification. most nations schedule bortezomib under hs 29339990 and sitc 51577. as of q4 2014, bortezomib remains the us fda preferred term for this commodity. bortezomib bears us nlm identifiers umls id c1176309 and nci concept code c1851. smiles: o=c(nc(cc(c)c)[b](o)o)c(nc(=o)c1nccnc1)cc1ccccc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. calusterone. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c21h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0678g6q58a, chemically known as 17beta-hydroxy-7beta,17-dimethylandrost-4-en-3-one but generally known as calusterone, which bears us nih compound identifier 28204. european medicines agency schedules calusterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06060mig. the term calusterone is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). calusterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule calusterone under hs 29372900 and sitc 54153. as of q4 2014, calusterone remains the us fda preferred term for this commodity. calusterone bears us nlm identifiers umls id c0006790 and nci concept code c337. smiles: oc1(c2(c(c3c(c4(c(=cc(=o)cc4)cc3c)c)cc2)cc1)c)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. cetrorelix. this classification denotes a gonadotropin releasing hormone inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oon1hfz4ba. european medicines agency schedules cetrorelix in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07459mig. cetrorelix generally arises in the molecular formula c70h92cln17o14. the term cetrorelix is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31.) cetrorelix is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cetrorelix under hs 29371900 and sitc 54154. as of q4 2014, cetrorelix remains the us fda preferred term for this commodity. cetrorelix bears us nlm identifiers umls id c0209366 and nci concept code c2481. smiles: clc1ccc(cc(nc(=o)c(nc(=o)c)cc2cc3c(cc2)cccc3)c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)nc(c(=o)n2c(ccc2)c(=o)nc(c)c(=o)n)cccnc(=n)n)cc(c)c)cccnc(=o)n)cc2ccc(o)cc2)co)cc2cccnc2)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. cioteronel. this classification denotes an anti-androgen with the molecular formula c16h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1rth95874z, chemically known as 1,5-cis-verknupften but generally known as cioteronel, which bears us nih compound identifier 55994. european medicines agency schedules cioteronel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06319mig. the term cioteronel is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). cioteronel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cioteronel under hs 29372900 and sitc 54153. as of q4 2014, cioteronel remains the us fda preferred term for this commodity. cioteronel bears us nlm identifiers umls id c0625429 and nci concept code c74119. smiles: o=c1cc2c(ccc2ccccc(oc)cc)c1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. degarelix. this classification denotes a gonadotropin releasing hormone inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sx0xji3a11. european medicines agency schedules degarelix in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27748. degarelix generally arises in the molecular formula c82h103cln18o16. the term degarelix is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48.) most nations schedule degarelix under hs 29371900 and sitc 54154. as of q4 2014, degarelix remains the us fda preferred term for this commodity. degarelix bears us nlm identifiers umls id c0971731 and nci concept code c48385. smiles: cc(c)cc(c(=o)nc(ccccnc(c)c)c(=o)n1cccc1c(=o)nc(c)c(=o)n)nc(=o)c(cc2=cc=c(c=c2)nc(=o)n)nc(=o)c(cc3=cc=c(c=c3)nc(=o)c4cc(=o)nc(=o)n4)nc(=o)c(co)nc(=o)c(cc5=cn=cc=c5)nc(=o)c(cc6=cc=c(c=c6)cl)nc(=o)c(cc7=cc8=cc=cc=c8c=c7)nc(=o)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. deslorelin. this classification denotes a gonadotropin-releasing hormone analog with the molecular formula c64h83n17o12, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tkg3i66tve, chemically known as 1-9-luteinizing hormone-releaasing factor (swine), 6-d-tryptophan-9-(n-ethyl-l-prolinamide)- but generally known as deslorelin, which bears us nih compound identifier 16129697. european medicines agency schedules deslorelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06998mig. the term deslorelin is an international non-proprietary name. deslorelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule deslorelin under hs 29371900 and sitc 54154. as of q4 2014, deslorelin remains the us fda preferred term for this commodity. deslorelin bears us nlm identifiers umls id c0083220 and nci concept code c38709. smiles: o=c(n1c(ccc1)c(=o)ncc)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1[nh]cnc1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc1c2c([nh]c1)cccc2)cc(c)c)cccnc(=n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. fadrozole. this classification denotes a non-steroidal aromatase inhibitor with the molecular formula c14h13n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h3988m64pu, chemically known as benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)- but generally known as fadrozole, which bears us nih compound identifier 59693. european medicines agency schedules fadrozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07497mig. the term fadrozole is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). fadrozole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fadrozole under hs 29339990 and sitc 51577. as of q4 2014, fadrozole remains the us fda preferred term for this commodity. fadrozole bears us nlm identifiers umls id c0117234 and nci concept code c79911. smiles: n12c(cccc1cnc2)c1ccc(cc1)c#n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. dromostanolone or drostanolone. this classification denotes a therapeutic androgen with the molecular formula c20h32o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7dr7h00hdt, chemically known as (2r,5s,8r,9s,10s,13s,14s,17s)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one but generally known as dromostanolone, which bears us nih compound identifier 6011. smiles:cc1cc2(c(ccc3c2ccc4(c3ccc4o)c)cc1=o)c. dromostanolone or drostanolone bears us nlm identifiers umls id c0058753 and nci concept code c1076.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. epitiostanol. this classification denotes a therapeutic androgen and anabolic steroid with the molecular formula c19h30os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ye7586973l, chemically known as 2,3-epithioandrostan-17-ol but generally known as epitiostanol, which bears us nih compound identifier 3243. european medicines agency schedules epitiostanol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06572mig. the term epitiostanol is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). epitiostanol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule epitiostanol under hs 29372300 and sitc 54153. as of q4 2014, epitiostanol remains the us fda preferred term for this commodity. epitiostanol bears us nlm identifiers umls id c0059457 and nci concept code c1089. smiles: s1c2cc3(c4c(c5c(cc4)(c(o)cc5)c)ccc3cc12)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. erbulozole. this classification denotes a tubulin binding agent with the molecular formula c24h27n3o5s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78xgn2k5rx, chemically known as ethyl (+-)-cis-p-(((2-(imidazol-1-ylmethyl)-2-(p-methoxyphenyl)-1,3-dioxolan-4-yl)methyl)thio)carbanilate but generally known as erbulozole, which bears us nih compound identifier 71347. the term erbulozole is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). as of q4 2014, erbulozole remains the us fda preferred term for this commodity. erbulozole bears us nlm identifiers umls id c0059504 and nci concept code c73258. smiles: ccoc(=o)nc1=cc=c(c=c1)scc2co[c@](o2)(cn3c=cn=c3)c4=cc=c(c=c4)oc. .. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. formestane. this classification denotes a steroidal aromatase inhibitor with the molecular formula c19h26o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pub9t8t355, chemically known as 4-hydroxyandrost-4-ene-3,17-dione but generally known as formestane, which bears us nih compound identifier 11273. european medicines agency schedules formestane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07784mig. the term formestane is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules formestane in its anatomical therapeutic chemical (atc) classification. formestane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule formestane under hs 29372300 and sitc 54153. as of q4 2014, formestane remains the us fda preferred term for this commodity. formestane bears us nlm identifiers umls id c0048306 and nci concept code c974. smiles: o=c1c2(c(c3c(c4(c(=c(o)c(=o)cc4)cc3)c)cc2)cc1)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. fosfestrol. this classification denotes a hormonal antineoplastic agent with the molecular formula c18h22o8p2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a0e0nma80f, chemically known as 4,4-stilbenediol, .alpha., .alpha.-diethyl-, diphosphate, disodium salt but generally known as fosfestrol, which bears us nih compound identifier 3032325. european medicines agency schedules fosfestrol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07795mig. world health organization schedules fosfestrol in its anatomical therapeutic chemical (atc) classification. fosfestrol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fosfestrol under hs 29199090 and sitc 51631. as of q4 2014, fosfestrol remains the us fda preferred term for this commodity. fosfestrol bears us nlm identifiers umls id c0060692 and nci concept code c1105. smiles: p(=o)(oc1ccc(c(=c(\\cc)c2ccc(op(=o)(o)o)cc2)/cc)cc1)(o)o.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. gonadorelin. this classification denotes a gnrh1 gene with the molecular formula c55h75n17o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9o7312w37g, chemically known as gonadotropin, luteinizing hormone-releasing hormone, synthetic but generally known as gonadorelin, which bears us nih compound identifier 36523. european medicines agency schedules gonadorelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07960mig. the term gonadorelin is an international non-proprietary name. world health organization schedules gonadorelin in its anatomical therapeutic chemical (atc) classification. gonadorelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule gonadorelin under hs 29371900 and sitc 54154. as of q4 2014, gonadorelin remains the us fda preferred term for this commodity. smiles: o=c(n1c(ccc1)c(=o)ncc(=o)n)c(nc(=o)c(nc(=o)cnc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1[nh]cnc1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc(c)c)ccc/n=c(/n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. histrelin. this classification denotes a gonadotropin-releasing hormone analog, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h50h3s3w74. european medicines agency schedules histrelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08046mig. histrelin generally arises in the molecular formula c66h86n18o12. the term histrelin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) histrelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule histrelin under hs 29371900 and sitc 54154. as of q4 2014, histrelin remains the us fda preferred term for this commodity. histrelin bears us nlm identifiers umls id c0121902 and nci concept code c74270. smiles: o=c(n1c(ccc1)c(=o)ncc)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1nc[nh]c1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc1ncn(c1)cc1ccccc1)cc(c)c)cccnc(=n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. inocoterone. this classification denotes an anti-androgen with the molecular formula c18h26o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier onu02d116s, chemically known as (3s,3as,9as,9bs)-6-ethyl-3-hydroxy-3a-methyl-2,3,4,5,8,9,9a,9b-octahydro-1h-cyclopenta[a]naphthalen-7-one but generally known as inocoterone, which bears us nih compound identifier 11776794. european medicines agency schedules inocoteronein its extended eudravigilance medicinal product dictionary or xevmpd under index sub08189mig. most nations schedule inocoterone under hs 29379000 and sitc 54155. as of q4 2014, inocoterone remains the us fda preferred term for this commodity. smiles: ccc1=c2ccc3(c(c2ccc1=o)ccc3o)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. nafarelin. this classification denotes a gonadotropin-releasing hormone analog with the molecular formula c66h83n17o13, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1x0094v6jv, chemically known as luteinizing hormone-releasing factor (pig), 6-(3-(2-naphthalenyl)-d-alanine)- but generally known as nafarelin, which bears us nih compound identifier 16129618. european medicines agency schedules nafarelin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09115mig. the term nafarelin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules nafarelin in its anatomical therapeutic chemical (atc) classification. nafarelin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nafarelin under hs 29371900 and sitc 54154. as of q4 2014, nafarelin remains the us fda preferred term for this commodity. nafarelin bears us nlm identifiers umls id c0064906 and nci concept code c61613. smiles: o=c(n1c(ccc1)c(=o)ncc(=o)n)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c1nc(=o)cc1)cc1nc[nh]c1)cc1c2c([nh]c1)cccc2)co)cc1ccc(o)cc1)cc1cc2c(cc1)cccc2)cc(c)c)cccnc(=n)n.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. lanreotide. this classification denotes a somatostatin receptor agonist with the molecular formula c54h69n11o10s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0g3de8943y, chemically known as l-threoninamide, 3-(2-naphthalenyl)-d-alanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2-7)-disulfide but generally known as lanreotide, which bears us nih compound identifier 71349. european medicines agency schedules lanreotide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08402mig. world health organization schedules lanreotide in its anatomical therapeutic chemical (atc) classification. lanreotide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lanreotide under hs 29349990 and sitc 51579. as of q4 2014, lanreotide remains the us fda preferred term for this commodity. lanreotide bears us nlm identifiers umls id c0209211 and nci concept code c1523. smiles: s1scc(nc(=o)c(n)cc2cc3c(cc2)cccc3)c(=o)nc(c(=o)nc(cc2c3c([nh]c2)cccc3)c(=o)nc(ccccn)c(=o)nc(c(c)c)c(=o)nc(c1)c(=o)nc(c(o)c)c(=o)n)cc1ccc(o)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. lapatinib. this classification denotes an epidermal growth factor receptor tyrosine kinase inhibitor with the molecular formula c29h26clfn4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0vua21238f. european medicines agency schedules lapatinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25379. the term lapatinib is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 1, 2004, list 51). most nations schedule lapatinib under hs 29349990 and sitc 51579. as of q4 2014, lapatinib remains the us fda preferred term for this commodity. lapatinib bears us nlm identifiers umls id c1506770 and nci concept code c26653. smiles: clc1cc(nc2ncnc3c2cc(c2oc(cnccs(=o)(=o)c)cc2)cc3)ccc1occ1cc(f)ccc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. lasofoxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c28h31no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 337g83n988, chemically known as 2-naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5r-cis)- but generally known as lasofoxifene, which bears us nih compound identifier 216416. european medicines agency schedules lasofoxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27754. the term lasofoxifene is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules lasofoxifene in its anatomical therapeutic chemical (atc) classification. most nations schedule lasofoxifene under hs 29339990 and sitc 51577. as of q4 2014, lasofoxifene remains the us fda preferred term for this commodity. lasofoxifene bears us nlm identifiers umls id c0672898 and nci concept code c80679. smiles: o(ccn1cccc1)c1ccc(c2c(ccc3c2ccc(o)c3)c2ccccc2)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. liarozole. this classification denotes a non-steroidal aromatase inhibitor with the molecular formula c17h13cln4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k0q29tgv9y, chemically known as 1h-benzimidazole, 5-((3-chlorophenyl)-1h-imidazol-1-ylmethyl)- but generally known as liarozole, which bears us nih compound identifier 60652. european medicines agency schedules liarozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14356mig. the term liarozole is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). most nations schedule liarozole under hs 29332990 and sitc 51573. as of q4 2014, liarozole remains the us fda preferred term for this commodity. liarozole bears us nlm identifiers umls id c0165479 and nci concept code c1433. smiles: clc1cc(c(n2ccnc2)c2cc3[nh]cnc3cc2)ccc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. mecasermin. this classification denotes a therapeutic insulin-like growth factor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7gr9i2683o. european medicines agency schedules mecasermin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08672mig. mecasermin generally arises in the molecular formula c331h512n94o101s7. the term mecasermin is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32.) mecasermin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mecasermin under hs 29371900 and sitc 54154. smiles:. as of q4 2014, mecasermin remains the us fda preferred term for this commodity. . mecasermin bears us nlm identifiers umls id c0904505 and nci concept code c2262.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. mitotane. this classification denotes an anti-adrenal with the molecular formula c14h10cl4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78e4j5ib5j, chemically known as 2,4-dichlorophenyldichlorethane but generally known as mitotane, which bears us nih compound identifier 4211. european medicines agency schedules mitotane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09010mig. the term mitotane is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules mitotane in its anatomical therapeutic chemical (atc) classification. mitotane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, mitotane remains the us fda preferred term for this commodity. mitotane bears us nlm identifiers umls id c0026256 and nci concept code c664. smiles: clc(cl)c(c1ccc(cl)cc1)c1c(cl)cccc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. terfluranol. this classification denotes an antineoplastic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wuf1dl156g. european medicines agency schedules terfluranol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10922mig. terfluranol generally arises in the molecular formula c17h17f3o2. the term terfluranol is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18.) terfluranol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terfluranol under hs 29081900 and sitc 51244. as of q4 2014, terfluranol remains the us fda preferred term for this commodity. terfluranol bears us nlm identifiers umls id c2699917 and nci concept code c75292. smiles: fc(f)(f)cc(c(c1ccc(o)cc1)c)c1ccc(o)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. nilotinib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c28h22f3n7o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f41401512x. european medicines agency schedules nilotinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25225. the term nilotinib is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56). most nations schedule nilotinib under hs 29335990 and sitc 51576. as of q4 2014, nilotinib remains the us fda preferred term for this commodity. nilotinib bears us nlm identifiers umls id c1721377 and nci concept code c48375. smiles: cl.fc(f)(f)c1cc(n2cc(nc2)c)cc(nc(=o)c2cc(nc3nc(c4cccnc4)ccn3)c(cc2)c)c1.o.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. octreotide. this classification denotes a somatostatin receptor agonist with the molecular formula c49h66n10o10s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rwm8ccw8gp, chemically known as l-cysteinamide, d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (r-(r*,r*))- but generally known as octreotide, which bears us nih compound identifier 383414. european medicines agency schedules octreotide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09417mig. the term octreotide is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules octreotide in its anatomical therapeutic chemical (atc) classification. octreotide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule octreotide under hs 29371900 and sitc 54154. as of q4 2014, octreotide remains the us fda preferred term for this commodity. octreotide bears us nlm identifiers umls id c0028833 and nci concept code c711. smiles: s1scc(nc(=o)c(n)cc2ccccc2)c(=o)nc(c(=o)nc(cc2c3c([nh]c2)cccc3)c(=o)nc(ccccn)c(=o)nc(c(o)c)c(=o)nc(c1)c(=o)nc(c(o)c)co)cc1ccccc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. sulprostone. this classification denotes a prostaglandin analogue with the molecular formula c23h31no7s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 501q5eq1gm, chemically known as 16-phenoxy-omega-17,18,19,20-tetranor prostaglandin e2 methylsulfonylamide but generally known as sulprostone, which bears us nih compound identifier 5312153. european medicines agency schedules sulprostone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10760mig. the term sulprostone is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules sulprostone in its anatomical therapeutic chemical (atc) classification. sulprostone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulprostone under hs 29375000 and sitc 54156. as of q4 2014, sulprostone remains the us fda preferred term for this commodity. sulprostone bears us nlm identifiers umls id c0075628 and nci concept code c84191. smiles: s(=o)(=o)(nc(=o)ccc/c=c\\cc1c(c(o)cc1=o)/c=c/c(o)coc1ccccc1)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. zindoxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c21h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1irs95m8dn, chemically known as 1h-indol-5-ol, 2-(4-(acetyloxy)phenyl)-1-ethyl-3-methyl-, acetate (ester) but generally known as zindoxifene, which bears us nih compound identifier 65645. european medicines agency schedules zindoxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00163mig. the term zindoxifene is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). zindoxifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zindoxifene under hs 29339990 and sitc 51577. as of q4 2014, zindoxifene remains the us fda preferred term for this commodity. zindoxifene bears us nlm identifiers umls id c0078808 and nci concept code c66696. smiles: o(c1cc2c(n(c(c2c)c2ccc(oc(=o)c)cc2)cc)cc1)c(=o)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. terguride. this classification denotes a lisuride analog, ergoline, and dopamine agonist with the molecular formula c20h28n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 21ojt43q88, chemically known as 9,10-alpha-dihydrolisuride but generally known as terguride, which bears us nih compound identifier 37816. european medicines agency schedules terguride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10923mig. world health organization schedules terguride in its anatomical therapeutic chemical (atc) classification. terguride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule terguride under hs 29396900 and sitc 54146. as of q4 2014, terguride remains the us fda preferred term for this commodity. smiles: o=c(nc1cc2c(n(c1)c)cc1c3c2cccc3[nh]c1)n(cc)cc.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. trilostane. this classification denotes a 3-hydroxysteroid dehydrogenase inhibitor and steroidal aromatase inhibitor and anti-adrenal with the molecular formula c20h27no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l0fpv48q5r, chemically known as 5-alpha-androstane-2-alpha-carbonitrile, 4-alpha,5-epoxy-17-beta-hydroxy-3-oxo- but generally known as trilostane, which bears us nih compound identifier 26163. european medicines agency schedules trilostane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11297mig. the term trilostane is an international non-proprietary name. world health organization schedules trilostane in its anatomical therapeutic chemical (atc) classification. trilostane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trilostane under hs 29372900 and sitc 54153. as of q4 2014, trilostane remains the us fda preferred term for this commodity. trilostane bears us nlm identifiers umls id c0077144 and nci concept code c1263. smiles: o1c23c(c4c(c5c(cc4)(c(o)cc5)c)cc3)(cc(c(=o)c12)c#n)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. vapreotide. this classification denotes a somatostatin receptor agonist with the molecular formula c57h70n12o9s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2pk59m9gff, chemically known as l-tryptophanamide, d-phenylalanyl-l-cysteinyl-l-tyrosyl-d-tryptophyl-l-lysyl-l-valyl-l-cysteinyl-, cyclic (2->7)-disulfide but generally known as vapreotide, which bears us nih compound identifier 71306. european medicines agency schedules vapreotide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00026mig. the term vapreotide is an international non-proprietary name. world health organization schedules vapreotide in its anatomical therapeutic chemical (atc) classification. vapreotide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vapreotide under hs 29349990 and sitc 51579. as of q4 2014, vapreotide remains the us fda preferred term for this commodity. vapreotide bears us nlm identifiers umls id c0164678 and nci concept code c1429. smiles: s1scc(nc(=o)c(n)cc2ccccc2)c(=o)nc(c(=o)nc(cc2c3c([nh]c2)cccc3)c(=o)nc(ccccn)c(=o)nc(c(c)c)c(=o)nc(c1)c(=o)nc(cc1c2c([nh]c1)cccc2)c(=o)n)cc1ccc(o)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. vorozole. this classification denotes a non-steroidal aromatase inhibitor with the molecular formula c16h13cln6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1e2s9yxv2a, chemically known as 6-((4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl)-1-methyl-1h-benzotriazole,d- but generally known as vorozole, which bears us nih compound identifier 60796. european medicines agency schedules vorozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00088mig. the term vorozole is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules vorozole in its anatomical therapeutic chemical (atc) classification. vorozole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vorozole under hs 29339990 and sitc 51577. as of q4 2014, vorozole remains the us fda preferred term for this commodity. vorozole bears us nlm identifiers umls id c0286224 and nci concept code c1601. smiles: clc1ccc(c(n2ncnc2)c2cc3n(nnc3cc2)c)cc1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. zanoterone. this classification denotes an anti-androgen with the molecular formula c23h32n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xq5v1w49jg, chemically known as 1-(methylsulfonyl)-1h-5alpha,17alpha-pregn-20-yno(3,2-c)pyrazol-17-ol but generally known as zanoterone, which bears us nih compound identifier 60180. european medicines agency schedules zanoterone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00139mig. the term zanoterone is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). zanoterone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zanoterone under hs 29372900 and sitc 54153. as of q4 2014, zanoterone remains the us fda preferred term for this commodity. zanoterone bears us nlm identifiers umls id c0078493 and nci concept code c74123. smiles: s(=o)(=o)(n1nc2cc3c(c4c(c5c(cc4)(c(o)(cc5)c#c)c)cc3)(cc2c1)c)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. tamoxifen. this classification denotes a selective estrogen receptor modulator and protein kinase c inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 094zi81y45. european medicines agency schedules tamoxifen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10825mig. tamoxifen generally arises in the molecular formula c26h29no. the term tamoxifen is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13.) tamoxifen is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tamoxifen under hs 29221980 and sitc 51461. as of q4 2014, tamoxifen remains us fdas preferred term for this commodity. tamoxifen bears us nlm identifiers umls id c0039286 and nci concept code c62078. smiles: o(c1ccc(/c(=c(\\cc)c2ccccc2)c2ccccc2)cc1)ccn(c)c.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. tamoxifen citrate. this classification denotes a selective estrogen receptor modulator and protein kinase c inhibitor with the molecular formula c26h29no.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7frv7310n6. european medicines agency schedules tamoxifen citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04672mig. the term tamoxifen citrate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule tamoxifen citrate under hs 29221990 and sitc 51461. as of q4 2014, tamoxifen citrate remains us fdas preferred term for this commodity. tamoxifen citrate bears us nlm identifiers umls id c0919390 and nci concept code c855. smiles: cc/c(=c(\\c1ccccc1)/c2ccc(cc2)occn(c)c)/c3ccccc3.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. anastrozole. this classification denotes a non-steroidal aromatase inhibitor with the molecular formula c17h19n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2z07myw1az, chemically known as 1,3-benzenediacetonitrile, alpha,alpha,alpha,alpha-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)- but more generally known as anastrozole, which bears us nih compound identifier 2187. european medicines agency schedules anastrozole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05502mig. the term anastrozole is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules anastrozole in its anatomical therapeutic chemical (atc) classification. anastrozole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule anastrozole under hs 29339990 and sitc 51577. as of q4 2014, anastrozole remains us fdas preferred term for this commodity. anastrozole bears us nlm identifiers umls id c0290883 and nci concept code c1607. smiles: n1(ncnc1)cc1cc(c(c)(c)c#n)cc(c(c)(c)c#n)c1.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. leuprorelin. this classification denotes a gonadotropin-releasing hormone analog, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier efy6w0m8tg. european medicines agency schedules leuprolide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08449mig. leuprolide generally arises in the molecular formula c59h84n16o12. the term leuprolide is a european pharmacopoeia designation.. "
"hormones and antihormones. this classification denotes chemical substances having a specific regulatory effect on the activity of a certain organ or organs. the term was originally applied to substances secreted by various endocrine glands and transported in the bloodstream to the target organs. it is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. this classification also codifies preparations that prohibit the function of hormones or, at any rate, reduces their affects.. enzalutamide. an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-resistant prostate cancer.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. . "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. asparaginase. this classification denotes a natural antineoplastic product hydrolase enzyme that converts l-asparagine and water to l-aspartate and nh3. ec 3.5.1.1. with the molecular formula c1377h2208n382o442s17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g4fq3cky5r, chemically known as e. coli l-asparagine amidohydrolase but generally known as asparaginase. european medicines agency schedules asparaginase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12950mig. world health organization schedules asparaginase in its anatomical therapeutic chemical (atc) classification. as of q4 2014, asparaginase remains the us fda preferred term for this commodity.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. paclitaxel. this classification denotes a taxane compound and taxane-site binding agent with the molecular formula c47h51no14, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p88xt4is4d, chemically known as 12-benzoate, 9-ester with (2r,3s)-n-benzoyl-3-phenylisoserine but generally known as paclitaxel, which bears us nih compound identifier 36314. european medicines agency schedules paclitaxel in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09583mig. the term paclitaxel is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules paclitaxel in its anatomical therapeutic chemical (atc) classification. paclitaxel is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule paclitaxel under hs 29329950 and sitc 51569. as of q4 2014, paclitaxel remains the us fda preferred term for this commodity. paclitaxel bears us nlm identifiers umls id c0144576 and nci concept code c1411. smiles: o1c2c(oc(=o)c)(c3c(c(o)c2)(c(=o)c(oc(=o)c)c2=c(c(oc(=o)c(o)c(nc(=o)c4ccccc4)c4ccccc4)cc(o)(c3oc(=o)c3ccccc3)c2(c)c)c)c)c1.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. porfimer sodium. this classification denotes a photosensitizing agent with the molecular formula (c34h35n4nao5)n.(c34h33n4nao4)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier y3834sik5f, chemically known as 21h,23h-porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21h,23h-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl- but generally known as porfimer sodium, which bears us nih compound identifier 57166. european medicines agency schedules porfimer sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03955mig. the term porfimer sodium is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules porfimer sodium in its anatomical therapeutic chemical (atc) classification. most nations schedule porfimer sodium under hs 38249064 and sitc 59899. as of q4 2014, porfimer sodium remains the us fda preferred term for this commodity. porfimer sodium bears us nlm identifiers umls id c0058031 and nci concept code c1071. smiles: cc1=c(c2=cc3=nc(=cc4=nc(=cc5=c(c(=c(n5)c=c1n2)c(c)oc(c)c6=c(c7=cc8=c(c(=c(n8)c=c9c(=c(c(=n9)c=c1c(=c(c(=n1)c=c6n7)c)ccc(=o)o)ccc(=o)o)c)c)c(c)o)c)c)c(=c4ccc(=o)o)c)c(=c3c)ccc(=o)o)c(c)o.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. pegaspargase. this classification denotes a protein synthesis inhibitor with the molecular formula c1377h2208n382o442s17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7d96ir0ppm, more generally known as pegaspargase. european medicines agency schedules pegaspargase in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03666mig. the term pegaspargase is an international non-proprietary name or inn. see who inn reference publication, volume 5, no. 3 1991, list 31. pegaspargase is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pegaspargase under hs 35079090 and sitc 51691. as of q4 2014, pegaspargase remains the us fda preferred term for this commodity. pegaspargase bears us nlm identifiers umls id c0071568 and nci concept code c1200. smiles: none.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. sodium phenylbutyrate. this classification denotes a phenylbutyrate and antineoplastic agent with the molecular formula c10h11o2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nt6k61736t, chemically known as benzenebutanoic acid, sodium salt but generally known as sodium phenylbutyrate, which bears us nih compound identifier 15585. european medicines agency schedules sodium phenylbutyrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12586mig. world health organization schedules sodium phenylbutyrate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, sodium phenylbutyrate remains the us fda preferred term for this commodity. sodium phenylbutyrate bears us nlm identifiers umls id c0718066 and nci concept code c1440. smiles: c1=cc=c(c=c1)cccc(=o)[o-].[na+].. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. aminolevulinic acid. this classification denotes a photosensitizing agent with the molecular formula c5h9no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 88755taz87, chemically known as pentanoic acid, 5-amino-4-oxo-, hydrochloride but generally known as aminolevulinic acid, which bears us nih compound identifier 137. european medicines agency schedules aminolevulinic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12853mig. world health organization schedules aminolevulinic acid in its anatomical therapeutic chemical (atc) classification. as of q4 2014, aminolevulinic acid remains the us fda preferred term for this commodity. aminolevulinic acid bears us nlm identifiers umls id c0002563 and nci concept code c234. smiles: o=c(ccc(=o)o)cn.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. methyl aminolevulinate. this classification denotes a photosensitizing agent with the molecular formula c6h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 585nm85kym, chemically known as pentanoic acid, 5-amino-4-oxo-, methyl ester but generally known as methyl aminolevulinate, which bears us nih compound identifier 157922. european medicines agency schedules methyl aminolevulinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22645. world health organization schedules methyl aminolevulinate in its anatomical therapeutic chemical (atc) classification. as of q4 2014, methyl aminolevulinate remains the us fda preferred term for this commodity. methyl aminolevulinate bears us nlm identifiers umls id c1134467 and nci concept code c76305. smiles: o(c(=o)ccc(=o)cn)c.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. paclitaxel poliglumex. this classification denotes a taxane compound and paclitaxel preparation, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tq64fz98zn. european medicines agency schedules paclitaxel poliglumex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27755. paclitaxel poliglumex generally arises in the molecular formula c10h16n2o7(c52h56n2o16)n(c5h7no3)n. the term paclitaxel poliglumex is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 3, 2004, list 52.) most nations schedule paclitaxel poliglumex under hs 39089000 and sitc 57539. as of q4 2014, paclitaxel poliglumex remains the us fda preferred term for this commodity. paclitaxel poliglumex bears us nlm identifiers umls id c1702776 and nci concept code c1795. smiles: cc1=c2c(c(=o)c3(c(cc4c(c3c(c(c2(c)c)(cc1oc(=o)c(c(c5=cc=cc=c5)nc(=o)c6=cc=cc=c6)oc(=o)ccc(c(=o)nc(ccc(=o)o)c(=o)o)nc(=o)c(ccc(=o)o)n)o)oc(=o)c7=cc=cc=c7)(co4)oc(=o)c)o)c)oc(=o)c.. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. porfimer. this classification denotes a photosensitizing agent with the molecular formula (c34h36n4o5)n.(c34h34n4o4)n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m15h03k69b, chemically known as 21h,23h-porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21h,23h-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl- but generally known as porfimer, which bears us nih compound identifier 57166. european medicines agency schedules porfimer in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03954mig. porfimer is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, porfimer remains the us fda preferred term for this commodity. porfimer bears us nlm identifiers umls id cl386365 and nci concept code c76306. smiles: cc1=c(c2=cc3=nc(=cc4=nc(=cc5=c(c(=c(n5)c=c1n2)c(c)oc(c)c6=c(c7=cc8=c(c(=c(n8)c=c9c(=c(c(=n9)c=c1c(=c(c(=n1)c=c6n7)c)ccc(=o)o)ccc(=o)o)c)c)c(c)o)c)c)c(=c4ccc(=o)o)c)c(=c3c)ccc(=o)o)c(c)o. .. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. temoporfin. this classification denotes a photosensitizing agent with the molecular formula c44h32n4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fu21s769pf, chemically known as 3,3,3,3-(7,8-dihydroporphyrin-5,10,15,20-tetrayl)tetraphenol but generally known as temoporfin, which bears us nih compound identifier 60751. european medicines agency schedules temoporfin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10888mig. the term temoporfin is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules temoporfin in its anatomical therapeutic chemical (atc) classification. as of q4 2014, temoporfin remains the us fda preferred term for this commodity. temoporfin bears us nlm identifiers umls id c0379149 and nci concept code c1669. smiles: oc1cc(c2=c3[nh]c(=c(c4=nc(=c(c5[nh]c(c(=c6n=c2cc6)c2cc(o)ccc2)cc5)c2cc(o)ccc2)c=c4)c2cc(o)ccc2)cc3)ccc1. .. "
"natural antineoplastic products. this classification denotes s natural substances that inhibit or prevent the proliferation of new abnormal growths of tissue or neoplasms.. paclitaxel ceribate. this classification denotes a taxane compound and taxane-site binding agent c51h57no18, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b3c86e80a0, chemically known as 7.beta.-((2rs)-2,3-dihydroxypropoxycarbonyloxy)-1-hydroxy-9-oxo-5.beta.,20-epoxytax-11-ene-2.alpha.,4,10.beta.,13.alpha.-tetrayl 4,10-diacetate 2-benzoate 13-((2r,3s)-3-benzamido-2-hydroxy-3-phenylpropanoate), but more generally known as paclitaxel ceribate, which bears us nih compound identifier 16760673. as of q4 2014, paclitaxel ceribate remains us fdas preferred term for this commodity. paclitaxel ceribate bears us nlm identifiers umls id c3273125 and nci concept code c96934. most nations, for tariff and trade purposes, schedule paclitaxel ceribate under hs 29329950 and sitc 51569. smiles: cc1=c2[c@h](c(=o)[c@@]3([c@h](c[c@@h]4[c@]([c@h]3[c@@h]([c@@](c2(c)c)(c[c@@h]1oc(=o)[c@@h]([c@@h](c5ccccc5)nc(=o)c6ccccc6)o)o)oc(=o)c7ccccc7)(co4)oc(=o)c)oc(=o)occ(co)o)c)oc(=o)c.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. . "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. capecitabine. this classification denotes a pyrimidine antagonist with the molecular formula c15h22fn3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6804dj8z9u, chemically known as pentyl 1-(5-deoxy-beta-d-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinecarbamate but generally known as capecitabine, which bears us nih compound identifier 60953. european medicines agency schedules capecitabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12474mig. the term capecitabine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules capecitabine in its anatomical therapeutic chemical (atc) classification. most nations schedule capecitabine under hs 29349990 and sitc 51579. as of q4 2014, capecitabine remains the us fda preferred term for this commodity. capecitabine bears us nlm identifiers umls id c0671970 and nci concept code c1794. smiles: fc1cn(c2oc(c(o)c2o)c)c(=o)nc1nc(=o)occccc.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. dasatinib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c22h26cln7o2s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rbz1571x5h, chemically known as 5-thiazolecarboxamide, n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)- but generally known as dasatinib, which bears us nih compound identifier 3062316. european medicines agency schedules dasatinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23322. world health organization schedules dasatinib in its anatomical therapeutic chemical (atc) classification. most nations schedule dasatinib under hs 29341000 and sitc 51579. as of q4 2014, dasatinib remains the us fda preferred term for this commodity. dasatinib bears us nlm identifiers umls id c1455147 and nci concept code c38713. smiles: clc1c(nc(=o)c2sc(nc3nc(nc(n4ccn(cc4)cco)c3)c)nc2)c(ccc1)c.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. erlotinib. this classification denotes an epidermal growth factor receptor tyrosine kinase inhibitor with the molecular formula c22h23n3o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j4t82ndh7e, chemically known as 4-quinazolinamine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, but generally known as erlotinib, which bears us nih compound identifier 176870. european medicines agency schedules erlotinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub16423mig. the term erlotinib is an international non-proprietary name. world health organization schedules erlotinib in its anatomical therapeutic chemical (atc) classification. most nations schedule erlotinib under hs 29335995 and sitc 51576. as of q4 2014, erlotinib remains the us fda preferred term for this commodity. erlotinib bears us nlm identifiers umls id c1135135 and nci concept code c65530. smiles: o(c1c(occoc)cc2ncnc(nc3cc(ccc3)c#c)c2c1)ccoc.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. gefitinib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c22h24clfn4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s65743jhbs, chemically known as 4-quinazolinamine, n-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)- but generally known as gefitinib, which bears us nih compound identifier 123631. european medicines agency schedules gefitinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20637. the term gefitinib is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). world health organization schedules gefitinib in its anatomical therapeutic chemical (atc) classification. most nations schedule gefitinib under hs 29349990 and sitc 51579. as of q4 2014, gefitinib remains the us fda preferred term for this commodity. gefitinib bears us nlm identifiers umls id c1122962 and nci concept code c1855. smiles: clc1cc(nc2ncnc3c2cc(occcn2ccocc2)c(oc)c3)ccc1f.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. imatinib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c29h31n7o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bkj8m8g5hi, chemically known as benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)- but generally known as imatinib, which bears us nih compound identifier 5291. european medicines agency schedules imatinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25387. the term imatinib is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). world health organization schedules imatinib in its anatomical therapeutic chemical (atc) classification. most nations schedule imatinib under hs 29335995 and sitc 51576. as of q4 2014, imatinib remains the us fda preferred term for this commodity. imatinib bears us nlm identifiers umls id c0935989 and nci concept code c62035. smiles: o=c(nc1cc(nc2nc(c3cccnc3)ccn2)c(cc1)c)c1ccc(cn2ccn(cc2)c)cc1.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. pazopanib. this classification denotes a tyrosine kinase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7rn5dr86ck. european medicines agency schedules pazopanib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29175. pazopanib generally arises in the molecular formula c21h23n7o2s. the term pazopanib is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 3, 2006, list 56.) as of q4 2014, pazopanib remains the us fda preferred term for this commodity. pazopanib bears us nlm identifiers umls id c1831796 and nci concept code c74547. smiles: cc1=c(c=c(c=c1)nc2=nc=cc(=n2)n(c)c3=cc4=nn(c(=c4c=c3)c)c)s(=o)(=o)n.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. semaxanib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c15h14n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71ia9s35aj, chemically known as 3-((z)-(3,5-dimethylpyrrol-2-yl)methylene)-2-indolinone but generally known as semaxanib, which bears us nih compound identifier 5329098. european medicines agency schedules semaxanib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32269. the term semaxanib is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). most nations schedule semaxanib under hs 29337900 and sitc 51561. as of q4 2014, semaxanib remains the us fda preferred term for this commodity. semaxanib bears us nlm identifiers umls id c1135174 and nci concept code c1831. smiles: o=c1nc2c(/c1=c/c1[nh]c(cc1c)c)cccc2.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. sorafenib. this classification denotes a protein kinase inhibitor with the molecular formula c21h16clf3n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9zoq3tzi87, chemically known as 2-pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-n-methyl- but generally known as sorafenib, which bears us nih compound identifier 216239. european medicines agency schedules sorafenib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23139. the term sorafenib is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules sorafenib in its anatomical therapeutic chemical (atc) classification. most nations schedule sorafenib under hs 29333999 and sitc 51574. as of q4 2014, sorafenib remains the us fda preferred term for this commodity. sorafenib bears us nlm identifiers umls id c1516119 and nci concept code c61948. smiles: clc1c(cc(nc(=o)nc2ccc(oc3cc(ncc3)c(=o)nc)cc2)cc1)c(f)(f)f.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. sunitinib. this classification denotes a tyrosine kinase inhibitor and angiogenesis activator inhibitor with the molecular formula c22h27fn4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v99t50803m, chemically known as 1h-pyrrole-3-carboxamide, n-(2-(diethylamino)ethyl)-5-((z)-(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl)-2,4-dimethyl- but generally known as sunitinib, which bears us nih compound identifier 5329102. european medicines agency schedules sunitinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22321. the term sunitinib is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55). world health organization schedules sunitinib in its anatomical therapeutic chemical (atc) classification. sunitinib is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sunitinib under hs 29337900 and sitc 51561. as of q4 2014, sunitinib remains the us fda preferred term for this commodity. sunitinib bears us nlm identifiers umls id c1176020 and nci concept code c71622. smiles: fc1cc2/c(=c/c3[nh]c(c(c3c)c(=o)nccn(cc)cc)c)c(=o)nc2cc1.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. vandetanib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c22h24brfn4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yo460oq37k, chemically known as 4-quninazolinamine, n-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)- but generally known as vandetanib, which bears us nih compound identifier 3081361. european medicines agency schedules vandetanib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29174. the term vandetanib is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53). world health organization schedules vandetanib in its anatomical therapeutic chemical (atc) classification. most nations schedule vandetanib under hs 29335995 and sitc 51576. as of q4 2014, vandetanib remains the us fda preferred term for this commodity. vandetanib bears us nlm identifiers umls id c1384659 and nci concept code c2737. smiles: brc1cc(f)c(nc2ncnc3cc(occ4ccn(cc4)c)c(oc)cc23)cc1.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. vatalanib. this classification denotes a tyrosine kinase inhibitor with the molecular formula c20h15cln4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5dx9u76296, chemically known as 1-phthalazinamine, n-(4-chlorophenyl)-4-(4-pyridinylmethyl)- but generally known as vatalanib, which bears us nih compound identifier 151194. european medicines agency schedules vatalanib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26999. the term vatalanib is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 3-4, 2001, list 46). most nations schedule vatalanib under hs 29333999 and sitc 51574. as of q4 2014, vatalanib remains the us fda preferred term for this commodity. vatalanib bears us nlm identifiers umls id c0912586 and nci concept code c1868. smiles: clc1ccc(nc2nnc(c3c2cccc3)cc2ccncc2)cc1.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. afatinib. this classification denotes a quinazoline and antineoplastic agent and tyrosine kinase inhibitor, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 41ud74l59m. european medicines agency schedules afatinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32268. as of q4 2014, afatinib remains the us fda preferred term for this commodity. afatinib bears us nlm identifiers umls id c1879772 and nci concept code c66940. smiles: cn(c)c/c=c/c(=o)nc1=c(c=c2c(=c1)c(=nc=n2)nc3=cc(=c(c=c3)f)cl)o[c@h]4ccoc4.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. dasatinib hydrate. this classification denotes a tyrosine kinase inhibitor with the molecular formula c22h26cln7o2s.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rbz1571x5h, chemically known as 5-thiazolecarboxamide, n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)- but more generally known as dasatinib, which bears us nih compound identifier 3062316. european medicines agency schedules dasatinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23322. world health organization schedules dasatinib in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule dasatinib hydrate under hs 29341000. smiles: cc1cccc(c1nc(=o)c2cnc(s2)nc3cc(nc(n3)c)n4ccn(cc4)cco)cl.o.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. erlotinib hydrochloride. this classification denotes an epidermal growth factor receptor tyrosine kinase inhibitor with the molecular formula c22h23n3o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier da87705x9k, chemically known as 4-quinazolinamine, n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride but more generally known as erlotinib hydrochloride, which bears us nih compound identifier 176871. european medicines agency schedules erlotinib hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21050. as of q4 2014, erlotinib hydrochloride remains us fdas preferred term for this commodity. erlotinib hydrochloride bears us nlm identifiers umls id c0910101 and nci concept code c2693. most nations, for tariff and trade purposes, schedule erlotinib hydrochloride under hs 29335995 and sitc 51576. smiles: coccoc1cc2c(cc1occoc)ncnc2nc3cccc(c3)c#c.cl.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. imatinib mesiate or mesylate. this classification denotes a tyrosine kinase inhibitor with the molecular formula c29h31n7o.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8a1o1m485b, chemically known as benzamide, 4-((4-methyl-1-piperazinyl)methyl)-n-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)aminophenyl)-, methanesulfonate salt, but more generally known as imatinib mesylate, which bears us nih compound identifier 5291. european medicines agency schedules imatinib mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25387. as of q4 2014, imatinib mesylate remains us fdas preferred term for this commodity. imatinib mesylate bears us nlm identifiers umls id c0939537 and nci concept code c1687. most nations, for tariff purposes, schedule imatinib mesylate under hs 29335995. smiles: cc1ccc(cc1nc2nccc(n2)c3cccnc3)nc(=o)c4ccc(cc4)cn5ccn(cc5)c.cs(=o)(=o)o.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. sorafenib tosylate. this classification denotes a protein kinase inhibitor with the molecular formula c21h16clf3n4o3.c7h8o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5t62q3b36j, chemically known as 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate), but more generally known as sorafenib tosylate, which bears us nih compound identifier 216239. european medicines agency schedules sorafenib tosylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub23139. sorafenib tosylate bears us nlm identifiers umls id c1676709 and nci concept code c2194. most nations, for tariff purposes, schedule sorafenib tosylate under hs 29333999. smiles: cc1ccc(cc1)s(=o)(=o)o.cnc(=o)c1cc(ccn1)oc2ccc(cc2)nc(=o)nc3ccc(c(c3)c(f)(f)f)cl.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. sunitinib malate. this classification denotes a tyrosine kinase inhibitor and angiogenesis activator inhibitor with the molecular formula c22h27fn4o2.c4h6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lvx8n1ut73. european medicines agency schedules sunitinib malate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22366. the term sunitinib malate is a united states adopted name designation. as of q4 2014, sunitinib malate remains us fdas preferred term for this commodity. sunitinib malate bears us nlm identifiers umls id c1700685 and nci concept code c26673. most nations, for tariff and trade purposes, schedule sunitinib malate under hs 29337900 and sitc 51561. smiles: ccn(cc)ccnc(=o)c1c(c([nh]c1c)/c=c\\2/c3cc(ccc3nc2=o)f)c.c([c@@h](c(=o)o)o)c(=o)o.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. vatalanib succinate. this classification denotes a tyrosine kinase inhibitor with the molecular structure c20h15cln4.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, v5fub77031 chemically known as 1-phthalazinamine, n-(4-chlorophenyl)-4-(4-pyridinylmethyl)-, butanedioate (1:1), but more commonly known as vatalanib succinate, which bears us nih compound identifier 151193. european medicines agency schedules vatalanib succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32570. as of q4 2014, vatalanib succinate remains us fdas preferred term for this commodity. vatalanib succinate bears us nlm identifiers umls id c1524078 and nci concept code c74945. most nations, for tariff and trade purposes, schedule vatalanib succinate under hs 29333999 and sitc 51574. smiles: c1ccc2c(c1)c(nnc2nc3ccc(cc3)cl)cc4ccncc4.c(cc(=o)o)c(=o)o.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. bosutinib. this classification denotes a tyrosine kinase inhibitor with the molecular structure c26h29cl2n5o3, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier, 5018v4aez0 chemically known as 3-quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methyl-1-piperazinyl)propoxy)-, but more commonly known as bosutinib, which bears u.s. national institutes of health compound identifier 5328940. european medicines agency schedules bosutinib in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29176. the term bosutinib is an international non-proprietary name or inn (see world health organization inn reference publication, volume 20, no. 3, 2006, list 56).. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. ceritinib. a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (alk)-positive metastatic non-small cell lung cancer (nsclc) who have progressed on or are intolerant to crizotinib.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. palbociclib. a kinase inhibitor indicated for the treatment of hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as initial endocrine based therapy in postmenopausal women or fulvestrant in women with disease progression following endocrine therapy.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. ibrutinib. a type of kinase inhibitor. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. ruxolitinib. a type of kinase inhibitor used to treat myelofibrosis.. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. idelalisib. a type of kinase inhibitor. "
"tyrosine kinase inhibitors. this classification denotes a protein-tyrosine kinase family that was originally identified by homology to the rous sarcoma virus oncogene protein pp60(v-src). they interact with a variety of cell-surface receptors and participate in intracellular signal transduction pathways. oncogenic forms of src-family kinases can occur through altered regulation or expression of the endogenous protein and by virally encoded src (v-src) genes.. trametinib. a type of kinase inhibitor. "
"antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors. this classification denotesantineoplastic agents made from or based in part on antineoplastic agent immunotoxins, or antineoplastic keratinocyte growth factors. . "
"antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors. this classification denotesantineoplastic agents made from or based in part on antineoplastic agent immunotoxins, or antineoplastic keratinocyte growth factors. denileukin diftitox. this classification denotes an immunotoxin and fusion toxin with the molecular formula c2560h4042n678o799s17, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 25e79b5ctm, more generally known as denileukin diftitox. european medicines agency schedules denileukin diftitox in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06975mig. the term denileukin diftitox is an international non-proprietary name or inn. see who inn reference publication, volume 12 no. 2 1999, list 40. as of q4 2014, denileukin diftitox remains the us fda preferred term for this commodity.. "
"antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors. this classification denotesantineoplastic agents made from or based in part on antineoplastic agent immunotoxins, or antineoplastic keratinocyte growth factors. palifermin. this classification denotes a therapeutic fibroblast growth factor with the molecular formula c729h1156n204o207s10, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qms40680k6, more generally known as palifermin. european medicines agency schedules palifermin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21058. the term palifermin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3, 2002, list 48. most nations schedule palifermin under hs 29332990 and sitc 51573. smiles:. as of q4 2014, palifermin remains the us fda preferred term for this commodity. . palifermin bears us nlm identifiers umls id c0677829 and nci concept code c2455.. "
"antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors. this classification denotesantineoplastic agents made from or based in part on antineoplastic agent immunotoxins, or antineoplastic keratinocyte growth factors. alitretinoin. this classification denotes a retinoic acid agent with the molecular formula c20h28o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1ua8e65kdz, chemically known as 2,4,6,8-nonatetraenoic acid, 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (all-e)- but more generally known as alitretinoin, which bears us nih compound identifier 444795. european medicines agency schedules alitretinoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00344mig. the term alitretinoin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules alitretinoin in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule alitretinoin under hs 29362100 and sitc 54112. as of q4 2014, alitretinoin remains us fdas preferred term for this commodity. alitretinoin bears us nlm identifiers umls id c0281666 and nci concept code c1574. smiles: oc(=o)/c=c(/c=c/c=c(/c=c/c1=c(cccc1(c)c)c)c)c.. "
"antineoplastic agents, antineoplastic agent immunotoxins and antineoplastic keratinocyte growth factors. this classification denotesantineoplastic agents made from or based in part on antineoplastic agent immunotoxins, or antineoplastic keratinocyte growth factors. etoglucid. this classification denotes an antineoplastic alkylating agent with the molecular formula c12h22o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4f9kua0t4d, chemically known as 4,7,10,13-tetraoxahexadecane, 1,2:15,16-diepoxy- (8ci) but more generally known as etoglucid, which bears us nih compound identifier 16058. european medicines agency schedules etoglucid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07326mig. the term etoglucid is an international non-proprietary name. world health organization schedules etoglucid in its anatomical therapeutic chemical (atc) classification. etoglucid is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule etoglucid under hs 29109000 and sitc 51615. as of q4 2014, etoglucid remains us fdas preferred term for this commodity. etoglucid bears us nlm identifiers umls id c0015039 and nci concept code c489. smiles: o1c(c1)coccoccoccocc1oc1.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. . "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. bleomycin/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an200. this va drug class (an200) classifies this compound as belonging to the group antineoplastic antibiotics.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. cyclophosphamide/mannitol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an100. this va drug class (an100) classifies this compound as belonging to the group antineoplastics, alkylating agents.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. doxorubicin/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an200. this va drug class (an200) classifies this compound as belonging to the group antineoplastic antibiotics.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. ifosfamide/mesna. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an100. this va drug class (an100) classifies this compound as belonging to the group antineoplastics, alkylating agents.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. methotrexate/sodium chloride. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an300. this va drug class (an300) classifies this compound as belonging to the group antineoplastics, antimetabolites.. "
"combination antineoplastics. this classification denotes combination drugs that inhibit or prevent the proliferation of neoplasms, or proliferation of new abnormal growths of tissue, and which are therefore called anti-neoplastics or antineoplastics. typical combination antineoplastic constituents are bleomycin, cyclophosphamide, doxorubicin, ifosfamide, methotrexate, and sodium chloride.. sodium chloride/vinblastine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class an900. this va drug class (an900) classifies this compound as belonging to the group antineoplastic, other.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. . "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. busulfan. this classification denotes an alkylsulfonate compound with the molecular formula c6h14o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier g1ln9045dk, chemically known as 1,4-dimethylsulfonyloxybutane but more generally known as busulfan, which bears us nih compound identifier 2478. busulfan most often comes in base and mannitol forms. european medicines agency schedules busulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05993mig. the term busulfan is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules busulfan in its anatomical therapeutic chemical (atc) classification. busulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule busulfan under hs 29053985 and sitc 51229. as of q4 2014, busulfan remains us fdas preferred term for this commodity. busulfan bears us nlm identifiers umls id c0700015 and nci concept code c321. smiles: s(=o)(=o)(occccos(=o)(=o)c)c.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. improsulfan. this classification denotes an alkylsulfonate compound with the molecular formula c8h19no6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 32y1f7n1zd, chemically known as 3,3-iminodi-1-propanol dimethanesulfonate (ester) but more generally known as improsulfan, which bears us nih compound identifier 18949. european medicines agency schedules improsulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08160mig. the term improsulfan is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). improsulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule improsulfan under hs 29221980 and sitc 51461. as of q4 2014, improsulfan remains us fdas preferred term for this commodity. improsulfan bears us nlm identifiers umls id c1512683 and nci concept code c2308. smiles: s(=o)(=o)(occcncccos(=o)(=o)c)c.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. improsulfan hydrochloride. this classification denotes an alkylsulfonate compound c8h19no6s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ghx2mnt176, chemically known as 1-propanol, 3,3-iminobis-, dimethanesulfonate (ester), hydrochloride, but more generally known as improsulfan hydrochloride, which bears us nih compound identifier 18948. most nations, for tariff and trade purposes, schedule improsulfan hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, improsulfan hydrochloride remains us fdas preferred term for this commodity. smiles: cs(=o)(=o)occcncccos(=o)(=o)c.cl.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. improsulfan tosilate. this classification denotes an alkylsulfonate compound with the molecular formula c8h19no6s2.c7h8o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v878j97jff, chemically known as bis(3-methylsulfonyloxypropyl)amine p-toluenesulfonate, but more generally known as improsulfan tosilate, which bears us nih compound identifier 153709. european medicines agency schedules improsulfan tosilate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08160mig. most nations, for tariff purposes, schedule improsulfan tosilate under hs 29221980. smiles: cc1ccc(cc1)s(=o)(=o)o.cs(=o)(=o)occcncccos(=o)(=o)c.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. mannosulfan. this classification denotes an alkylsulfonate compound with the molecular formula c10h22o14s4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 135fq40l36, chemically known as 1,2,5,6-tetramethanesulphonyl-d-mannite but more generally known as mannosulfan, which bears us nih compound identifier 24140. european medicines agency schedules mannosulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08644mig. the term mannosulfan is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules mannosulfan in its anatomical therapeutic chemical (atc) classification. mannosulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mannosulfan under hs 29054980 and sitc 51229. as of q4 2014, mannosulfan remains us fdas preferred term for this commodity. mannosulfan bears us nlm identifiers umls id c0065696 and nci concept code c83904. smiles: cs(=o)(=o)occ(c(c(c(cos(=o)(=o)c)os(=o)(=o)c)o)o)os(=o)(=o)c.. "
"alkylating agent alkanesulfonic acids. this classification denotes sulfonic acid derivatives that are substituted with an aliphatic hydrocarbon group, substances called alkanesulfonic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkanesulfonic acids.. treosulfan. this classification denotes an alkylsulfonate compound with the molecular formula c6h14o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier co61er3epi, chemically known as 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate, (s-(r*,r*))- (9ci) but more generally known as treosulfan, which bears us nih compound identifier 9296. european medicines agency schedules treosulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11235mig. the term treosulfan is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules treosulfan in its anatomical therapeutic chemical (atc) classification. treosulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule treosulfan under hs 29054980 and sitc 51229. as of q4 2014, treosulfan remains us fdas preferred term for this commodity. treosulfan bears us nlm identifiers umls id c0076959 and nci concept code c1257. smiles: s(=o)(=o)(occ(o)c(o)cos(=o)(=o)c)c.. "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. . "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. amifostine monohydrate. this classification denotes a cytoprotective agent with the molecular formula c5h15n2o3ps.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l693h6mm64, chemically known as ethanethiol, 2-((3-aminopropyl)amino)-, dihydrogen phosphate (ester), monohydrate, but more generally known as amifostine monohydrate, which bears us nih compound identifier 83996. european medicines agency schedules amifostine monohydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12846mig. most nations, for tariff and trade purposes, schedule amifostine monohydrate under hs 29309085. smiles: c(cn)cnccsp(=o)(o)o.o.. "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. dacarbazine. this classification denotes a triazene compound with the molecular formula c6h10n6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7gr28w0fji, chemically known as 5-(3,3-dimethyltriaz-1-en-1-yl)-1h-imidazole-4-carboxamide but more generally known as dacarbazine, which bears us nih compound identifier 5281007. european medicines agency schedules dacarbazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06882mig. the term dacarbazine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules dacarbazine in its anatomical therapeutic chemical (atc) classification. dacarbazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule dacarbazine under hs 29332990 and sitc 51573. as of q4 2014, dacarbazine remains us fdas preferred term for this commodity. dacarbazine bears us nlm identifiers umls id c0010927 and nci concept code c411. smiles: o=c(n)c1=nc=n/c1=n\\nn(c)c.. "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. dacarbazine citrate. this classification denotes a triazene compound with the molecular formula c6h10n6o.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9uyu348nif. european medicines agency schedules dacarbazine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01547mig. as of q4 2014, dacarbazine citrate remains us fdas preferred term for this commodity. most nations, for tariff and trade purposes, schedule dacarbazine citrate under hs 29332990 and sitc 51573. smiles: cn(c)/n=n/c1c(nc[nh]1)c(=o)n.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. procarbazine. this classification denotes a triazene compound with the molecular formula c12h19n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 35s93y190k, chemically known as p-toluamide, n-isopropyl-.alpha.- (2-methylhydrazino)-, monohydrochloride but more generally known as procarbazine, which bears us nih compound identifier 4915. european medicines agency schedules procarbazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10057mig. the term procarbazine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules procarbazine in its anatomical therapeutic chemical (atc) classification. procarbazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule procarbazine under hs 29280090 and sitc 51486. as of q4 2014, procarbazine remains us fdas preferred term for this commodity. procarbazine bears us nlm identifiers umls id c0033223 and nci concept code c62072. smiles: cc(c)nc(=o)c1=cc=c(c=c1)cnnc.. "
"alkylating agent amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amides.. procarbazine hydrochloride. this classification denotes an antineoplastic agent with the molecular formula c12h19n3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xh0nph5zx8, chemically known as p-toluamide, n-isopropyl-.alpha.- (2-methylhydrazino)-, monohydrochloride but more generally known as procarbazine hydrochloride, which bears us nih compound identifier 4915. european medicines agency schedules procarbazine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15017mig. as of q4 2014, procarbazine hydrochloride remains us fdas preferred term for this commodity. procarbazine hydrochloride bears us nlm identifiers umls id c0205909 and nci concept code c773. most nations, for tariff and trade purposes, schedule procarbazine hydrochloride under hs 29280090 and sitc 51486. smiles: cc(c)nc(=o)c1ccc(cc1)cnnc.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. . "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. ambamustine. this classification denotes a nitrogen mustard compound with the molecular formula c29h39cl2fn4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ib1h345f24, chemically known as n-(3-(m-(bis(2-chloroethyl)amino)phenyl)-n-(3-(p-fluorophenyl)-l-alanyl)-l-alanyl)-l-methionine, ethyl ester but more generally known as ambamustine, which bears us nih compound identifier 178137. ambamustine most often comes in base and hydrochloride forms. european medicines agency schedules ambamustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05392mig. the term ambamustine is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). ambamustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ambamustine under hs 29309085 and sitc 51549. as of q4 2014, ambamustine remains us fdas preferred term for this commodity. ambamustine bears us nlm identifiers umls id c0244456 and nci concept code c73320. smiles: clccn(c1cc(cc(nc(=o)c(n)cc2ccc(f)cc2)c(=o)nc(ccsc)c(=o)occ)ccc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. atrimustine. this classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula c41h47cl2no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xc0k09b7k4, chemically known as estradiol 3-benzoate 17-glycolate, 4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate but more generally known as atrimustine, which bears us nih compound identifier 53181. european medicines agency schedules atrimustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05605mig. the term atrimustine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). atrimustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule atrimustine under hs 29224995 and sitc 51465. as of q4 2014, atrimustine remains us fdas preferred term for this commodity. atrimustine bears us nlm identifiers umls id c0105764 and nci concept code c1348. smiles: clccn(c1ccc(cccc(=o)occ(=o)oc2c3(c(c4c(cc3)c3c(cc4)cc(oc(=o)c4ccccc4)cc3)cc2)c)cc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. bendamustine. this classification denotes a nitrogen mustard compound with the molecular formula c16h21cl2n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9266d9p3pq, chemically known as 2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride but more generally known as bendamustine, which bears us nih compound identifier 65628. bendamustine most often comes in base and hydrochloride forms. european medicines agency schedules bendamustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05707mig. the term bendamustine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules bendamustine in its anatomical therapeutic chemical (atc) classification. bendamustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule bendamustine under hs 29339990 and sitc 51577. as of q4 2014, bendamustine remains us fdas preferred term for this commodity. bendamustine bears us nlm identifiers umls id c0525079 and nci concept code c73261. smiles: clccn(c1cc2nc(n(c2cc1)c)cccc(=o)o)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. bofumustine. this classification denotes a nitrogen mustard compound with the molecular formula c18h21cln4o9, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6p52d0j76b, chemically known as 1-(2-chloroethyl)-3-(2,3-o-isopropylidene-d-ribofuranosyl)-1-nitrosourea 5-(p-nitrobenzoate) but more generally known as bofumustine, which bears us nih compound identifier 100269. european medicines agency schedules bofumustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05865mig. the term bofumustine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). bofumustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule bofumustine under hs 29329970 and sitc 51569. as of q4 2014, bofumustine remains us fdas preferred term for this commodity. bofumustine bears us nlm identifiers umls id c2825244 and nci concept code c80533. smiles: clccn(n=o)c(=o)nc1oc(c2oc(oc12)(c)c)coc(=o)c1ccc([n](=o)o)cc1.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. chlorambucil. this classification denotes a nitrogen mustard compound with the molecular formula c14h19cl2no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 18d0sl7309, chemically known as p-n,n-di-(beta-chloroethyl)aminophenyl butyric acid but more generally known as chlorambucil, which bears us nih compound identifier 2708. european medicines agency schedules chlorambucil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06172mig. the term chlorambucil is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules chlorambucil in its anatomical therapeutic chemical (atc) classification. chlorambucil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule chlorambucil under hs 29224995 and sitc 51465. as of q4 2014, chlorambucil remains us fdas preferred term for this commodity. chlorambucil bears us nlm identifiers umls id c0008163 and nci concept code c362. smiles: clccn(c1ccc(cccc(=o)o)cc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. chlormethine hydrochloride. this classification denotes a nitrogen mustard compound with the molecular formula c5h11cl2n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l0mr697hhi, chemically known as 2,2-dichloro-n-methyldiethylamine but more generally known as chlormethine hydrochloride, which bears us nih compound identifier 4033. european medicines agency schedules chlormethine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01220mig. most nations, for tariff and trade purposes, schedule chlormethine hydrochloride under hs 29211980. smiles: cn(cccl)cccl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. cyclophosphamide. this classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula c7h15cl2n2o2p.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8n3dw7272p, chemically known as 2h-1,3,2-oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide but more generally known as cyclophosphamide, which bears us nih compound identifier 2907. european medicines agency schedules cyclophosphamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06859mig. world health organization schedules cyclophosphamide in its anatomical therapeutic chemical (atc) classification. cyclophosphamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cyclophosphamide under hs 29349990 and sitc 51579. as of q4 2014, cyclophosphamide remains us fdas preferred term for this commodity. cyclophosphamide bears us nlm identifiers umls id c0010583 and nci concept code c405. smiles: clccn(p1(=o)occcn1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. bendamustine hydrochloride. this classification denotes a nitrogen mustard compound with the molecular formula c16h21cl2n3o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 981y8sx18m, chemically known as 2-benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride but more generally known as bendamustine hydrochloride, which bears us nih compound identifier 77082. the base compound, bendamustine, most often comes in base and hydrochloride forms. european medicines agency schedules bendamustine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00696mig. as of q4 2014, bendamustine hydrochloride remains us fdas preferred term for this commodity. bendamustine hydrochloride bears us nlm identifiers umls id c1529660 and nci concept code c61565. most nations, for tariff and trade purposes, schedule bendamustine hydrochloride under hs 29339990 and sitc 51577. smiles: cn1c2ccc(cc2nc1cccc(=o)o)n(cccl)cccl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. chlormethine or mechlorethamine. this classification denotes a nitrogen mustard compound with the molecular formula c5h11cl2n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 50d9xsg0vr, chemically known as 2,2-dichloro-n-methyldiethylamine but more generally known as chlormethine, which bears us nih compound identifier 4033. european medicines agency schedules chlormethine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06186mig. the term chlormethine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules chlormethine in its anatomical therapeutic chemical (atc) classification. chlormethine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. chlormethine or mechlorethamine bears us nlm identifiers umls id c0025033 and nci concept code c62056. smiles: clccn(cccl)c.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. ifosfamide. this classification denotes a nitrogen mustard compound with the molecular formula c7h15cl2n2o2p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier um20qqm95y, chemically known as 1,3,2-oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide but more generally known as ifosfamide, which bears us nih compound identifier 3690. european medicines agency schedules ifosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08125mig. the term ifosfamide is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules ifosfamide in its anatomical therapeutic chemical (atc) classification. ifosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ifosfamide under hs 29349990 and sitc 51579. as of q4 2014, ifosfamide remains us fdas preferred term for this commodity. ifosfamide bears us nlm identifiers umls id c0020823 and nci concept code c564. smiles: clccn1p(=o)(occc1)ncccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. mafosfamide. this classification denotes a nitrogen mustard compound with the molecular formula c9h19cl2n2o5ps2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5970hh9923, chemically known as ethanesulfonic acid, 2-(((2r,4r)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl)thio)-, rel- but more generally known as mafosfamide, which bears us nih compound identifier 104746. european medicines agency schedules mafosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08635mig. the term mafosfamide is an international non-proprietary name. mafosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mafosfamide under hs 29349990 and sitc 51579. as of q4 2014, mafosfamide remains us fdas preferred term for this commodity. mafosfamide bears us nlm identifiers umls id c0065506 and nci concept code c1150. smiles: clccn(p1(=o)occc(sccs(=o)(=o)o)n1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. mannomustine. this classification denotes a nitrogen mustard compound with the molecular formula c10h22cl2n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e60vwa40d2, chemically known as 1,6-bis(chloroethylamino)-1,6-dideoxy-d-mannite but more generally known as mannomustine, which bears us nih compound identifier 11337. european medicines agency schedules mannomustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08643mig. the term mannomustine is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). mannomustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mannomustine under hs 29221980 and sitc 51461. as of q4 2014, mannomustine remains us fdas preferred term for this commodity. mannomustine bears us nlm identifiers umls id c0024738 and nci concept code c2070. smiles: c(ccl)ncc(c(c(c(cncccl)o)o)o)o.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. melphalan. this classification denotes a nitrogen mustard compound with the molecular formula c13h18cl2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q41or9510p, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)- but more generally known as melphalan, which bears us nih compound identifier 4053. european medicines agency schedules melphalan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08728mig. the term melphalan is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules melphalan in its anatomical therapeutic chemical (atc) classification. melphalan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule melphalan under hs 29224995 and sitc 51465. as of q4 2014, melphalan remains us fdas preferred term for this commodity. melphalan bears us nlm identifiers umls id c0025241 and nci concept code c633. smiles: clccn(c1ccc(cc(n)c(=o)o)cc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. mafosfamide lysine. this classification denotes a nitrogen mustard compound with the molecular formula c9h19cl2n2o5ps2.c6h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hac3dq8pms, chemically known as cis-2-((2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl)thio)ethane sulfonate p-oxide l-lysine, but more generally known as mafosfamide lysine, which bears us nih compound identifier 5362268. european medicines agency schedules mafosfamide lysine or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08635mig. most nations, for tariff purposes, schedule mafosfamide lysine under hs 29349990. smiles: c1co[p@@](=o)(n[c@h]1sccs(=o)(=o)o)n(cccl)cccl.c(ccn)c[c@@h](c(=o)o)n.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. mannomustine dihydrochloride. this classification denotes a nitrogen mustard compound with the molecular formula c10h22cl2n2o4.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uoz2jjz3i5, chemically known as d-mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-, dihydrochloride, but more generally known as mannomustine dihydrochloride, which bears us nih compound identifier 11337. european medicines agency schedules mannomustine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08643mig. most nations, for tariff purposes, schedule mannomustine dihydrochloride under hs 29221980. smiles: c(ccl)nc[c@h]([c@h]([c@@h]([c@@h](cncccl)o)o)o)o.cl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. melphalan flufenamide. this classification denotes a nitrogen mustard compound c24h30cl2fn3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f70c5k4786, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)-l-phenylalanyl-4-fluoro-, ethyl ester, but more generally known as melphalan flufenamide, which bears us nih compound identifier 9935639. most nations, for tariff and trade purposes, schedule melphalan flufenamide under hs 29224995 and sitc 51465. as of q4 2014, melphalan flufenamide remains us fdas preferred term for this commodity. smiles: ccoc(=o)[c@h](cc1ccc(cc1)f)nc(=o)[c@h](cc2ccc(cc2)n(cccl)cccl)n.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. mannomustine hydrochloride. this classification denotes a nitrogen mustard compound c10h22cl2n2o4.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uoz2jjz3i5, chemically known as d-mannitol, 1,6-bis((2-chloroethyl)amino)-1,6-dideoxy-, dihydrochloride, but more generally known as mannomustine hydrochloride, which bears us nih compound identifier 9884430. most nations, for tariff and trade purposes, schedule mannomustine hydrochloride under hs 29221980 and sitc 51461. as of q4 2014, mannomustine hydrochloride remains us fdas preferred term for this commodity. smiles: c(ccl)nc[c@h]([c@h]([c@@h]([c@@h](cncccl)o)o)o)o.cl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. melphalan hydrochloride. this classification denotes a nitrogen mustard compound with the molecular formula c13h18cl2n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1vxp4v453t, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)- but more generally known as melphalan hydrochloride, which bears us nih compound identifier 4053. most nations, for tariff and trade purposes, schedule melphalan hydrochloride under hs 29224995 and sitc 51465. as of q4 2014, melphalan hydrochloride remains us fdas preferred term for this commodity. melphalan hydrochloride bears us nlm identifiers umls id c0771055 and nci concept code c48002. smiles: c1cc(ccc1c[c@@h](c(=o)o)n)n(cccl)cccl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. metamelfalan. this classification denotes a nitrogen mustard compound with the molecular formula c13h18cl2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3b30xbe7s2, chemically known as l-phenylalanine, 3-(bis(2-chloroethyl)amino)- (9ci) but more generally known as metamelfalan, which bears us nih compound identifier 14152. european medicines agency schedules metamelfalan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08806mig. the term metamelfalan is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). metamelfalan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule metamelfalan under hs 29224995 and sitc 51465. as of q4 2014, metamelfalan remains us fdas preferred term for this commodity. metamelfalan bears us nlm identifiers umls id c0127767 and nci concept code c83946. smiles: clccn(c1cc(cc(n)c(=o)o)ccc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. perfosfamide. this classification denotes a nitrogen mustard compound with the molecular formula c7h15cl2n2o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u880a4fuda, chemically known as 2h-1,3,2-oxazophosphorine, 2-(bis(2-chloroethyl)amino)-4-hydroperoxytetrahydro-, 2-oxide but more generally known as perfosfamide, which bears us nih compound identifier 38347. european medicines agency schedules perfosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09724mig. the term perfosfamide is an international non-proprietary name. perfosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule perfosfamide under hs 29349990 and sitc 51579. as of q4 2014, perfosfamide remains us fdas preferred term for this commodity. perfosfamide bears us nlm identifiers umls id c0163054 and nci concept code c1423. smiles: clccn(p1(=o)occc(oo)n1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. prednimustine. this classification denotes a nitrogen mustard compound with the molecular formula c35h45cl2no6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9403sio2s8, chemically known as 11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(4-(p-(bis(2-chloroethyl)amino)phenyl)butyrate) but more generally known as prednimustine, which bears us nih compound identifier 34457. european medicines agency schedules prednimustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10016mig. the term prednimustine is an international non-proprietary name or inn (see who inn reference publication, volume 28, no. 10 1974, list 14). world health organization schedules prednimustine in its anatomical therapeutic chemical (atc) classification. prednimustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule prednimustine under hs 29372900 and sitc 54153. as of q4 2014, prednimustine remains us fdas preferred term for this commodity. prednimustine bears us nlm identifiers umls id c0032949 and nci concept code c768. smiles: clccn(c1ccc(cccc(=o)occ(=o)c2(o)c3(c(c4c(c(o)c3)c3(c(=cc(=o)c=c3)cc4)c)cc2)c)cc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. sarcolysin. this classification denotes a nitrogen mustard compound with the molecular formula c13h18cl2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier a960m0g5tp, chemically known as l-phenylalanine, 4-(bis(2-chloroethyl)amino)- but more generally known as sarcolysin, which bears us nih compound identifier 4053. european medicines agency schedules sarcolysin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10448mig. the term sarcolysin is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). sarcolysin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule sarcolysin under hs 29224995 and sitc 51465. as of q4 2014, sarcolysin remains us fdas preferred term for this commodity. sarcolysin bears us nlm identifiers umls id c0025444 and nci concept code c61936. smiles: clccn(c1ccc(cc(n)c(=o)o)cc1)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. sufosfamide. this classification denotes an antipsychotic agent with the molecular formula c8h18cln2o5ps, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2208y59985, chemically known as 3-(2-chloroethyl)-2-(2-mesyloxyethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-2-oxide but more generally known as sufosfamide, which bears us nih compound identifier 65805. european medicines agency schedules sufosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10672mig. the term sufosfamide is an international non-proprietary name. sufosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule sufosfamide under hs 29349990 and sitc 51579. as of q4 2014, sufosfamide remains us fdas preferred term for this commodity. sufosfamide bears us nlm identifiers umls id c0075494 and nci concept code c73260. smiles: clccn1p(=o)(occc1)nccos(=o)(=o)c.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. trichlormethine. this classification denotes a nitrogen mustard compound with the molecular formula c6h12cl3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 66wbm7n0nm, chemically known as 2,2, 2-trichlorotriethylamine hydrochloride but more generally known as trichlormethine, which bears us nih compound identifier 5561. european medicines agency schedules trichlormethine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11264mig. the term trichlormethine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). trichlormethine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule trichlormethine under hs 29211980 and sitc 51451. as of q4 2014, trichlormethine remains us fdas preferred term for this commodity. trichlormethine bears us nlm identifiers umls id c0045236 and nci concept code c962. smiles: clccn(cccl)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. trofosfamide. this classification denotes a nitrogen mustard compound with the molecular formula c9h18cl3n2o2p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h64jru6gj0, chemically known as 3-(2-chloroethyl)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin 2-oxide but more generally known as trofosfamide, which bears us nih compound identifier 65702. european medicines agency schedules trofosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11331mig. the term trofosfamide is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules trofosfamide in its anatomical therapeutic chemical (atc) classification. trofosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule trofosfamide under hs 29349990 and sitc 51579. as of q4 2014, trofosfamide remains us fdas preferred term for this commodity. trofosfamide bears us nlm identifiers umls id c0077375 and nci concept code c1268. smiles: clccn1p(=o)(occc1)n(cccl)cccl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. uracil mustard or uramustine. this classification denotes a nitrogen mustard compound with the molecular formula c8h11cl2n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w7kq46gj8u, chemically known as 2,6-dihydroxy-5-bis(2-chloroethyl)aminopyrimidine but more generally known as uracil mustard, which bears us nih compound identifier 6194. european medicines agency schedules uracil mustard in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11383mig. the term uramustine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). smiles: clccn(cccl)c1c(=o)[nh]c(=o)[nh]c1.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. sarcolysin hydrochloride. this classification denotes a nitrogen mustard compound with the molecular formula c13h18cl2n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier geg3q4fc64, chemically known as alanine, 3-(p-(bis(2-chloroethyl)amino)phenyl)-, monohydrochloride, dl-, but more generally known as sarcolysin hydrochloride, which bears us nih compound identifier 4053. european medicines agency schedules sarcolysin hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10448mig. most nations, for tariff purposes, schedule sarcolysin hydrochloride under hs 29224995. smiles: c1cc(ccc1cc(c(=o)o)n)n(cccl)cccl.cl.. "
"alkylating agent nitrogen mustard compounds. this classification denotes cytotoxic chemotherapy agents, many based on c5h11cl2n or mustine, and which chemically closely resemble - or are often identical to - wwi blister agents, substances called nitrogen mustards, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrogen mustard compounds.. spiromustine. this classification denotes a nitrogen mustard compound with the molecular formula c14h23cl2n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j3hb83x76z, chemically known as 1,3-diazaspiro(4.5)decane-2,4-dione, 3-(2-(bis(2-chloroethyl)amino)ethyl)- but more generally known as spiromustine, which bears us nih compound identifier 41945. european medicines agency schedules spiromustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10630mig. the term spiromustine is an international non-proprietary name. spiromustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule spiromustine under hs 29332100 and sitc 51572. as of q4 2014, spiromustine remains us fdas preferred term for this commodity. spiromustine bears us nlm identifiers umls id c0075019 and nci concept code c1233. smiles: clccn(ccn1c(=o)c2(nc1=o)ccccc2)cccl.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. . "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. carmustine. this classification denotes a nitrosourea compound and dna adduct forming agent with the molecular formula c5h9cl2n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u68wg3173y, chemically known as 1,3-bis(beta-chloroethyl)-1-nitrosourea but more generally known as carmustine, which bears us nih compound identifier 2578. european medicines agency schedules carmustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06132mig. the term carmustine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules carmustine in its anatomical therapeutic chemical (atc) classification. carmustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule carmustine under hs 29241900 and sitc 51471. as of q4 2014, carmustine remains us fdas preferred term for this commodity. carmustine bears us nlm identifiers umls id c0007257 and nci concept code c349. smiles: clccn(n=o)c(=o)ncccl.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. ditiomustine. this classification denotes a nitrosourea compound with the molecular formula c10h18cl2n6o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 810o95170j, chemically known as 5,6-dithia-2,9,11-triazatridecanamide, 13-chloro-n-(2-chloroethyl)-n,11-dinitroso-10-oxo- but more generally known as ditiomustine, which bears us nih compound identifier 127547. european medicines agency schedules ditiomustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06334mig. the term ditiomustine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). ditiomustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ditiomustine under hs 29309085 and sitc 51549. as of q4 2014, ditiomustine remains us fdas preferred term for this commodity. ditiomustine bears us nlm identifiers umls id c1880367 and nci concept code c65443. smiles: c(cssccnc(=o)n(cccl)n=o)nc(=o)n(cccl)n=o.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. ecomustine. this classification denotes a nitrosourea compound with the molecular formula c10h18cln3o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7369r4j7s2, chemically known as methyl 3-(3-(2-chloroethyl)-3-nitrosoureido)-2,3-dideoxy-alpha-d-arabino-hexopyranoside but more generally known as ecomustine, which bears us nih compound identifier 65855. european medicines agency schedules ecomustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06449mig. the term ecomustine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). ecomustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ecomustine under hs 29329970 and sitc 51569. as of q4 2014, ecomustine remains us fdas preferred term for this commodity. ecomustine bears us nlm identifiers umls id c0056637 and nci concept code c77371. smiles: coc1cc(c(c(o1)co)o)nc(=o)n(cccl)n=o.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. fotemustine. this classification denotes a nitrosourea compound with the molecular formula c9h19cln3o5p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gq7jl9p5i2, chemically known as phosphonic acid, (1-((((2-chloroethyl)nitrosoamino)carbonyl)amino)ethyl)-, diethyl ester but more generally known as fotemustine, which bears us nih compound identifier 104799. european medicines agency schedules fotemustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07809mig. the term fotemustine is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules fotemustine in its anatomical therapeutic chemical (atc) classification. fotemustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, fotemustine remains us fdas preferred term for this commodity. fotemustine bears us nlm identifiers umls id c0060696 and nci concept code c1106. smiles: clccn(n=o)c(=o)nc(p(=o)(occ)occ)c.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. galamustine. this classification denotes a nitrogen mustard compound with the molecular formula c10h19cl2no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p771fdq1wj, chemically known as d-galactopyranose, 6-(bis(2-chloroethyl)amino)-6-deoxy- but more generally known as galamustine, which bears us nih compound identifier 65891. european medicines agency schedules galamustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07869mig. the term galamustine is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). galamustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule galamustine under hs 29329970 and sitc 51569. as of q4 2014, galamustine remains us fdas preferred term for this commodity. galamustine bears us nlm identifiers umls id c2700228 and nci concept code c76791. smiles: c(ccl)n(cccl)cc1c(c(c(c(o1)o)o)o)o.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. lomustine. this classification denotes a nitrosourea compound with the molecular formula c9h16cln3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7brf0z81kg, chemically known as 1-nitrosourea, 1-(2-chloroethyl)-3-cyclohexyl- but more generally known as lomustine, which bears us nih compound identifier 3950. european medicines agency schedules lomustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08567mig. the term lomustine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). world health organization schedules lomustine in its anatomical therapeutic chemical (atc) classification. lomustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule lomustine under hs 29242190 and sitc 51473. as of q4 2014, lomustine remains us fdas preferred term for this commodity. lomustine bears us nlm identifiers umls id c0699181 and nci concept code c617. smiles: clccn(n=o)c(=o)nc1ccccc1.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. nimustine. this classification denotes a nitrosourea compound with the molecular formula c9h13cln6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0s726v972k, chemically known as urea, n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(2-chloroethyl)-n-nitroso- but more generally known as nimustine, which bears us nih compound identifier 39214. european medicines agency schedules nimustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09299mig. the term nimustine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules nimustine in its anatomical therapeutic chemical (atc) classification. nimustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nimustine under hs 29335995 and sitc 51576. as of q4 2014, nimustine remains us fdas preferred term for this commodity. nimustine bears us nlm identifiers umls id c0028096 and nci concept code c693. smiles: clccn(n=o)c(=o)ncc1c(nc(nc1)c)n.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. cyclophosphamide anhydrous. this classification denotes a nitrogen mustard compound and immunosuppressant with the molecular formula c7h15cl2n2o2p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6uxw23996m, chemically known as 2h-1,3,2-oxazaphosphorin-2-amine, n,n-bis(2-chloroethyl)tetrahydro-, 2-oxide, but more generally known as cyclophosphamide anhydrous, which bears us nih compound identifier 2907. european medicines agency schedules cyclophosphamide anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06859mig. most nations, for tariff purposes, schedule cyclophosphamide anhydrous under hs 29349990. cyclophosphamide anhydrous bears us nlm identifiers umls id c1880207 and nci concept code c61694. smiles: c1cnp(=o)(oc1)n(cccl)cccl.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. neptamustine or pentamustine. this classification denotes a nitrosourea compound, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vb67o9fbgm. european medicines agency schedules neptamustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09201mig. neptamustine generally arises in the molecular formula c8h16cln3o2. the term neptamustine is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23.) neptamustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. neptamustine or pentamustine bears us nlm identifiers umls id c1882315 and nci concept code c66341. smiles: clccn(n=o)c(=o)ncc(c)(c)c.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. nimustine hydrochloride. this classification denotes a nitrosourea compound with the molecular formula c9h13cln6o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dfr965wkbu, chemically known as urea, n-((4-amino-2-methyl-5-pyrimidinyl)methyl)-n-(2-chloroethyl)-n-nitroso- but more generally known as nimustine hydrochloride, which bears us nih compound identifier 39214. european medicines agency schedules nimustine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03435mig. most nations, for tariff and trade purposes, schedule nimustine hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, nimustine hydrochloride remains us fdas preferred term for this commodity. nimustine hydrochloride bears us nlm identifiers umls id c0771987 and nci concept code c95325. smiles: cc1ncc(c(n1)n)cnc(=o)n(cccl)n=o.cl.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. ranimustine. this classification denotes a nitrosourea compound with the molecular formula c10h18cln3o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ryh2t97j77, chemically known as glucopyranoside, methyl-6-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-6-deoxy-, alpha-d- but more generally known as ranimustine, which bears us nih compound identifier 71741. european medicines agency schedules ranimustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10256mig. the term ranimustine is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules ranimustine in its anatomical therapeutic chemical (atc) classification. ranimustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ranimustine under hs 29329970 and sitc 51569. as of q4 2014, ranimustine remains us fdas preferred term for this commodity. ranimustine bears us nlm identifiers umls id c0243666 and nci concept code c1515. smiles: coc1c(c(c(c(o1)cnc(=o)n(cccl)n=o)o)o)o.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. semustine. this classification denotes a nitrosourea compound, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6yy7t1t567. european medicines agency schedules semustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10482mig. semustine generally arises in the molecular formula c10h18cln3o2. the term semustine is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12.) semustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, semustine remains us fdas preferred term for this commodity. semustine bears us nlm identifiers umls id c0036637 and nci concept code c827. most nations, for tariff and trade purposes, schedule semustine under hs 29242100 and sitc 51473. smiles: cc1ccc(cc1)nc(=o)n(cccl)n=o.. "
"alkylating agent nitrosourea compounds. this classification denotes compounds that bear a nitroso (r-no) group and a urea, substances called nitrosoureas, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent nitrosourea compounds.. tauromustine. this classification denotes a nitrosourea compound with the molecular formula c7h15cln4o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 511f69k76y, chemically known as 2-((((2-chloroethyl)nitrosoamino)carbonyl)amino)-n,n-dimethylethanesulfonamide but more generally known as tauromustine, which bears us nih compound identifier 55456. european medicines agency schedules tauromustine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10838mig. the term tauromustine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). tauromustine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tauromustine under hs 29350090 and sitc 51580. as of q4 2014, tauromustine remains us fdas preferred term for this commodity. tauromustine bears us nlm identifiers umls id c0044133 and nci concept code c954. smiles: clccn(n=o)c(=o)nccs(=o)(=o)n(c)c.. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. . "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. carboplatin. this classification denotes a platinum compound with the molecular formula c6h6o4.pt.2h3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bg3f62ond5, chemically known as cis-diammine(1,1-cyclobutanedicarboxylato) platinum but more generally known as carboplatin, which bears us nih compound identifier 38904. european medicines agency schedules carboplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06614mig. the term carboplatin is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). world health organization schedules carboplatin in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule carboplatin under hs 28439090 and sitc 52432. as of q4 2014, carboplatin remains us fdas preferred term for this commodity. carboplatin bears us nlm identifiers umls id c0079083 and nci concept code c1282. smiles: [pt]1[oh]c(=o)c2(ccc2)c(=o)[oh]1.n.n.. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. cisplatin. this classification denotes a radiosensitizing agent and platinum compound with the molecular formula 2cl.pt.2h3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q20q21q62j, chemically known as platinum(ii), diamminedichloro-, trans- but more generally known as cisplatin, which bears us nih compound identifier 2767. european medicines agency schedules cisplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07483mig. the term cisplatin is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules cisplatin in its anatomical therapeutic chemical (atc) classification. cisplatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cisplatin under hs 28439000 and sitc 52432. smiles: n.n.[cl-].[cl-].[pt+2].. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. enloplatin. this classification denotes a platinum compound with the molecular formula c7h16n2o.c6h6o4.pt, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c7ht2io79h, chemically known as platinum, (1,1-cyclobutanedicarboxylato(2-))(tetrahydro-4h-pyran-4,4-dimethanamine-n,n)-, (sp-4-2)- but more generally known as enloplatin, which bears us nih compound identifier 68737. european medicines agency schedules enloplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06536mig. the term enloplatin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). enoplatin bears nci cuid c95323 and umls id c0165431. enloplatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule cisplatin under hs 28439000 and sitc 52432. smiles: c1cc(c1)(c(=o)[o-])c(=o)[o-].c1coccc1(cn)cn.[pt+2].. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. nedaplatin. this classification denotes a platinum compound with the molecular structure c2h2o3.pt.2h3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 8uq3w6jxan chemically known as cis-diammine(glycolato-o(sup 1),o(sup 2))platinum, but more commonly known as nedaplatin, which bears us nih compound identifier 72120. european medicines agency schedules nedaplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09178mig. the term nedaplatin is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). bears nci cuid c61099 and umls id c0093999. most nations, for tariff and trade purposes, schedule nedaplatin under hs 28439000 and sitc 52432. smiles: c(c(=o)[o-])[o-].n.n.[pt+2].. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. oxaliplatin. this classification denotes a platinum compound with the molecular formula c8h14n2o4pt, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 04zr38536j, chemically known as (sp-4-3-(cis))-(1,2-cyclohexanediamine-n,n)(ethanedioato(2-)-o,o)platinum but more generally known as oxaliplatin, which bears us nih compound identifier 77994. european medicines agency schedules oxaliplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09490mig. the term oxaliplatin is an international non-proprietary name. world health organization schedules oxaliplatin in its anatomical therapeutic chemical (atc) classification. oxaliplatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule oxaliplatin under hs 28439090 and sitc 52432. as of q4 2014, oxaliplatin remains us fdas preferred term for this commodity. oxaliplatin bears us nlm identifiers umls id c0069717 and nci concept code c1181. smiles: [pt].oc(=o)c(=o)o.nc1c(n)cccc1.. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. satraplatin. this classification denotes a platinum compound with the molecular formula c6h13n.2c2h3o2.2cl.pt.h3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8d7b37t28g, chemically known as platinum, bis(acetato-o)amminedichloro(cyclohexanamine)-, (oc-6-43)- but more generally known as satraplatin, which bears us nih compound identifier 123974. european medicines agency schedules satraplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04333mig. the term satraplatin is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). world health organization schedules satraplatin in its anatomical therapeutic chemical (atc) classification. as of q4 2014, satraplatin remains us fdas preferred term for this commodity. satraplatin bears us nlm identifiers umls id c1142934 and nci concept code c1493. most nations, for tariff and trade purposes, schedule satraplatin under hs 28439090 and sitc 52432. smiles: cc(=o)[o-].cc(=o)[o-].c1ccc(cc1)n.n.[cl-].[cl-].[pt+4].. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. zeniplatin. this classification denotes a platinum compound with the molecular formula c6h6o4.c5h14n2o2.pt, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 40zq0a17it, chemically known as platinum, (2,2-bis(aminomethyl)-1,3-propanediol-n,n)(1,1-cyclobutanedicarboxylato(2-))-, (sp-4-2)- but more generally known as zeniplatin, which bears us nih compound identifier 60505. european medicines agency schedules zeniplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00146mig. the term zeniplatin is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). zeniplatin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, zeniplatin remains us fdas preferred term for this commodity. zeniplatin bears us nlm identifiers umls id c0055849 and nci concept code c1053. most nations, for tariff and trade purposes, schedule zeniplatin under hs 28439090 and sitc 52432. smiles: c1cc(c1)(c(=o)[o-])c(=o)[o-].c(c(cn)(co)co)n.[pt+2].. "
"alkylating agent organoplatinum compounds. this classification denotes organic compounds which contain as an integral part of the molecule the metal platinum, substances called organoplatinum compounds, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent organoplatinum compounds.. picoplatin. this classification denotes a platinum compound with the molecular structure c6h7n.2cl.pt.h3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, b5tan0l720 chemically known as platinum, amminedichloro(2-methylpyridine)-, (sp-4-3)-, but more commonly known as picoplatin, which bears us nih compound identifier 177358. european medicines agency schedules picoplatin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub29605. the term picoplatin is an international non-proprietary name or inn (see who inn reference publication, volume 17, no. 2, 2003, list 49). picoplatin bears us nlm identifiers umls id c0671135 and nci concept code c48416. most nations, for tariff and trade purposes, schedule picoplatin under hs 28439000 and sitc 52432. smiles: cc1ccccn1.n.[cl-].[cl-].[pt+2].. "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. . "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. droloxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c26h29no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0m67u6z98f, chemically known as phenol, 3-(1-(4-(2-(dimethylamino)ethoxy)phenyl)-2-phenyl-1-butenyl)-, (e)- but more generally known as droloxifene, which bears us nih compound identifier 3033767. european medicines agency schedules droloxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06405mig. the term droloxifene is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). droloxifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule droloxifene under hs 29221980 and sitc 51461. as of q4 2014, droloxifene remains us fdas preferred term for this commodity. droloxifene bears us nlm identifiers umls id c0047498 and nci concept code c969. smiles: o(c1ccc(/c(=c(/cc)c2ccccc2)c2cc(o)ccc2)cc1)ccn(c)c.. "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. idoxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c28h30ino, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 456uxe9867, chemically known as pyrrolidine, 1-(2-(4-(1-(4-iodophenyl)-2-phenyl-1-butenyl)phenoxy)ethyl)-, (e)- but more generally known as idoxifene, which bears us nih compound identifier 3034011. european medicines agency schedules idoxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08116mig. the term idoxifene is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). idoxifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule idoxifene under hs 29339990 and sitc 51577. as of q4 2014, idoxifene remains us fdas preferred term for this commodity. idoxifene bears us nlm identifiers umls id c0139560 and nci concept code c1406. smiles: ic1ccc(c(=c(\\cc)c2ccccc2)/c2ccc(occn3cccc3)cc2)cc1.. "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. ospemifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c24h23clo2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b0p231ilbk, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)ethanol but more generally known as ospemifene, which bears us nih compound identifier 3036505. european medicines agency schedules ospemifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33020. the term ospemifene is an international non-proprietary name or inn (see who inn reference publication, volume 16., no. 1.2002, list 47). most nations, for tariff and trade purposes, schedule ospemifene under hs 29094990 and sitc 51617. as of q4 2014, ospemifene remains us fdas preferred term for this commodity. ospemifene bears us nlm identifiers umls id c1313616 and nci concept code c76958. smiles: clcc/c(=c(/c1ccc(occo)cc1)c1ccccc1)c1ccccc1.. "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. raloxifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c28h27no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yx9162eo3i, chemically known as methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)- but more generally known as raloxifene, which bears us nih compound identifier 5035. european medicines agency schedules raloxifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10243mig. the term raloxifene is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules raloxifene in its anatomical therapeutic chemical (atc) classification. raloxifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule raloxifene under hs 29349990 and sitc 51579. as of q4 2014, raloxifene remains us fdas preferred term for this commodity. raloxifene bears us nlm identifiers umls id c0244404 and nci concept code c1518. smiles: s1c(c(c2c1cc(o)cc2)c(=o)c1ccc(occn2ccccc2)cc1)c1ccc(o)cc1.. "
"alkylating agent stilbenes. this classification denotes organic compounds that contain the functional group 1,2-diphenylethylene, substances called stilbenes, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent stilbenes.. toremifene. this classification denotes a selective estrogen receptor modulator with the molecular formula c26h28clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7nfe54o27t, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylamine citrate (1:1) but more generally known as toremifene, which bears us nih compound identifier 3005572. european medicines agency schedules toremifene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11197mig. the term toremifene is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules toremifene in its anatomical therapeutic chemical (atc) classification. toremifene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule toremifene under hs 29221980 and sitc 51461. as of q4 2014, toremifene remains us fdas preferred term for this commodity. toremifene bears us nlm identifiers umls id c0076836 and nci concept code c1256. smiles: clcc/c(=c(/c1ccc(occn(c)c)cc1)c1ccccc1)c1ccccc1.oc(cc(=o)o)(cc(=o)o)c(=o)o.. "
"alkylating agent triazines. this classification denotes substances consisting of heterocyclic rings that contain three nitrogen atoms at 1,2,4 or 1,3,5 or 2,4,6, substances called triazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent triazines.. . "
"alkylating agent triazines. this classification denotes substances consisting of heterocyclic rings that contain three nitrogen atoms at 1,2,4 or 1,3,5 or 2,4,6, substances called triazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent triazines.. amifostine. this classification denotes a cytoprotective agent with the molecular formula c5h15n2o3ps.3h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m487qf2f4v, chemically known as 2-((3-aminopropyl)amino)-ethanethiol, dihydrogen phosphate ester (9ci) but more generally known as amifostine, which bears us nih compound identifier 2141. amifostine most often comes in base, ethiofos, and hyrdate forms. european medicines agency schedules amifostine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12846mig. world health organization schedules amifostine in its anatomical therapeutic chemical (atc) classification. amifostine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule amifostine under hs 29309085 and sitc 51549. as of q4 2014, amifostine remains us fdas preferred term for this commodity. amifostine bears us nlm identifiers umls id c0591467 and nci concept code c488. smiles: s(p(=o)(o)o)ccncccn.. "
"alkylating agent triazines. this classification denotes substances consisting of heterocyclic rings that contain three nitrogen atoms at 1,2,4 or 1,3,5 or 2,4,6, substances called triazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent triazines.. temozolomide. this classification denotes a triazene compound and gonadotropin releasing hormone inhibitor with the molecular formula c6h6n6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yf1k15m17y, chemically known as 3,4-dihydro-3-methyl-4-oxoimidazo(5,1-d)-as-tetrazine-8-carboxamide but more generally known as temozolomide, which bears us nih compound identifier 5394. european medicines agency schedules temozolomide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10889mig. the term temozolomide is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules temozolomide in its anatomical therapeutic chemical (atc) classification. temozolomide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule temozolomide under hs 29339990 and sitc 51577. as of q4 2014, temozolomide remains us fdas preferred term for this commodity. temozolomide bears us nlm identifiers umls id c0076080 and nci concept code c1244. smiles: o=c1n2c(nnn1c)c(nc2)c(=o)n.. "
"alkylating agent amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amines.. . "
"alkylating agent amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amines.. altretamine. this classification denotes an ethylenimine compound with the molecular formula c9h18n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q8bih59o7h, chemically known as 2,4,6-tris(dimethylamino)-s-triazine but more generally known as altretamine, which bears us nih compound identifier 2123. european medicines agency schedules altretamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05382mig. the term altretamine is an international non-proprietary name or inn (see who inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules altretamine in its anatomical therapeutic chemical (atc) classification. altretamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule altretamine under hs 29336980 and sitc 51576. as of q4 2014, altretamine remains us fdas preferred term for this commodity. altretamine bears us nlm identifiers umls id c0019453 and nci concept code c544. smiles: n(c1nc(n(c)c)nc(n(c)c)n1)(c)c.. "
"alkylating agent amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent amines.. altretamine hydrochloride. this classification denotes an ethylenimine compound with the molecular formula c9h18n6.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30fq7qg6vm. most nations, for tariff and trade purposes, schedule altretamine hydrochloride under hs 29336980. as of q4 2014, altretamine hydrochloride remains us fdas preferred term for this commodity. smiles: cn(c)c1nc(nc(n1)n(c)c)n(c)c.cl.. "
"alkylating agent alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alcohols.. . "
"alkylating agent alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alcohols.. defosfamide. this classification denotes a nitrogen mustard compound with the molecular formula c9h20cl3n2o3p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0w33021s30, chemically known as phosphorodiamidic acid, n,n-bis(2-chloroethyl)-n-(3-hydroxypropyl)-, (2-chloroethyl) ester but more generally known as defosfamide, which bears us nih compound identifier 71164. european medicines agency schedules defosfamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06944mig. the term defosfamide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). defosfamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule defosfamide under hs 29299000 and sitc 51489. as of q4 2014, defosfamide remains us fdas preferred term for this commodity. defosfamide bears us nlm identifiers umls id c1511757 and nci concept code c2069. smiles: clccn(p(=o)(occcl)nccco)cccl.. "
"alkylating agent alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alcohols.. mitobronitol. this classification denotes a biomaterial with the molecular formula c6h12br2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5up30yed7n, chemically known as 1,2,3,4,5,6-hexanehexol but more generally known as mitobronitol, which bears us nih compound identifier 453. european medicines agency schedules mitobronitol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09001mig. the term mitobronitol is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules mitobronitol in its anatomical therapeutic chemical (atc) classification. mitobronitol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mitobronitol under hs 29055999 and sitc 51229. as of q4 2014, mitobronitol remains us fdas preferred term for this commodity. mitobronitol bears us nlm identifiers umls id c0026236 and nci concept code c659. smiles: oc(c(o)c(o)co)c(o)co.. "
"alkylating agent alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alcohols.. mitolactol. this classification denotes a radiosensitizing agent and epoxide compound with the molecular formula c6h12br2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lj2p1sik8y, chemically known as 1,6-dideoy-1,6-dibromo-d-mannitol but more generally known as mitolactol, which bears us nih compound identifier 4208. european medicines agency schedules mitolactol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09005mig. the term mitolactol is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). mitolactol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mitolactol under hs 29055999 and sitc 51229. as of q4 2014, mitolactol remains us fdas preferred term for this commodity. mitolactol bears us nlm identifiers umls id c0026252 and nci concept code c662. smiles: brcc(o)c(o)c(o)c(o)cbr.. "
"alkylating agent alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alcohols.. ritrosulfan. this classification denotes an antineoplastic alkylating agent with the molecular formula c10h24n2o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yiy0662kx9, chemically known as 3,14-dioxa-2,15-dithia-6,11-diazahexadecane-8,9-diol, 2,2,15,15-tetraoxide, (r*,s*)- (9ci) but more generally known as ritrosulfan, which bears us nih compound identifier 20107. european medicines agency schedules ritrosulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10344mig. the term ritrosulfan is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). ritrosulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule ritrosulfan under hs 29221980 and sitc 51461. as of q4 2014, ritrosulfan remains us fdas preferred term for this commodity. ritrosulfan bears us nlm identifiers umls id c0073401 and nci concept code c75294. smiles: cs(=o)(=o)occncc(c(cnccos(=o)(=o)c)o)o.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. . "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. azatepa. this classification denotes an ethylenimine compound with the molecular formula c8h14n5ops, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d57i4z650l, chemically known as p,p-bis(1-aziridinyl)-n-ethyl-n-1,3,4-thiadiazol-2-ylphosphinic amide but more generally known as azatepa, which bears us nih compound identifier 31321. european medicines agency schedules azatepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05646mig. the term azatepa is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). azatepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule azatepa under hs 29349990 and sitc 51579. smiles: ccn(c1=nn=cs1)p(=o)(n2cc2)n3cc3.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. benzodepa. this classification denotes an ethylenimine compound with the molecular formula c12h16n3o3p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q30t24ym3f, chemically known as carbamic acid, (bis(1-aziridinyl)phosphinyl)-, phenylmethyl ester but more generally known as benzodepa, which bears us nih compound identifier 16111. european medicines agency schedules benzodepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05758mig. the term benzodepa is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). benzodepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule benzodepa under hs 29339990 and sitc 51577. as of q4 2014, benzodepa remains us fdas preferred term for this commodity. benzodepa bears us nlm identifiers umls id c0608440 and nci concept code c1759. smiles: c1cn1p(=o)(nc(=o)occ2=cc=cc=c2)n3cc3.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. diaziquone. this classification denotes an ethylenimine compound with the molecular formula c16h20n4o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier fql5eup13w, chemically known as 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone but more generally known as diaziquone, which bears us nih compound identifier 42616. european medicines agency schedules diaziquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07070mig. the term diaziquone is an international non-proprietary name. diaziquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule diaziquone under hs 29339990 and sitc 51577. as of q4 2014, diaziquone remains us fdas preferred term for this commodity. diaziquone bears us nlm identifiers umls id c0113600 and nci concept code c1363. smiles: o=c1c(=c(nc(=o)occ)c(=o)c(=c1nc(=o)occ)n1cc1)n1cc1.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. meturedepa. this classification denotes an ethylenimine compound with the molecular formula c11h22n3o3p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 43255365if, chemically known as ethyl n-(bis(2,2-dimethylethylenimido)phosphoro)carbamate but more generally known as meturedepa, which bears us nih compound identifier 15456. european medicines agency schedules meturedepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08923mig. the term meturedepa is an international non-proprietary name. meturedepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule meturedepa under hs 29339990 and sitc 51577. as of q4 2014, meturedepa remains us fdas preferred term for this commodity. meturedepa bears us nlm identifiers umls id c0609940 and nci concept code c1760. smiles: ccoc(=o)np(=o)(n1cc1(c)c)n2cc2(c)c.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. pumitepa. this classification denotes an antineoplastic alkylating agent with the molecular formula c12h19n8op, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7ayy495re0, chemically known as p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methylpurin-6-yl)phosphinic amide but more generally known as pumitepa, which bears us nih compound identifier 68669. european medicines agency schedules pumitepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10160mig. the term pumitepa is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). pumitepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pumitepa under hs 29335995 and sitc 51576. as of q4 2014, pumitepa remains us fdas preferred term for this commodity. pumitepa bears us nlm identifiers umls id c0060632 and nci concept code c73239. smiles: cn1c=nc2=c1c(=nc(=n2)n(c)c)np(=o)(n3cc3)n4cc4.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. thiotepa. this classification denotes an ethylenimine compound with the molecular formula c6h12n3ps, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 905z5w3gkh, chemically known as 1,1,1-phosphinothioylidynetrisaziridine but more generally known as thiotepa, which bears us nih compound identifier 5453. european medicines agency schedules thiotepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10985mig. the term thiotepa is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules thiotepa in its anatomical therapeutic chemical (atc) classification. thiotepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule thiotepa under hs 29339990 and sitc 51577. as of q4 2014, thiotepa remains us fdas preferred term for this commodity. thiotepa bears us nlm identifiers umls id c0039871 and nci concept code c875. smiles: s=p(n1cc1)(n1cc1)n1cc1.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. tretamine or triethylenemelamine. this classification denotes an ethylenimine compound with the molecular formula c9h12n6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f7iy6hzg9d, chemically known as 2,4,6-tris(ethylenimino)-s-triazine but more generally known as tretamine, which bears us nih compound identifier 5799. european medicines agency schedules tretamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11243mig. the term tretamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). tretamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. tretamine or triethylenemelamine bears us nlm identifiers umls id c0040975 and nci concept code c29858. smiles: n1(cc1)c1nc(n2cc2)nc(n2cc2)n1.. "
"alkylating agent aziridines. this classification denotes saturated azacyclopropane compounds, called aziridines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent aziridines.. triaziquone. this classification denotes an ethylenimine compound with the molecular formula c12h13n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f3d5d9p25i, chemically known as 2,3,5-tris-ethyleniminoquinone-(1,4) but more generally known as triaziquone, which bears us nih compound identifier 6235. european medicines agency schedules triaziquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11257mig. the term triaziquone is an international non-proprietary name. world health organization schedules triaziquone in its anatomical therapeutic chemical (atc) classification. triaziquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule triaziquone under hs 29339990 and sitc 51577. as of q4 2014, triaziquone remains us fdas preferred term for this commodity. triaziquone bears us nlm identifiers umls id c0040878 and nci concept code c903. smiles: c1cn1c2=cc(=o)c(=c(c2=o)n3cc3)n4cc4.. "
"alkylating agent carbamates. this classification denotes derivatives of carbamic acid (h2nc(=o)oh) such as n-substituted and o-substituted carbamic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkylating agent carbamates.. . "
"alkylating agent carbamates. this classification denotes derivatives of carbamic acid (h2nc(=o)oh) such as n-substituted and o-substituted carbamic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkylating agent carbamates.. carboquone. this classification denotes an ethylenimine compound with the molecular formula c15h19n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1cb0hbt12c, chemically known as 2,5-cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-6 (2-hydroxy-1-methoxyethyl)-3-methyl-, carbamate but more generally known as carboquone, which bears us nih compound identifier 2569. european medicines agency schedules carboquone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06616mig. the term carboquone is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules carboquone in its anatomical therapeutic chemical (atc) classification. carboquone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule carboquone under hs 29339990 and sitc 51577. as of q4 2014, carboquone remains us fdas preferred term for this commodity. carboquone bears us nlm identifiers umls id c0006971 and nci concept code c342. smiles: o(c(c1=c(n2cc2)c(=o)c(=c(n2cc2)c1=o)c)coc(=o)n)c.. "
"alkylating agent carbamates. this classification denotes derivatives of carbamic acid (h2nc(=o)oh) such as n-substituted and o-substituted carbamic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkylating agent carbamates.. enpromate. this classification denotes a nitrogen mustard compound with the molecular formula c22h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hbs2850e4h, chemically known as 1,1-diphenyl-2-propynyl-n-cyclohexylcarbamate but more generally known as enpromate, which bears us nih compound identifier 24912. european medicines agency schedules enpromate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06548mig. the term enpromate is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). enpromate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule enpromate under hs 29242995 and sitc 51479. as of q4 2014, enpromate remains us fdas preferred term for this commodity. enpromate bears us nlm identifiers umls id c0050514 and nci concept code c83689. smiles: o(c(=o)nc1ccccc1)c(c1ccccc1)(c1ccccc1)c#c.. "
"alkylating agent carbamates. this classification denotes derivatives of carbamic acid (h2nc(=o)oh) such as n-substituted and o-substituted carbamic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent alkylating agent carbamates.. uredepa. this classification denotes an ethylenimine compound with the molecular formula c7h14n3o3p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9v30jz75ab, chemically known as carbamic acid, (bis(1-aziridinyl)phosphinyl)-, ethyl ester but more generally known as uredepa, which bears us nih compound identifier 9332. european medicines agency schedules uredepa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11385mig. the term uredepa is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). uredepa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule uredepa under hs 29339990 and sitc 51577. as of q4 2014, uredepa remains us fdas preferred term for this commodity. uredepa bears us nlm identifiers umls id c1519821 and nci concept code c2072. smiles: p(=o)(n1cc1)(n1cc1)nc(=o)occ.. "
"alkylating agent carboxylic acids. this classification denotes organic compounds containing the carboxy group (-cooh), substances called carboxylic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent carboxylic acids.. . "
"alkylating agent carboxylic acids. this classification denotes organic compounds containing the carboxy group (-cooh), substances called carboxylic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent carboxylic acids.. aceglatone. this classification denotes a glucuronidase inhibitor with the molecular formula c10h10o8, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 347q3ooj13, chemically known as 2,5-di-o-acetyl-d-glucosaccharo-1,4:6,3-dilactone but more generally known as aceglatone, which bears us nih compound identifier 1980. european medicines agency schedules aceglatone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05207mig. the term aceglatone is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). aceglatone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, aceglatone remains us fdas preferred term for this commodity. aceglatone bears us nlm identifiers umls id c0050406 and nci concept code c984. smiles: cc(=o)oc1c2c(c(c(=o)o2)oc(=o)c)oc1=o.. "
"alkylating agent carboxylic acids. this classification denotes organic compounds containing the carboxy group (-cooh), substances called carboxylic acids, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent carboxylic acids.. azelaic acid. this classification denotes an anti-infective agent with the molecular formula c9h16o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f2vw3d43yt, chemically known as 1,9-nonanedioic acid but more generally known as azelaic acid, which bears us nih compound identifier 2266. european medicines agency schedules azelaic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05648mig. the term azelaic acid is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules azelaic acid in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule azelaic acid under hs 29171390 and sitc 51389. as of q4 2014, azelaic acid remains us fdas preferred term for this commodity. azelaic acid bears us nlm identifiers umls id c0052761 and nci concept code c47407. smiles: c(cccc(=o)o)cccc(=o)o.. "
"alkylating agent piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent piperazines.. . "
"alkylating agent piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent piperazines.. pipobroman. this classification denotes an antineoplastic alkylating agent with the molecular formula c10h16br2n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6q99rdt97r, chemically known as 1,4-bis(3-bromopropionyl)piperazine but more generally known as pipobroman, which bears us nih compound identifier 4842. european medicines agency schedules pipobroman in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09875mig. the term pipobroman is an international non-proprietary name. world health organization schedules pipobroman in its anatomical therapeutic chemical (atc) classification. pipobroman is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pipobroman under hs 29335995 and sitc 51576. as of q4 2014, pipobroman remains us fdas preferred term for this commodity. pipobroman bears us nlm identifiers umls id c0031965 and nci concept code c750. smiles: c1cn(ccn1c(=o)ccbr)c(=o)ccbr.. "
"alkylating agent piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent piperazines.. piposulfan. this classification denotes an alkylsulfonate compound with the molecular formula c12h22n2o8s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vy5dpn1tdu, chemically known as 1,4-dihydracryloylpiperazine dimethanesulfonate (ester) but more generally known as piposulfan, which bears us nih compound identifier 17458. european medicines agency schedules piposulfan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09878mig. the term piposulfan is an international non-proprietary name. piposulfan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule piposulfan under hs 29335995 and sitc 51576. as of q4 2014, piposulfan remains us fdas preferred term for this commodity. piposulfan bears us nlm identifiers umls id c0663942 and nci concept code c1783. smiles: s(=o)(=o)(occc(=o)n1ccn(cc1)c(=o)ccos(=o)(=o)c)c.. "
"alkylating agent cytokines. this classification denotes immuno-proteins that affect cell signaling, and include proteins such as chemokines, interferons, interleukins, and lymphokines, and that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent cytokines.. . "
"alkylating agent cytokines. this classification denotes immuno-proteins that affect cell signaling, and include proteins such as chemokines, interferons, interleukins, and lymphokines, and that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent cytokines.. irofulven. this classification denotes an antineoplastic alkylating agent with the molecular formula c15h18o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 6b799ih05a, chemically known as spiro(cyclopropane-1,5(5h)-inden)-7(6h)-one, 6-hydroxy-3-(hydroxymethyl)-2,4,6-trimethyl-, (r)- but more generally known as irofulven, which bears u.s. national institutes of health compound identifier 148189. european medicines agency schedules irofulven in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02773mig. the term irofulven is an international non-proprietary name. most nations schedule irofulven under hs 29144090 and sitc 51629. as of q4 2014, irofulven remains the us fda preferred term for this commodity. irofulven bears us nlm identifiers umls id c0532362 and nci concept code c1717. smiles: oc1(c2(cc2)c(=c2c(=cc(=c2co)c)c1=o)c)c.. "
"alkylating agent cytokines. this classification denotes immuno-proteins that affect cell signaling, and include proteins such as chemokines, interferons, interleukins, and lymphokines, and that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term alkylating agent cytokines.. oprelvekin. this classification denotes a therapeutic interleukin with the molecular formula c854h1411n253o235s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) hm5641ga6f, more generally known as oprelvekin. european medicines agency schedules oprelvekin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14704mig. the term oprelvekin is an international non-proprietary name or inn. see world health organization inn reference publication, volume 11, no. 3 1997, list 38. oprelvekin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oprelvekin under hs 30021095 and sitc 54163. as of q4 2014, oprelvekin remains the us fda preferred term for this commodity. oprelvekin bears us nlm identifiers umls id c0537670 and nci concept code c1303.. "
